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 Abstract 
 
 
Introduction 
The gut barrier protects the body against harmful substances and microbes. It consists of  the gut 
mucosa, the immune system and the microflora. Crosstalk between these elements determines 
the mucosal response to stresses. In this thesis, we have studied how the gut mucosa in a living 
organism reacts to two stress stimuli: Salmonella and fructo-oligosaccharides (FOS). For this we 
used transcriptome analysis.  
Results 
Changes in detoxification, glucose, lipid, peptide and ion transport and proteolysis were part of  
the early gene expression responses of  the rat intestinal mucosa. Neither Salmonella nor FOS 
altered the expression of  barrier related genes such as tight junction, mucin or toll like receptor 
genes. In contrast, energy metabolism was clearly affected by FOS and could be responsible for 
the increased permeability induced by FOS. The gene expression response to Salmonella in rats 
was subtle, this differs from the responses observed in cell culture studies. In contrast to the 
general expectation, the colon was as much a target for Salmonella as the ileum. FOS increased 
the expression of  Salmonella induced genes, including defence genes, coinciding with increased 
Salmonella infection. This showed that increase in defence genes reflects a reduced rather than 
improved gut barrier function, as is often assumed. Several new candidate biomarker genes were 
identified, such as pancreatitis associated protein (Pap), lipocalin, calprotectin and phospholipase 
A2. PAP protein was studied in more detail. Its response dependent excretion suggests that it can 
potentially be used as a non invasive marker. Finally, based on the difficulties encountered in 
analysing transcriptomic data, we propose a framework to identify biologically relevant genes.  
Conclusion 
We identified biological processes not earlier associated to gut barrier functioning. Expected 
barrier processes were not induced, thus gut barrier research should not focus on expected 
barrier processes alone. Extrapolating data from model systems of  the barrier to the intact animal 
should be done with great care, as overlap in gene expression is low. Transcriptome analyses have 
significantly increased the understanding of  the actual in vivo barrier processes and have delivered 
potential new gut health biomarkers. 
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1 Introduction 
 
The primary function of  the intestinal epithelium is to digest and absorb nutrients. At the same 
time it has to prevent infiltration of  pathogens and harmful compounds. This barrier function is 
important for an organism’s health and is tightly controlled. Disturbance can be caused by 
pathogens, harmful compounds or nutrients, and may lead to diarrhoea, infectious disease or 
uncontrolled inflammation38. Reduction of  early or mild disturbances could prevent the onset of  
harmful inflammation reactions. However little is known about the early processes involved in 
disturbances of  the intestinal epithelium.  
Understanding of  the epithelial barrier responses is limited to model systems such as in vitro cell 
cultures, or ex vivo epithelial tissue cultures. These models cannot provide a full overview of  the 
multifactorial in vivo situation, where the luminal content, the gut microflora and the gut immune 
system influence the responses of  the intestinal epithelium. Therefore, to obtain an overview of  
the early responses of  the intestinal epithelium, examination of  the in vivo situation is required. 
Examination of  gut barrier mechanisms is possible only after challenging the barrier through 
induction of  stress. This indicates whether the gut barrier is able to resist the stress or not, and it 
reveals which processes appear to be necessary to resist the stress. In this study, we chose two 
types of  challenges: a pathogenic bacterial challenge and a dietary challenge. 
Dietary components can affect the intestinal epithelium directly or indirectly, via changes in the 
intestinal contents or changes in the endogenous microflora. Human15 and animal16,103 studies 
have shown that diet can modulate intestinal infections. For example, Salmonella infection is 
sensitive to dietary modulation by calcium and by fructo-oligosaccharides (FOS). Calcium 
decreases colonization and translocation of  Salmonella, whereas FOS increases translocation of  
this pathogen in rats. However the Salmonella-induced biological processes in the intestinal 
mucosa and the possible dietary modulation of  these processes are not known.  
DNA microarray technology allows thousands of  genes to be studied at the same time and has 
been successful in identifying in vivo molecular responses of  intestinal tissues to commensal 
bacteria, pathogens or nutrients111,112. This technique is not restricted to a priori defined biological 
processes, but identifies all processes active at the time of  examination.  
 
The aim of  this thesis research was to identify the early gene expression response of  the 
intestinal mucosa in rats to two challenges that adversely affect the barrier function: Salmonella 
and FOS. We used transcriptomic analysis to look at the whole genome. Increased insight into 
the molecular response of  the gut barrier allows monitoring of  gut health and the development 
of  nutrients or pharmaceuticals that are able to modulate early mucosal responses and improve 
intestinal resistance, for example to infectious disease.  
 
 
2 Intestinal mucosal barrier 
 
To provide optimal nutrient absorption, the mucosal surface of  the intestinal tract is large. In 
adult humans it represents a surface area of  approximately 200m2, which is 100 times larger than 
the surface of  the skin. In rats, the gut surface is 25 times larger than the skin surface25. This large 
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surface area, which is in constant contact with the external environment, makes the intestinal 
mucosa an important target for harmful compounds, such as pathogenic microorganisms, toxins 
or harmful nutrients. Fortunately, the gastro intestinal (GI) track is equipped with several 
mechanisms that prevent survival of  ingested microorganisms. For example, the acidic 
environment of  the stomach39, bile117 and pancreatic enzymes of  the small intestine88, and 
motility in the small intestine93. These mechanisms prevent survival and colonization of  
microorganisms in the intestinal lumen. Despite these mechanisms, the intestinal epithelium is 
constantly exposed to unwanted compounds. Successful resistance to these compounds is 
possible due to the intestinal mucosal barrier. This barrier consists of  a monolayer of  epithelial 
cells, the mucosal immune system and the microflora (figure 1). These three components are in 
continuous interaction with each other. 
Immune cells
Epithelial 
monolayer
Mucus 
layer
Microflora
Pathogens
Figure 1. The intestinal barrier aligns the entire gastro-intestinal system.  
 
2.1 The epithelium 
The epithelial cells are tightly sealed to each other with tight junctions (TJs). These TJs between 
the cells regulate intestinal permeability of  fluids and small molecules5,98, and can be affected by 
pathogens, cytotoxic compounds and cytokines84,113. The exact regulation mechanism of  TJs is 
not known, although it is clear that the cytoskeleton is involved45. To prevent bacterial invasion 
through gaps in the epithelial layer, that occur due to loss of  damaged cells or apoptosis, adjacent 
epithelial cells rapidly migrate to the edge of  the gap116. This process is called regeneration, and 
after the rapid migration of  cells, the epithelium is restored by induced proliferation. Thus 
regeneration, proliferation and apoptosis are necessary to maintain the epithelial layer and are 
therefore tightly regulated. 
The mucosal epithelial layer is not only a tight monolayer that separates the outside luminal 
environment from the inside of  the body. It also has an important warning function to the 
immune system, and it actively defends itself  against bacteria by producing a sticky mucus layer 
and antimicrobials62,74. The cell types in the intestinal epithelial layer responsible for these 
functions are enterocytes, goblet cells, Paneth cells, entero-endocrine cells and microfold cells (M-
cells).  
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The most abundant cell type in the intestinal epithelium is the enterocyte. Enterocytes are not 
only important in nutrient absorption, but also actively communicate with the immune system by 
producing cytokines and chemokines. In vitro studies have shown that a wide range of  stimuli, 
including pathogens and physical damage, induce the production of  cytokines such as interleukin 
8, interleuking 1β and tumour necrosis factor α, as well as chemokines such as macrophage 
inflammatory protein 2 and monocyte chemoattractant protein-170,78. These signalling molecules 
attract neutrophils and leukocytes to the injured area100.  
Another abundant cell type is the goblet cell. Goblet cells produce a mucus layer that protects the 
intestinal epithelium against physical damage and infiltration of  pathogens simply by acting as a 
molecular sieve21,61,72. Physical, chemical or infectious stimuli trigger goblet cells to release mucin 
glycoproteins to the luminal side to form the hydrated viscous mucus layer91. Goblet cells also 
produce trefoil factors. These peptides tie mucin glycoproteins together, resulting in increased 
viscosity and therefore increased protection. Trefoils also play a role in the rapid repair of  
epithelial damage58,69. A wide range of  stimuli, including pathogens, dietary fibres or changes in 
the normal microflora, are able to change mucus composition. The mechanisms responsible for 
this observed change in composition require further study24.  
Another type of  epithelial cell that has a role in the defence are the Paneth cells.  These cells are 
responsible for the production of  antimicrobial peptides such as defensins and bacteriolytic 
enzymes such as trypsin, lyzosyme and phospholipase a2. Antimicrobials are constitutively 
produced at low levels and are induced by proinflammatory cytokines and exposure to bacteria.  
α -Defensin is the most abundant antimicrobial and is able to destroy a wide range of  bacteria by 
disrupting the bacterial cell membrane. Together, these Paneth cell products control the bacterial 
milieu in the intestine7,46,73. In addition, they serve as signalling molecules that communicate 
between the innate and adaptive immune systems.  
 
2.2 The immune system  
The immune system of  the intestine has a complex task; it not only has to react to pathogens and 
harmful compounds, but it also must tolerate the constant flow of  food antigens and the 
abundant non-pathogenic microflora. The intestine is responsible for about 70-80% of  the 
body’s immune system, indicating its importance in general defence35. The immune system of  the 
intestine contains specialized immune tissues, including the Peyer's patches (PPs) and the 
mesenteric lymph nodes. Besides these tissues, the immune system consists of  several cell types 
that are scattered through the epithelial mucosal layer, such as dendritic cells, IgA producing B-
lymphocytes, and T-lymphocytes94. Together, these tissues are called gut-associated lymphoid 
tissue. 
PPs and dendritic cells are essential to the early immune response. The PPs are aggregates of  
lymphoid tissue in the small intestine that are covered with M-cells80. These M-cells constantly 
sample luminal content to the PPs. The dendritic cells, that are spread throughout the epithelium, 
sample and transport luminal antigens across the epithelial layer through epithelial TJs85. All 
sampled antigens are presented to B- and T-cells in the PPs, which determine the outcome of  an 
immune response56. Upon activation B-cells produce large quantities of  immunoglobulin A (IgA) 
at the mucosal surface. IgA prevents antigens, for instance bacteria, from attaching to mucosal 
cells and subsequently prevents these bacteria from entering the epithelium. The most important 
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characteristic of  IgA, compared to other immunoglobulins, is that it removes antigens in a non-
inflammatory manner1.   
The immune system can be divided into the rapid responding innate immunity and the slow 
responding adaptive immunity; the rapid innate immune response is non-specific and is active in 
the first few days of  an infection. In addition, it activates the adaptive immune system97. This 
slower responding adaptive response is observed 4 to 7 days after infection and involves the 
generation of  immunological memory. The innate immune system is not only provided by 
specialized immune cells, but also partly by the intestinal epithelial cells. Both cell types express 
pattern recognition receptors, such as toll-like receptors, that recognize different pathogen 
components and play an important role in the host recognition of  microflora versus pathogens86. 
For example, flagellin – part of  the Salmonella outer membrane – is recognized by toll-like 
receptor 5 and lipopolysaccharides by toll-like receptor 4. Activation of  these various toll-like 
receptors induce production of  a range of  cytokines and chemokines by both the enterocytes 
and immune cells2,31,79. Cytokines communicate with the adaptive immune system through either 
pro-inflammatory cytokines (interleukin 1, tumour necrosis factor α, interferon γ) or anti 
inflammatory cytokines (interleukin 4, interleukin 10, interferon α). And the chemokines, such as 
macrophage inflammatory protein 3 α, and mast cell protease 1,  that recruit neutrophils, 
macrophages and dendritic cells to the site of  infection29,30.  
 
2.3 The microflora 
The gastrointestinal tract is occupied by a large number of  microorganisms, also knows as 
commensal microflora. In comparison, humans have ten times more bacteria in their gut than 
cells in their body12,66. Most of  these bacteria reside in the large intestine. The stomach and small 
intestine contain relatively few bacteria due to bactericidal activity of  gastric acid, bile and 
pancreatic enzymes, as well as motility in the small intestine43. The intestinal microflora bacteria 
are important for the host because they provides the host with energy and nutrients. These 
nutrients are produced by bacterial digestion of  otherwise indigestible polysaccharides, including 
plant-derived pectins, cellulose and resistant starches9. In addition, the intestinal microflora play 
an important role in normal gut function and maintaining host health50. For example, absence of  
microflora in germ-free animals results in underdeveloped immune system and underdeveloped 
metabolism of  fatty acids, bile acids and cholesterol42. Moreover, the microflora provide a barrier 
against intruding foodborne pathogens through competition for substrates and mucosal adhesion 
sites. In addition, organic acid-producing (lactic acid and SCFAs) members of  the microflora 
reduce luminal pH, which inhibits growth of  most pathogens64,109. The importance of  the role 
for the microflora in intestinal barrier function is indicated by the decreased resistance to luminal 
pathogens in humans treated with antibiotics10,102.  
The composition of  the microflora is influenced by host factors such as antimicrobials and 
mucus, and external factors such as diet. For instance, almost all carbohydrates that reach the 
colon provide a substrate for the microflora and affect its growth and metabolic activity. 
Researchers are very interested in non-digestible oligosaccharides, which are claimed to increase 
the growth of  beneficial bacteria at the expense of  less beneficial and pathogenic bacteria; 
specifically, the lactic acid bacteria bifidobacteria and lactobacilli are increased at the cost of, e.g., 
bacteroides, clostridia, enterobacteria 13,40.  
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Together, the epithelium, the immune system and the microflora interact with each other through 
multiple mechanisms to provide an effective barrier to pathogens (figure 2). Because of  these 
interactions, an in vivo approach is required to obtain a complete overview of  the intestinal 
mucosa response to a pathogenic or other stress challenges. However most data on the gut 
mucosal barrier come from model studies using cell culture studies focusing on one cell type or 
from ex vivo studies where epithelial tissue is studied without luminal content and microflora51. 
These models are important to examine specific issues of  barrier defence, but are hard to 
extrapolate to the in vivo situation, where all systems are shown to interact with each other. 
Furthermore, insight into dietary modulation of  intestinal mucosa also requires an in vivo 
approach, since dietary components influence the gut barrier by affecting intestinal content, the 
composition and activity of  the microflora and the functioning of  the intestinal epithelium87.  
  
Microflora
Epithelium
Immune system
PathogensNutrients
Barrier
Antimicrobials
Cytokines
Chemokines
IgA
Cytoskeleton
changesAltered microfloraDigestion
Antimicrobials
Mucus
Metabolism
Protection
Immune 
development
Survival
Figure 2. Schematic overview of 
interactions between the three 
components that are involved in 
gut barrier functioning; the 
epithelium, the immune system 
and the microflora. External 
factors such as nutrients and 
pathogens influence the barrier.  
 
3 External factors affecting the gut barrier 
 
Changes or disruptions of  one of  the barrier components may signal the onset of  intestinal 
inflammation, resulting in further damage of  the intestinal mucosa27,67. The early phase of  
disturbed barrier homeostasis, such as bacterial adhesion or induced intestinal permeability, is 
sensitive to modulation by nutrients or pharmaceuticals65,90, for example, dietary calcium was 
shown to inhibit Escherichia coli infection induced diarrhoea15. Intervention of  this early response 
could prevent or decrease induction of  inflammation. Enhanced mechanistic understanding of  
the early host mucosal responses to pathogens or harmful compounds is essential for developing 
dietary products or pharmaceuticals that are able to modulate these early mucosal responses 
These early molecular responses of  the intestinal mucosa in rats can be examined using 
challenges that adversely affect the barrier function. Two good model systems in rats are 
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Salmonella and dietary FOS. Salmonella infection in rats offers a good model system because the 
infection is sensitive to dietary modulation by calcium and FOS16,103,105. Dietary FOS is a good 
model because FOS increases intestinal permeability and stimulates Salmonella translocation106, 
indicating mucosal stress.  
 
3.1 Intestinal bacterial infections 
Not all ingested foodborne pathogens induce disease, most pathogens will not survive the upper 
gastrointestinal-tract defence mechanisms, and the ones that do survive are mainly prevented 
from adhesion to the intestinal mucosa by the ileal motility and the colonic microflora. However, 
pathogenic bacteria that are able to adhere to the mucosal surface can start to colonize the gut, 
and in case of  an invasive pathogen they will try to invade the host cells. Bacterial adhesion and 
invasion may be the most critical events sensitive to dietary modulation and may be a target for 
strengthening host resistance. 
Salmonella  
Salmonella is one of  the main causes of  gastrointestinal infections in Europe and the USA 48,83. 
Salmonella is a family of  Gram-negative enteropathogenic bacteria that successfully colonizes a 
wide range of  animal hosts, including humans. There are two major groups of  Salmonella 
species: 1) Salmonella typhi and paratyphi, which mainly infect the small intestine and cause systemic 
typhoid fever; 2) non-typhoid Salmonella such as S. typhimurium and S. enteritidis, which induce 
gastroenteritis with mucosal neutrophil infiltration in the small intestine and the colon. From 
these species, Salmonella enteritidis is the most common cause of  food-borne salmonellosis in 
humans, causing approximately 80% of  reported cases in Europe48 .  
Salmonella is frequently used as model pathogen to study fundamental mechanisms of  bacterial 
pathogenesis82. However research in living organisms and particularly research on the colon in 
limited.  
Effect of Salmonella on the intestine 
In the first step in the infection process, Salmonella adheres to the brush border of  intestinal 
cells17. An alternative route of  invasion occurs via M-cells covering the Peyer’s patches or 
following capture by dendritic cells60,80.  
Salmonella invades the host by using its type III secretion system, a specialized virulence strategy 
that injects bacterial proteins into the host cytoplasm. These bacterial proteins influence the host 
cytoskeleton, resulting in membrane ruffles that enclose the bacteria in large Salmonella-
containing vesicles41,44. Salmonella modifies these vesicles to prevent their fusion with the 
lysosomal compartment, enabling survival and bacterial replication18. This shows that Salmonella 
can modulate host cell functions by manipulating the host’s cytoskeleton and vesicle machinery. 
Other host cellular functions that are induced by Salmonella are toll-like receptor 5 signalling and 
production of  antimicrobials89. Salmonella-host interactions could affect more processes that 
have not yet been defined. 
Rat model 
Early Salmonella-host interactions are most often studied in cell culture systems. Another widely 
used model in Salmonella research is the murine, bovine or rabbit ligated ileal loop model51. This 
model system is useful to study specific genes or molecules, but lacks both a natural route of  
infection and the luminal contents important in host defence. A good animal model should 
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closely mimic the human situation because in the end findings need to be validated in de human 
situation. The bovine is the model closest to S. enteritidis infection in humans. It is not useful for 
nutritional studies because the gastro-intestinal system of  the bovine is completely different than 
the system in humans. The rat is a good small animal model for Salmonella infection that mimics 
the human situation47,76. For example, the infection of  Salmonella is self-limiting in both humans 
and rats. Where in humans the infection limits to the intestine, in rats systemic infection of  the 
spleen and liver is observed92. However, in humans systemic infection is not uncommon in 
Salmonella-infected elderly, young children and immuno-comprised subjects. Although in vivo or 
ex vivo studies on Salmonella infection mainly focus on the ileum, infection of  colonic mucosa is 
also mentioned in humans and rats68,114. Therefore both the ileal and the colonic mucosa are 
important study subjects in Salmonella-host studies. 
 
3.2 Nutritional modulation of the intestinal epithelium 
All nutrients pass the intestinal epithelium, and several nutrients are known to ameliorate 
gastrointestinal integrity. Examples are sulphur-amino acids, glutamine, arginine, zinc, n-3 fatty 
acids and butyrate28,119. There is a great deal of  commercial and scientific interest in prebiotics, 
which are claimed to increase intestinal resistance. However, in vivo studies on the role of  
prebiotics in the defence against foodborne pathogens are scarce19,20. In contrast to general 
expectations, a rat study on the resistance-enhancing properties of  the prebiotics FOS showed 
that dietary FOS increases intestinal permeability and translocation of  Salmonella in rats106. 
Furthermore, FOS increased indicators of  colonic injury in a rat model for intestinal 
inflammation36. Together these results indicate that FOS induces mild mucosal stress. A diet high 
in calcium on the other hand, shows to decrease translocation of  Salmonella in rats and 
counteracts the negative effects of  FOS on Salmonella translocation103. 
The above results indicate that nutrients can modulate intestinal barrier function. However very 
little is known about the molecular mechanisms responsible for this dietary modulation of  the 
gut mucosal barrier. Increased insight in these molecular mechanisms could help to develop other 
nutrients that improve mucosal barrier functioning. FOS has a clear effect on intestinal 
permeability and on Salmonella infection and is therefore an interesting model nutrient to 
examine molecular mechanisms involved in gut mucosal barrier functioning.  
FOS 
FOS is found in many plant species, including wheat, onion, banana and chicory, and is 
comprised of  one terminal glucose molecule and 2-5 fructose units linked by β(2-1) bonds52. The 
digestive enzymes of  humans and animals cannot digest the β(2-1) bonds, therefore FOS arrives 
in the large intestine unchanged where it is hydrolyzed and metabolized by the endogenous 
microflora.  Indeed, when FOS is consumed by ileostoma patients, the average recovery at the 
terminal ileum lies around 89% of  the material consumed8,34, whereas fecal recovery of  FOS in 
healthy subjects is close to zero3,71. The major end products of  FOS fermentation by bacteria are 
lactate and the short chain fatty acids (SCFAs) acetate, propionate and butyrate115, which are 
taken up by the epithelial cells. FOS stimulates growth of  bifidobacteria and lactobacilli when 
consumed in amounts of  5-20 grams per day for humans14,40,107. Prebiotics are claimed to 
exclusively promote growth of  bifidobacteria and lactobacilli115, however studies in rats have not 
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clearly demonstrated this exclusivity49, in fact FOS has been shown to stimulate the growth of  
both bifidobacteria and enterobacteria in rats105.   
Effect of FOS on the intestine 
As mentioned above, FOS alters the microflora in vivo. This can modulate the intestinal barrier 
function because it has been shown that alterations in the composition of  the microfora affect 
the epithelium and possibly the immune system50,55. The fermentation products of  FOS, the 
SCFA’s acetate, propionate and butyrate, are also known to affect epithelial cells, as these organic 
acids provide energy to colonic epithelial cells, decrease luminal pH and influence absorption of  
calcium and magnesium23. Production of  modest quantities of  SCFAs is essential for normal 
colonic mucosal function96. However, fermentation of  large quantities of  FOS could cause 
overproduction of  SCFAs. This overproduction may damage the intestinal epithelium, especially 
when cells are chronically exposed to these high levels of  SCFAs6,63,75. Thus FOS or its 
fermentation products clearly affects the mucosal epithelium and its barrier function. Therefore it 
is interesting to use FOS as a barrier challenge to clarify the molecular mechanisms causing these 
effects.   
Rat model  
The rat is a good model organism for nutritional studies on gut health because results from 
nutritional studies on calcium and FOS on gut health parameters in rats are validated in 
humans15,104. Although the rat and human gastrointestinal tract share the same overall 
organization, a clear difference is the cecum. In rats the length of  the cecum accounts for about 
26% of  the total length of  the large intestine, whereas in humans this is only about 5% 25. There 
is also a difference between the quantities of  bacteria within the small intestine. In humans, only 
a few bacteria remain in the small intestine, while in rats 106-108 CFU per gram content is 
present54. However it has been shown that FOS does not stimulate lactobacilli growth in the rat 
ileum106, indicating that FOS fermentation is limited to the distal gut in both rat and human. 
Furthermore, faecal bifidobacteria, faecal wet weight, faecal lactate and mucin secretion are 
similarly influenced by FOS in rats and in humans104.   
 
 
4 Transcriptome analysis   
 
Transcriptomics, or DNA microarray technology, enables researchers to study thousands of  
genes at the same time. The technique has rapidly evolved from its introduction in the mid-
1990’s95.  
A major advantage of  this technique is that all biological processes active at the time of  
examination are identified. New biological processes, formerly not related to the studied subject, 
can be detected with this technique. This is interesting in studies that examine complex systems, 
for example the intestine. Previous studies on the in vivo response of  the intestinal tissue to 
pharmaceuticals, commensal bacteria, pathogens and nutrients have successfully used 
transcriptome analysis50,59,111,112. Because the molecular mucosal response of  the intestine to 
Salmonella and FOS is an unexplored area of  research, this technique is chosen to enable analysis 
of  all biological processes involved in the response. 
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4.1 Transcriptomic  technique 
Transcriptome analysis identifies and quantifies messenger RNA (mRNA) levels of  genes in cells 
or tissues. The mRNA levels in cells or tissue are indicative of  ongoing biological processes. This 
provides insights into the response of  cells or tissues to a wide range of  stimuli, including 
pathogens or nutrients. More traditional methods to examine mRNA levels are Northern 
blotting4 and quantitative real-time reverse transcription polymerase chain reaction (Q-PCR)81. 
These methods allow targeted analysis of  a relatively small number of  genes chosen by the 
researcher. The microarray technology allows rapid analysis of  thousands of  genes 
simultaneously32, see BOX 1. This type of  analysis covers all the biological processes that occur 
in the cell or tissue under examination. Several types of  microarray platforms are available, for 
example self-spotted cDNA arrays, self-spotted oligo arrays, and commercially available arrays 
from Agilent118 or Affymetrix22.  
In addition to large scale study of  genes, the proteins and metabolites can also be studied on a 
large scale; this is called proteomics or metabolomics. Information on proteins and metabolites is 
closer to physiology than information on gene transcripts. However, transcriptomics generates 
much larger data sets then proteomics or metabolomics, and there is more data about genes in 
databases than about proteins and metabolites. In this thesis, the transcriptomic technique is 
chosen, since this is the most comprehensive technique at this moment.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BOX 1. Transcriptomic technique 
The sequences of thousands of genes are available for whole genomes; this allows the design of sequence fragments or 
probes representing individual genes. These gene-specific probes are printed on nylon membranes, glass slides or silicon 
chips. Hybridization of single stranded DNA allows determination of mRNA levels of all genes spotted on the array. 
Procedure: 1) Isolation of mRNA from biological samples. 2) Fluorescent label incorporation into cDNA copy of the mRNA. 
3) Hybridization of labeled sample to the array: each cDNA anneals to the complementary cDNA probe for a specific gene 
on the surface. 4) Scanning the array to determine the fluorescent amount of labeled cDNA hybridized to each spot.  
5) Quantification of the fluorescent signal, and data normalization to enable comparison between the different arrays. (For 
full colour figure, see page 162) 
 
1
2
3 4 5
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4.2 From genes to mechanism. 
The challenging task in transcriptomics is to extract biological data from long lists of  gene 
expression data. As not all genes on the genome are expressed in all tissues, these non-expressed 
genes are first removed from the dataset. From the remaining gene list, the genes that are 
differentially expressed under the different experimental conditions need to be identified, because 
these genes reflect the biological processes changed by the experimental condition. Several 
approaches exist to obtain biological insight into the list of  differentially expressed genes. One 
approach is to select genes of  interest by defining a threshold value. This threshold can be fold 
change or a test derived p-value, or any other ranking factor derived from the test used. The 
genes above this threshold are selected for further biological interpretation. The difficulty with 
these large datasets is the chance of  identifying false positive differences between conditions. 
Statistical tests adapted to transcriptomic data analysis have been developed that can handle these 
large datasets, such as false discovery rate11 or significance analysis of  microarray data108, and 
many other tests are appearing.  
Another approach to identify differentially expressed genes is to focus on genes with similar 
behaviour. Programs such as cluster analysis, self-organizing maps or principle component 
analysis are able to group genes with similar expression patterns101,110. The idea is that genes 
reacting similarly to a specific stimulus could somehow be functionally related.  
All selection options are followed by manual data mining in scientific literature and databases 
such as Gene Ontology (GO)37, National Center for Biotechnology Information (NCBI)77 and 
Kyoto Encyclopedia of  Genes and Genomes (KEGG)53 to obtain biological information of  each 
selected gene. These approaches are often used, but have the drawback that they are time 
consuming and depend greatly on the researcher’s biological knowledge and preferences. 
Biological information of  the selected genes can also come from pathway analysis programs, 
which is more objective and faster than manual data mining. These programs categorize 
differentially changed genes into biological processes usually based on Gene Ontology 
categories57. In addition to classification in biological processes, these programs can also group 
genes based on cellular localization or metabolic pathways33. The use of  pathway programs 
improves the likelihood of  identifying biological processes affected by the experimental treatment 
and is therefore a requirement in transcriptomic studies99.  
 
4.3 Intestinal genomics 
Altered conditions in the intestinal tract lead to complex interactions between many barrier 
components, ultimately leading to altered molecular responses in the epithelial cells. Several 
studies have proven that gene expression studies in epithelial cells can confirm known processes 
important in gut functioning, but more importantly they all reveal novel insights into gut 
functioning. Examples are the effect of  dietary heme on colonic gene expression112, altered gene 
expression in intestinal biopsies from inflammatory bowel disease patients26, time dependent 
Trichinella induced gene expression in the mouse intestine59, and commensal microflora induced 
gene expression in formerly germfree mice50. The newly found processes offer important new 
understanding and possibilities for further gut research outside the boundaries of  common 
knowledge. 
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5 Outline of this thesis 
 
The aim of  this research was to identify the gene expression response of  the intestinal epithelium 
in rats to two harmful challenges which assault the barrier function; Salmonella and FOS. To 
obtain insight into the epithelial response to diets and pathogens, an in vivo approach is required, 
because the barrier function of  the intestinal mucosa is a result of  complex interactions between 
epithelial cells, luminal content, different epithelial cells and the immune system. 
Since little is known about the various intestinal responses that are influenced in vivo by 
Salmonella and FOS, transcriptomics is used to obtain a complete insight into all biological 
processes that differ between treatment conditions.  
This research can help to reveal molecular responses important in maintenance of  the intestinal 
barrier. 
 
Chapter 2 describes the gene expression response of  the rat ileum at different times after oral 
infection of  Salmonella. The aim was to identify the point in time when Salmonella induces gene 
expression changes in the ileum, focusing on both the mucosal layer and the Peyer’s patches.  
 
It is widely assumed that Salmonella invades the body through the ileum. However FOS, which 
affects the colon, has been shown to affect Salmonella infection. Chapter 3 therefore examines 
the gene expression of  the colon mucosa at different time points after Salmonella infection. It 
also examines the effect of  FOS on Salmonella-induced genes.  
 
In both the ileum and the colon, Salmonella induces Pancreatitis associated protein (PAP) 
mRNA. The purpose of  Chapter 4 is to examine PAP protein levels in the mucosa and faeces 
and to define which cells produce PAP in the ileum. 
 
Chapter 5 explores a new method to select subtle gene expression differences from 
transcriptomic datasets. Chapter 6 examines the FOS-induced gene expression on colon mucosa 
without infection to identify which processes are most likely involved in the FOS induced 
intestinal permeability.  
 
The final Chapter of  this thesis (Chapter 7) summarizes and discusses the main findings, 
discusses recommendations for future studies and provides a conclusion.  
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Abstract  
 
Data on the molecular response of  the intestine to the food-borne pathogen Salmonella are 
derived from in vitro studies, whereas in vivo data are lacking. We performed an oral S. enteritidis 
infection study in Wistar rats to obtain insight in the in vivo response in time. Expression profiles 
of  ileal mucosa (IM) and Peyer’s patches (PP) were generated using DNA microarrays at days 1, 
3, and 6 postinfection.  An overview of  Salmonella regulated processes was obtained and 
confirmed by quantitative real-time PCR on pooled and individual samples. Salmonella-induced 
gene expression responses in vivo are fewer and smaller than observed in vitro and the response 
develops over a longer period of  time. Few effects are seen at day 1 and mainly occur in IM, 
suggesting the mucosa as the primary site of  invasion. Later, a bigger response is observed, 
especially in PP. Decreased expression of  anti-microbial peptides genes (in IM at day 1) suggests 
inhibition of  this process by Salmonella. Newly identified target processes are carbohydrate 
transport (increased expression in IM at day 1) and phase I and phase II detoxification (decreased 
expression at days 3 and 6). Increase of  cytokine and chemokine expression occurs at later time 
points, both in PP and IM. Pancreatitis-associated protein, lipocalin 2, and calprotectin, potential 
inflammatory marker proteins, showed induced expression from day 3 onward. We conclude that 
the in vivo gene expression response of  the ileum to Salmonella differs to a large extent from the 
response seen in vitro. 
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Introduction  
 
The enteric pathogen Salmonella enterica serovar enteritidis is one of  the main causes of  gastro-
intestinal infection in Europe and the USA16,35. Incidence of  infection is highest in children, 
elderly and immuno-suppressed individuals. In severe cases, illness is the result of  translocation 
from the intestine, mainly the distal ileum, into the bloodstream. Little is known of  the response 
of  intestinal cells to the Salmonella infection in vivo. Insight in the in vivo responses is required to 
assess the relevance of  in vitro models and as a starting point to develop strategies to prevent 
infection, for example by dietary intervention. To obtain an overview of  the gene expression 
response of  the ileum mucosa to Salmonella, we used DNA microarray technology. This 
technology has been used to analyze the gene transcription response of  epithelial cell lines 
exposed to various bacterial pathogens in vitro, such as Vibrio cholerae, Listeria monocytogenes, Shigella 
flexneri, and Salmonella 2,13,36,49. These pathogens initiated an immune response in the intestinal cell 
lines within minutes to hours. However, in vitro studies do not necessarily represent the in vivo 
situation. The relevant time frame in vivo is days rather than hours. Furthermore, monocultures in 
vitro lack interaction with other cell types of  the epithelial barrier. In vitro cells also lack the 
microflora and the mucus layer, which are essential components of  host-bacterial 
interaction19,38,48. Some of  these limitations are overcome in ligated-ileal-loop models, where 
Salmonella is directly introduced into the ileal lumen. However, these loop models lack luminal 
contents, and the natural route of  pathogenic delivery is omitted. As far as we know, no in vivo 
gene expression studies of  the intestine have been performed after oral gavage of  Salmonella.  
 
Two distinct tissues in the ileum have been identified as targets for Salmonella entry into the host: 
the ileum mucosa (IM) and the Peyer’s patches (PP) 10,56. One of  the major functions of  the IM is 
to absorb nutrients. Its large surface primarily consists of  absorptive enterocytes and secretory 
Paneth and Goblet cells. PP are immune tissues that are part of  the gut-associated lymphoid 
tissue. M cells are located in the follicle-associated epithelium overlaying the PP that have a role 
in sampling of  pathogens7,21. The initial site of  Salmonella contact and subsequent translocation 
in the small intestine is not clear17,53. Because the primary site of  response to Salmonella is not 
known in rats we decided to study the course of  the molecular response of  both target tissues to 
Salmonella in vivo. We chose Wistar rats for our studies, because these have successfully been used 
in mechanistic infection studies 3,50. Since diet affects Salmonella colonization and translocation, 
we used a diet low in calcium and high in fat. This diet results in a low resistance to food-borne 
bacterial infections4,5. As in these studies, we used a dose of  Salmonella that causes a self-limiting 
infection, which is most commonly observed in humans.  
 
To examine time-dependent molecular responses of  both IM and PP to oral S. enteritidis 
infection, intestinal tissue of  infected and noninfected controls was collected at different time 
points postinfection (p.i.) (or sham treatment) and pooled samples were analyzed by microarrays. 
The microarray analysis provided an overview of  Salmonella-targeted processes. In our analysis 
we focused on processes represented by at least three genes showing more than two-fold 
variation from non-infected controls. A selection of genes from every regulated process was 
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analyzed by quantitative PCR of RNA samples from individual rats to obtain information about 
the interindividual biological variation. 
 
 
Materials and Methods 
 
Animals, diet and infection 
The experimental protocol was approved by the animal welfare committee of  Wageningen 
University (Wageningen, the Netherlands). Specific pathogen-free male outbred Wistar rats (WU, 
Harlan, Horst, the Netherlands) 9 weeks old, mean body weight 285 g, were housed individually 
in metabolic cages. All animals were kept in a temperature (22-24°C) and humidity controlled (50-
60%) room with a 12 h light/dark cycle (lights on from 6 AM to 6 PM). Rats were fed a purified 
diet during the whole experimental period. Compared with the AIN-93 diet 39, diets were low in 
calcium (20 mmol CaHPO4·2H2O/kg) and high in fat content (200 g fat/kg)51, to mimic the 
composition of  a Western human diet. Food and demineralized drinking water were supplied ad 
libitum. Food intake was recorded every day and body weight every 2 days.  
Both the control group and the infected group were comprised of  24 rats. Per section time point, 
eight rats of  each group were killed to collect intestinal samples (described below in more detail). 
The animals were acclimatized to housing and diet for 11 days, after which they were orally 
infected with S. enteritidis (clinical isolate, phage type 4 according to international standards; 
B1214 culture of  NIZO food research, Ede, the Netherlands). In the morning, half  of  the 
animals (n= 3 x 8) were orally infected by gastric gavage with 1 ml of  saline containing 3 x 109 
colony forming units (CFU) S. enteritidis. The other half  of  the animals (n = 3 x 8) were sham 
treated and received saline only. S. enteritidis was cultured and stored, as described earlier 5. Fresh 
fecal samples were collected on days 1, 2, 3, and 6 p.i. and analyzed for viable Salmonella by 
plating 10-fold dilutions in sterile saline on modified brilliant green agar (Oxoid, Basingstoke, 
UK) and incubating aerobically overnight at 37°C. Sulphamandelate (Oxoid) was added to the 
agar plates to suppress swarming bacteria, such as Proteus species. The detection limit of  this 
method was 102 CFU/g fecal wet weight. Total 24 h urine samples were collected on the last day 
before and on 6 consecutive days after infection. Urine was preserved with oxytetracycline and 
frozen until analyzed for the nitric oxide metabolites nitrite and nitrate (NOx) by a colorimetric 
method (Nr. 1746081; Roche diagnostics, Mannheim, Germany). At 1, 3, and 6 days p.i., 
Salmonella-exposed rats and their corresponding controls were killed by carbon dioxide 
inhalation. The mesenteric lymph nodes (MLN), spleen, and liver were excised aseptically, 
weighed, homogenized (Ultraturrax Pro200, Pro Scientific Oxford, CT) in sterile saline, serially 
diluted, and plated to culture for Salmonella, as described above. The detection limit was 102 
CFU/g tissue. The distal ileum (defined as the last 12 cm of  the small intestine proximal to the 
cecum) was taken out. The three most distal PP of  this intestinal segment were excised and 
weighed. To obtain IM, the ileum was then longitudinally opened and ileal contents were 
removed by a quick rinse in cold 154 mM KCl. Subsequently, the mucosa was scraped off  using a 
spatula. The PP and IM were immediately frozen in liquid nitrogen and stored at -80°C for RNA 
extraction.  
    - 30 -
                                                                         Salmonella-induced gene expression in the ileum 
RNA isolation 
PP and IM scrapings were homogenized in liquid N2 using a mortar and pestle cooled with liquid 
N2.(Fisher Emergo, Landsmeer, The Netherlands). Total RNA was isolated from these 
homogenates using TRIzol reagent (Invitrogen, San Diego, CA) according to the manufacturer’s 
instructions. Total RNA was purified using RNeasy columns (Qiagen, Chatsworth, CA). Absence 
of  RNA degradation was checked on a 1% Tris-borate-EDTA buffer/agarose gel after 1 hour 
incubation at 37°C. The purity and concentration were measured with the Nanodrop (Isogen Life 
Science, Maarssen, The Netherlands). OD A260/A280 ratios were all between 2.08 and 2.10, 
indicating good quality of  RNA. 
 
cDNA synthesis 
For microarray hybridization, mRNA of  eight rats per time point per treatment was pooled. Each 
pool consisted of  equal amounts of  RNA of  IM or PP from each rat. Arrays were performed in 
duplicate. For this, RNA pools were split and separately reverse transcribed and labeled with Cy5. 
A standard reference sample, consisting of  a pool of  all RNA extracted from IM and PP, was 
labeled with Cy3. For each oligo array, 40 μg of  total RNA was used to make Cy5 or Cy3 labeled 
cDNA. Total RNA was mixed with 4 μg T21 primer, heated at 65°C for 3 min (RNA 
denaturation) followed by 25°C for 10 min (primer annealing). cDNA was synthesized by adding 
5x first strand buffer (Invitrogen), 10 mM DTT, 0.5 mM dATP, 0.5 mM dGTP, 0.5 mM dTTP, 
0.04 mM dCTP, 0.04 mM Cy5-dCTP or Cy3-dCTP, 1.2 U RnaseOUT and 6 U SuperScript II 
reverse transcriptase to a total volume of  62.5 μL. The reaction was incubated at 42°C for 2 h. 
Purification, precipitation and denaturation of  the labeled cDNA were performed as described 
earlier 54.  
 
Analysis of mRNA expression by oligo arrays 
The rat 10K oligoset (MWG-Biotech, Ebersberg, Germany) used consists of  50-mer rat 
oligonucleotides representing 9715 rat genes, 100 replicate oligos (8 different genes, 12-14 
replicas each), and 169 control oligos (MWG Biotech). The 10K rat MWG oligoset together with 
an additional set of  104 50-mer oligos representing infection related genes, were printed on Ultra 
Gaps slides (Corning) using the Microgrid II arrayer (BioRobotics Ltd. Cambridge, UK). After 
printing, microarrays were allowed to dry at room temperature. The microarrays were 
immobilized by UV cross linking (120 mJ of  UV energy). The microarray slides were 
prehybridized at 42°C for 4 hours in prehybridization buffer containing 5x SSC, 0.2% SDS, 5x 
Denhardt’s, 200 μg/ml herring sperm DNA, 50% formamide. After prehybridization, all slides 
were washed twice in MilliQ and once in isopropanol. After being washed, the microarray slides 
were dried by centrifugation (2 min, 2000rpm). Then the Cy5 labeled cDNAs of  the Salmonella 
infected and control groups were mixed 1:1 with the Cy3 reference labeled cDNA (all in 
duplicate). Hybridization was performed in a Gene frame (Westburg, the Netherlands) in a 
volume of  150 μL. The microarrays were hybridized overnight at 42°C in a humid hybridization 
chamber. After hybridization the arrays were washed and dried as described elsewhere 54. Arrays 
were scanned using the Scanarray Express HT (Perkin Elmer, Wellesley, MA) at a laserpower of  
90% and a photo-multiplier tube voltage of  55%. 
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Data analysis 
The software package Array Vision (version 7.0, Imaging Research, Ontario, Canada) was used to 
extract data from the scanned images. Median density values and background values of  each spot 
were extracted for both the (Cy5) and the reference samples (Cy3). Only the spots with average 
Cy5 and Cy3 values that were twofold above the background value were included in the data 
analysis. Of  the 9819 genes present on the array, 6792 spots fulfilled this criterion. Data 
normalization was performed with the software package GeneMaths XT (Applied Maths, Sint-
Martens-Latem, Belgium) as described elsewhere37. The microarray data are deposited in 
ArrayExpress (http://www.ebi.ac.uk/arrayexpress; E-MEXP-636). The microarray data were 
analyzed using Microsoft Excel (fold change) and GeneMaths XT (principal component analysis, 
hierarchical clustering). All groups (controls and infected) were hybridized in duplicate. The few 
genes with a more than twofold difference between technical duplicates were excluded for further 
analysis. The noninfected control groups of  each time point were hybridized separately. Since no 
differences between the different days were observed, as analyzed by PCA analysis, the controls 
were averaged as one group per tissue. Fold changes in transcription levels between Salmonella 
infected and control samples were calculated from the mean signal values of  infected samples of  
IM or PP on the different time points versus the mean of  the control IM or PP. Genes that 
changed more than twofold at one of  the time points compared with either control IM or PP 
were selected for pathway analysis.   
 
Processes were identified using statistical over-representation in Metacore (GeneGo, St. Joseph, 
MI), a highly curated web-based application for identification of  gene ontology processes in 
input gene sets32. The program uses annotation databases and creates a list of  gene ontology 
processes that are ranked according to their p-value. To assess whether processes were selected 
by chance, the Metacore pathway analysis was repeated with 15 random sets of  187 genes and the 
average p-values of  each process, of  all 15 sets, were used as a surrogate number for false 
discovery. Since only 30% of  the genes were annotated to gene ontology processes, processes 
with a p-value of  <0.01 were manually supplemented with the remaining significant genes using 
biological databases (BIOCarta, Gene Ontology, GenMAPP, KEGG) and scientific literature. 
Genes with analogous function or unequivocally being part of  the same functional process or 
pathway were included, whereas far-away members were excluded. To conclude that a biological 
process was differentially affected in infected versus control, two criteria were used: 1) initial p-
value in Metacore had to be smaller than p<0.01 and 2) at least three genes of  that process had 
to be changed more than twofold upon Salmonella infection. The use of  two criteria for selection 
was used to prevent overinterpretation and thus possible misinterpretation.  
 
Analysis of mRNA expression by quantitative real-time PCR 
Quantitative real-time PCR (Q-PCR) on individual samples and pooled samples was performed 
to confirm differences in mRNA levels. It was considered unnecessary to analyze all (3 x 8) non-
infected control animals individually because the array data of  the control groups killed at days 1, 
3, and 6 were highly similar. Instead, nine control animals were randomly chosen for individual 
RT verification. One microgram of  RNA of  all individual samples was used for the cDNA 
synthesis using the iScript cDNA synthesis kit of  Bio-Rad Laboratories (Veenendaal, The 
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Netherlands). Real-time reactions were performed by means of  the iQ SYBR Green Supermix of  
Bio-Rad using the MyIQ single-color real-time PCR detection system (Bio-Rad). Each reaction 
(25 µl) contained 12.5 µl of  iQ SYBR green supermix, 1 µl of  forward primer (400 nM), 1 µl of  
reverse primer (400 nM), 8.5 µl of  RNase-free water and 2 µl of  diluted cDNA. The following 
cycles were performed 1 x 3 min at 95°C,  40 amplification cycles (40 x 10 s 95°C, 45 s 60°C), 1 x 
1 min at 95 °C, 1 x 1 min at 62 °C and a melting curve (80 x 10 s at 55 °C with an increase of  0.5 
°C per 10 s). A negative control without cDNA template was run with every assay. The optimal 
melting point of  dsDNA (Tm) and the efficiency of  the reaction were optimized beforehand. A 
Tm of  60 °C was chosen for all reactions, and a PCR efficiency of  90-110% (3.2 < slope > 3.8) 
together with a correlation coefficient of  > 0.99 were accepted. Data were normalized against the 
reference genes β-actin (Actb) and pleckstrin homology domain-containing family A member 3 
(Plekha3). Primers were designed using Beacon designer 4 (Premier Biosoft International, Palo 
Alto, CA). For sequences, see supplemental table 2.1. A standard curve for all genes, including 
reference genes was generated using serial dilutions of  a pooled sample (cDNA from all 
reactions). mRNA levels were determined from the appropriate standard curve. Samples with 
mRNA levels below the lowest standard value were given a value not lower than half  the value of  
this lowest standard, corresponding to the detection level. Analysis of  all individual samples was 
performed in duplicate. Statistical analysis of  the data was performed in Prism 4 (Prism 4, 
GraphPad software, San Diego, CA) using Student’s t-test. p<0.05 (*) was considered statistically 
significant and p<0.01 (**) highly significant. 
 
 
Results 
Physiological response to Salmonella 
In agreement with previous studies, food consumption and growth of  the Wistar rats were not 
affected by Salmonella infection. High translocation of  Salmonella to mesenteric lymph nodes, 
but not the liver and spleen, was seen at day 1 (table 1). This implies that at day 1, Salmonella has 
already crossed the intestinal barrier. Spleen and liver showed colonization by Salmonella at later 
time points. NOx, as a parameter of  systemic infection, was found to be increased from day 3 
onward (table 1). 
 
Gene expression induced by Salmonella in IM and PP 
The oligonucleotide micorarray contained 9715 genes. After hybridization of  RNA from ileal 
mucosa (IM) and Peyer’s patches (PP), the expression of  6792 genes was more than twofold 
above the background in one or both tissues. The expression of  187 genes (98 genes in IM, 128 
genes in PP) was altered more than two fold in at least one of  the Salmonella-infected groups 
compared with the uninfected controls (days 1, 3, and 6) (Supplemental table 2.3 and 
Supplemental table 2.4 are available at the website of  Physiological Genomics). 
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Table 1. Viable Salmonella counts in feces, mesenteric lymph nodes, spleen, and liver and NOx concentrations in urine of rats 1, 
3 and 6 days post infection.  
 
  Salmonella (logCFU/g)a 
Control Day 1 p.i. Day 3 p.i. Day 6 p.i. 
Feces N.D. 7.22±0.19 5.92±0.24 6.04±0.32 
MLN N.D. 3.38±0.43 5.85±0.13 5.44±0.05 
Spleen N.D. N.D 3.20±0.33 3.49±0.05 
Liver N.D. N.D N.D 2.45±0.12 
NOx (μmol/day)b 6.56±0.23 6.84±0.22 9.62±1.13 33.44±5.13 
 
 
 
 
 
 
 
 
 
a The rats were orally infected with 3 x 109 colony-forming units of S. enteritidis or sham treated. Salmonella counts are 
expressed in log values as means ± SEM (n=8). N.D. = not detected. 
b NOx values are means   SEM (n=8). 
 
(http://physiolgenomics.physiology.org/). For subsequent analyses, the non-infected controls of  
the three different section days were taken as one group, since their expression pattern fully 
overlapped. No differentially expressed genes (cut-off  ratio of  >1.5) could be identified when 
the three control groups were compared to each other (data not shown). At day 1 p.i., only small 
effects in Salmonella-induced gene expression were observed. Just five genes were affected more 
than two fold in the PP. A larger response was observed in IM, where 18 genes showed 
differential expression compared to controls. At days 3 and 6 p.i., a larger response was seen in 
both tissues and, in contrast to day 1, the response in PP was stronger than the response in IM. 
Most affected genes showed increased expression by Salmonella during the course of  infection. 
However, a notable portion of  the genes in IM at day 6 p.i. showed decreased expression (figure 
1). Some overlap in Salmonella-induced genes was seen in both tissues (figure 2). Assessment of  
epithelial, goblet and Paneth cell specific genes (data not shown) and several well known 
housekeeping genes (see table 3) indicated that the observed gene expression data did not result 
from changes in cellular composition of  the mucosa.  
To further characterize tissue-specific and common responses, the set of  187 genes showing at 
least twofold increased or decreased expression compared with the noninfected control level 
were classified in biological processes. Processes with p<0.01 were inferred to be meaningfully 
related to the Salmonella response. Several randomly selected sets of  187 genes were also 
classified into processes, for these sets the significance for all selected processes, obtained by 
Metacore pathway analysis, was not significant (p>0.05). Clearly, the significance of  the processes 
identified using the 187 Salmonella affected genes was much higher, making identification by 
chance highly unlikely. 
To prevent the occurrence of  false positive genes, and overinterpretation of  biological processes 
affected by Salmonella, we focused on biological processes with at least three genes exceeding the 
cut-off  >2.0. Additionally we observed that the genes within all functional groups, except for 
lipid and other transporters, showed a comparable pattern of  expression (table 3). Also, most 
processes showed a similar pattern of  expression in both IM as well as in PP, which strongly 
indicates that these processes are truly affected by Salmonella.  
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Figure 1. The number of differentially 
expressed genes with a fold change greater 
than 2 in ileal mucosa and ileal Peyer’s 
patches of rats orally infected with Salmonella 
at 1, 3 or 6 days postinfection compared to 
sham treated controls (A).  
 
 
The majority of  the differentially affected genes could be grouped into the following processes: 
immune response, inflammation, antimicrobial defense, complement cascade, detoxification, 
transport, and extracellular matrix organization (table 2). Genes belonging to these processes, but 
with a differential expression of  1.5 to 2.0- fold, are also included in the tables (tables 2 and 3).  
To confirm the Salmonella-induced effect on biological processes selected, we performed an 
independent array hybridization of  freshly pooled ileal mucosal RNA from the same infection 
study. The results of  this analysis confirmed all selected genes based on the two selection criteria 
applied; 1) twofold change cut-off; 2) at least three genes changed in a similar biological process. 
For the present study, this corroborates that the used selection criteria were robust and valid.  
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Mucosa Peyer’s patches
total only shared only total
 
Immune activation, inflammation and antimicrobial defense 
Genes encoding antimicrobial defense proteins defensin 5 (Def5), lysozyme (Lys), and matrilysin 
(Mmp7) showed a 1.7 to 2.0-fold decreased expression in IM at day 1 p.i. (table 3). Salmonella did 
not stimulate the expression of  genes related to the innate immune response and inflammation at 
day 1 p.i. The decreased expression of  antimicrobial defense genes had mostly disappeared at 
days 3 and 6 p.i., whereas expression of  those related to immune response and inflammation was 
clearly induced, with the strongest response observed at day 3. The PP showed a more 
pronounced immune and inflammatory response than the IM at days 3 and 6 p.i. (table 3). 
Lipocalin 2 (Lcn2) and pancreatitis-associated protein 3 (Pap3) encode for inflammatory response 
proteins whose expression was affected in PP and IM. Furthermore, one activator of  the 
complement cascade, tissue factor (coagulation factor) III, and three inhibitors of  this cascade, 
Decay-accelerating factor (Daf), Cd59 (protectin), and serpinG (C1 inhibitor), showed induced 
expression on Salmonella infection in both tissues (table3).  
 
Table 2. Biological processes in ileal mucosa and Peyer’s patches affected by Salmonella infection.   
Process Mucosaa  Peyer’s patchesa 
  up down  up  down 
Day 1       
 Carbohydrate transport   3 -  3 - 
 Transcription                        2 2  1 - 
 Antimicrobial            - 2  - - 
Day 3       
 Immune response                           7 -  32 - 
 Detoxification                      - 3  1 - 
 Extra cellular matrix 3 -  7 - 
 Complement 3 -  4 - 
 Transcription                       2 1  - - 
 Inflammation - -  7 - 
Day 6       
 Immune response                         9 -  35 - 
 Detoxification                      - 6  1 3 
 Inflammation - -  6 - 
 Extra cellular matrix - -  3 - 
a Numbers represent the amount of genes within that process exceeding a twofold or greater differential expression between 
oral infected and sham-treated rats at day 1, 3 and 6 postinfection. 
Figure 2. Comparative transcription 
profiles of differentially expressed genes 
with a fold change greater than 2 in ileal 
mucosa and ileal Peyer’s patches of rats 
orally infected with Salmonella at 1, 3 or 
6 days postinfection compared to sham 
treated controls. For both tissues the 
total, unique, and shared genes are 
presented. The numbers of shared genes 
modulated by Salmonella are indicted in 
bold type. 
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Table 3. Gene expression changes in genes related to immune activation, inflammation, antimicrobial defense, complement 
pathway, detoxification, transport and housekeeping. 
  Fold Changeb
Mucosa  Peyer’s patches Gene Namea Gene  
symbol 
Common 
alternative  
Accession 
number    1          3          6          1           3           6   
Activation immune system         
Interleukin 1 beta  Il-1β Il1b NM_031512 - 1.9 - - 6.0 2.8 
Interleukin 1 alpha Il-1α Il1a NM_017019 - 1.5 - - 4.0 1.5 
Interleukin 6 Il-6 Il6 NM_012589 - - - - 3.2 - 
Chemokine (C-X-C motif) ligand 1  CXCL1 Groα NM_030845 - 1.6 - - 11.4 2.4 
Chemokine (C-X-C motif) ligand 2  MIP-2 Groβ NM_053647 - - - - 2.5 - 
Neutrophil chemoattractant-2 
beta 
MIP-2B Groγ NM_138522 - 3.2 1.7 - 6.4 3.8 
Chemokine (C-X-C motif) ligand 5 Cinc-5 Lix NM_022214 - 2.1 - - 4.0 1.9 
Chemokine (C-X-Cmotif) ligand 10  Cinc-10 IP10 U22520 - 1.8 1.6 - 7.3 9.5 
Chemokine (C-X-Cmotif) ligand 11  Cinc-11 I-TAC AF179872 - - - - 5.2 6.6 
Chemokine (C-C motif) ligand 3  CCL3 Mip-1A NM_013025 - - - - 3.2 1.9 
Chemokine (C-C motif) ligand 4 CCL4 Mip-1B U06434 - - - - 2.2 1.7 
immunoglobulin alpha-chain IgA   - M13801 -1.6 -1.7 1.7 - - - 
immunoglobulin gamma-2a IgG2a   - L22654 - - - - - 2.0 
immunoglobulin gamma-2b IgG2b   - M13802 - - 1.7 - -1.6 1.7 
Inflammation markers         
Cyclooxygenase-2 Cox-2 Ptgs2 NM_017232 - - - - 2.2 - 
Nitric oxide synthase   Nos2 iNOS NM_012611 - 1.7 - - 5.0 2.4 
Superoxide dismutase Sod2 MnSod NM_017051 - - - - 4.5 3.1 
Calgranulin A  S100a8 NM_053822 - - - - 10.2 4.6 
Calgranulin B S100a9 
] 
Calpro
-tectin NM_053587 - 1.8 - - 5.8 2.3 
Lipocalin 2 Lcn2 Ngal X13295 - 3.5 2.4 - 34.3 12.7 
Pancreatitis associated protein III Reg3γ Pap3 U09193 - 2.0 1.9 - 2.6 1.7 
Antimicrobial defense, Paneth cell derived        
Defensin 5 Def5 Rd5 AF115768 -2.0 -2.2 - - - - 
Lysozym Lys   - NM_012771 -2.0 -1.8 - - - - 
Matrilysin MMP7   - NM_012864 -1.7 - 1.7 - - - 
Phospholipase a2, group iia Pla2g2a   - NM_031598 -1.4 1.9 2.6 - 2.0 2.1 
Complement pathway          
Tissue factor f3 F3 CD142 NM_013057 - 2.9 1.8 - 2.1 - 
Serine (or cysteine) peptidase 
inhibitor, clade G, member 1 
Serping
1 
C1Inh NM_199093 - 1.9 - - 1.8 2.2 
Decay accelerating factor GPI-
form 
CD55 Daf AB026903 - 2.8 1.8 - 2.8 1.9 
CD59 glycoprotein CD59 Protectin NM_012925 - 2.0 1.7 - 2.1 - 
Detoxification Phase I         
Cytochrome p450 1a1 Cyp1a1  - NM_012540 - -1.8 - - - - 
Cytochrome p450 2j4 Cyp2j4  - NM_023025 - - -2.0 - - - 
Cytochrome p450 2c24 Cyp2c24  - S59652 - -1.6 -3.8 - - -1.6 
Cytochrome p450 3a9 Cyp3a9  - U60085 - -1.5 -1.8 - -1.6 -1.5 
Cytochrome p450 4f1 Cyp4f1  - NM_019623 - -2.0 -2.4 - -1.8 -2.2 
Cytochrome p450 17a1 Cyp17a1  - NM_012753 - -1.8 -2.1 - -1.7 -1.9 
Cytochrome p450 7b1 Cyp7b1  - U36992 - 1.8 - - 3.4 1.9 
Epoxide hydrolase 1  Ephx1  - NM_012844 - -2.4 -2.2 - -1.7 -1.9 
Carboxylesterase 1 Ces1  - NM_031565 - -1.7 -1.7 - -1.8 -1.7 
Detoxification Phase II         
UDP glucuronosyltransferase 1 Ugt1a6  - D38067 - -2.0 -2.0 -1.6 - -1.8 
Glutathione S-transferase alpha 2 Gsta2  - NM_017013 - -1.7 - - -1.8 - 
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Glucose transporters           
glucose transporter Glut 5 Slc2a5 Glut5 NM_031741 3.3 - 1.5 1.8 - - 
na+/glucose cotransporter SGLT1 Slc5a1 Sglt1 NM_013033 2.9 1.5 - 2.4 - - 
glucose transporter Glut 2 Slc2a2 Glut2 NM_012879 2.9 1.7 - 2.3 - - 
glucose-transporter protein Slc2a1 Glut1 M22063 - - - - 1.9 1.7 
Lipid transporters           
apolipoprotein b  Apob   - U53873 1.9 - - 1.9 - - 
Apolipoprotein A-I Apoa1   - NM_012738 - - - - -2.6 - 
Apolipoprotein A-IV Apoa4   - NM_012737 - -1.7 -1.7 - -2.4 - 
lipid-binding protein Fabp5 E-Fabp U13253 - 2.0 1.7 - - 2.5 
sodium-dependent bile acid 
transporter 
Slc10a2   - NM_017222 1.9 - 1.5 - - - 
Other transporters           
organic anion transporter Phase I Slc22a7 Oat2 NM_053537 - 2.6 1.9 - 1.9 2.3 
oligopeptide transporter,  
member 1  
Slc15a1 Pept1 NM_057121 1.8 - - - -2.0 - 
Housekeeping genesc          
Actin beta  Actb  - NM_031144 -1.1 1.2 1.2 -1.4 1.5 -1.1 
Glyceraldehyde-3-phosphate 
dehydrogenase  
Gapdh  - 
NM_017008 1.1 1.1 -1.1 1.2 1.1 1.4 
Aldolase a, fructose-bisphosphate  Aldoa  - NM_012495 -1.1 -1.1 1.1 -1.1 1.3 1.4 
Phosphoglycerate kinase 1  Pgk  - NM_053291 1.1 1.3 1.0 1.2 1.3 1.3 
Adp-ribosylation factor 1  Arf1  - NM_022518 1.2 -1.2 1.1 -1.2 1.0 1.1 
H3 histone, family 3B  H3f3b  - BC086580 -1.1 1.0 1.0 -1.1 -1.1 1.0 
Succinate dehydrogenase 
complex, subunit A  
Sdha  - 
NP_569112          1.0 -1.1 1.0 1.1 -1.1 -1.1 
Pleckstrin homology domain-
containing family A member 3  
Plekha3  - 
NM_001013077   1.0 1.0 1.0 1.0 1.1 1.0 
a Genes with a fold-change in expression between rats that were orally infected by Salmonella relative to their sham-treated 
controls. The genes with fold-change greater than 1.5 are given for day 1, 3 and 6 postinfection in ileal mucosa and Peyer’s 
patches. 
b Fold change > 2.0 is shown in bold; a minus sign indicates lower expression in Salmonella-infected animals. 
c The fold change in expression of housekeeping genes is given for all groups. 
 
Detoxification genes 
A second group of  affected genes were detoxification genes, which showed lower expression at 
days 3 and 6 p.i. (table 3). This group consisted of  both phase I and II genes. Phase I genes 
encoding cytochrome P450 1a1 (Cyp1a1) , Cyp2j4, Cyp2c24, Cyp3a9, Cyp4f1, Cyp17a1, epoxide 
hydroxylase 1 (Ephx1), and carboxylesterase 1 (Ces1) showed lower expression, with the exception 
of  Cyp7b1 expression which was higher. Expression of  two phase II genes, encoding UDP-
glucuronosyltransferase 1 (Ugt1) and Glutathione S-transferase alpha 2 (Gsta2), was also lower. 
 
Transporters 
A third category of  genes affected by Salmonella infection was transporters (table 3). Three 
carbohydrate transporters, the apical located Sglt1 and Glut5 and basolateral located Glut2 showed 
higher expression, primarily at day 1 in both tissues studied. The other transporters that were 
affected showed diverse expression patterns (table 3).  
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Validation of Salmonella-regulated genes in individual animals by Q-PCR. 
To verify the Salmonella modulation of  certain biological processes, we selected genes from 
every process for Q-PCR confirmation. Pooled Q-PCR analysis was performed on genes 
involved in antimicrobial defense (Def  5, Lys, Mmp7), chemotaxis (Groα), inflammation (Lcn2, 
Pap3), phase I detoxification metabolism (Cyp3a9, Cyp4f1, Cyp1a1, Ephx), and glucose transport 
(Slc5a1, Slc2a2, Slc2a5). For individual analysis the genes Def5, Lcn2, Pap3, Cyp4f1 and  
 
Table 4. Gene expression differences (fold change) analyzed by DNA microarray and Q-PCR.  
Fold Changea. 
Ileal Mucosa  Peyer’s patches  
Gene 
symbol 
Accession 
number Micro 
array 
Q-PCR 
poolb
Q-PCR 
individualc
Microarray 
Q-PCR 
poolb
Q-PCR 
individualc
Day 1 Def5 AF115768 -2.0 - -2.2 - - - 
 Lys NM_012771 -2.0 -3.3 - - - - 
 MMP7 NM_012864 -1.7 -3.3 - - - - 
 Slc2a5 NM_031741 3.3 3.2 - 1.8 4.0 - 
 Slc2a2 NM_012879 2.9 3.8 - 2.3 8.4 - 
 Slc5a1 NM_013033 2.9 1.9 2.5 2.4 3.5 5.2 
Day 3 Groα NM_030845 1.6 - 3.0 11.4 - 13.0 
 Pap 3 U09193 2.0 - 4.2 2.6 - 3.7 
 Lcn X13295 3.5 - 5.2 34.3 - 30.1 
 Cyp1a1 NM_012540 -1.8 -5.0 - - - - 
 Cyp3a9 U60085 -1.5 -2.0 - -1.6 -1.4 - 
 Cyp4f1 NM_019623 -2.0 -2.5 -1.6 -1.8 -2.0 -2.0 
 Ephx NM_012844 -2.4 -2.5 - -1.7 -2.0 - 
Day6 Cyp3a9 U60085 -1.8 -2.5 - - - - 
 Cyp4f1 NM_019623 -2.4 -5.0 -3.6 -2.2 -2.5 -2.0 
  Ephx NM_012844 -2.2 -2.5 - -1.9 -1.3 - 
a Data are given as fold-change between rats that were orally infected by Salmonella and their sham-treated controls.  
b Fold change based on Q-PCR data of pooled samples. 
c Average fold change based on Q-PCR data of individual samples (n=8). The fold-change for Q-PCR was normalized against 
reference gene β-actin.  
 
Slc5a1 were chosen. β-Actin (Actb) and pleckstrin homology domain-containing family A member 
3 (Plekha3) were selected as reference genes because they showed constant and treatment-
independent expression in the array data (data not shown). All Q-PCR analyses on individual and 
pooled samples of  both IM and PP confirmed the microarray data since relative gene expression 
changes were similar using both methods (see table 4). In noninfected control animals, the 
expression of  Groα and Lcn2 was close to background, which may have affected the precise fold 
change. Analysis of  the individual samples by Q-PCR generally revealed large inter-individual 
variation in gene expression within treatment groups (figure 3). The gene expression of  several 
genes known to be affected by Salmonella in in vitro studies such as Tlr5 and the nuclear factor кb 
(Nf-кb) subunits RelA and P105 were not found to be affected based on array data. Q-PCR 
analysis confirmed the lack of  induction in this in vivo study (figure 3).  
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Figure 3. Individual mRNA expression of Na+/glucose cotransporter (Slc5a1), cytochrome P450 4f1 (Cyp4f1), defensin 5 
(Def5), pancreatitis-associated protein 3 (Pap3), lipocalin 2 (Lcn2),  chemokine Groα, Nuclear factor kappa-B, p105 (NF-кB) and 
Toll-like receptor 5 (Tlr5) of sham treated control rats (mean is set as 1) and of rats at 1, 3 and 6 days after oral infection by 
Salmonella as analyzed by Q-PCR. The expressions of the genes are relative to β-actin in ileal mucosa and in Peyer’s patches 
for the individual animals. Dotted line indicate lowest mRNA standard. The mean gene expression value within each group is 
indicated —. The asterisk indicates p< 0.05(*), p<0.01 (**), when comparing the infected group and the control group. Def5 
normalized with reference gene β-actin gave p= 0.07 for day 1 p.i., normalization with Plekha3 reached p<0.05. 
 
 
Discussion  
 
Overall in vivo response 
In this study, we used microarrays to follow the Salmonella enteritidis-induced gene expression 
changes in the ileum of  Wistar rats with time. In two target tissues, the IM and the ileal PP, only a 
very limited number of  genes was changed at 1 day p.i. Altogether, only 0.2% - 0.9% of  the 
genes in IM show a differential gene expression at day 1 through day 6 p.i. This contrasts with in 
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vitro responses of  human intestinal epithelial cells, where 5-35% of  the genes were found to be 
affected within the first 20 hours after infection with Salmonella compared with noninfected 
controls13. Infection of  intestinal cell lines (T84, CaCo-2) with other enteric bacteria for up to 3 
hours resulted in 4% differentially expressed genes compared to non-infected cells 36,49. Moreover, 
not only the number but also the magnitude of  most responses in our in vivo study are relatively 
small compared with gene expression changes in vitro, which may change up to 90-fold. Studies in 
bovine ileal loops infected with S. typhimurium showed an eight-fold increased expression of  pro-
inflammatory chemokine and cytokine genes within 6 hour p.i.43. In fact, no correlation 
(r2=0.0004) was found if  the genes that were found to be more than twofold altered in vitro in 
HT29 cells 3 hours after infection with  Salmonella 13 were compared with the in vivo response of  
the same 30 genes that were present in this study (see supplemental figure 2.1, and supplemental 
table 2.2). 
In vitro models can provide insight in mechanistic aspects of  Salmonella-host interaction in vivo. 
However, the large gene expression responses observed in Salmonella infection studies with HT-
29 cells13 are in contrast with the limited gene expression response observed in Salmonella 
infected intact mucosa or PP presented in our in vivo study. The overlap in genes observed to 
change in  in vitro studies13 and our in vivo study is very small. Several chemokines (Mip2/ Mip2α, 
Groα/Il-8) are induced in both type of  studies, but even then the time frame (3 hours in vitro 
versus 3 days in vivo) and magnitude clearly differ (91.5 and 78.0 fold in vitro and 1.4- and 2.5-fold 
in vivo for Il-8 and Mip2α, respectively).  
The in vitro response to Salmonella infection seems unphysiologically reactive, possibly due to the 
absence of  a protective intestinal microflora, mucus layer, and mucosal secretion of  
antimicrobials. As a result of  the absence of  these barriers, the number of  invasive Salmonella’s 
per cell is likely much higher in vitro than in vivo, and this will affect the response of  these cells. 
Additionally, whereas in vitro homogeneous cell types are studied, a natural heterogeneous mixture 
of  cell types is studied in vivo. This may affect the type and magnitude of  the gene expression 
response. It should be realized that a response of  a limited number of  specific cells to Salmonella 
at early time points of  the infection might have been missed in the present study due to possible 
dilution of  these cells in the heterogeneous cell populations present in the ileal mucosal scrapings 
and PP. Identification of  cell type-specific responses of, e.g., dendritic cells or other potential 
target cells can be addressed using laser microdissection to isolate a specific cell type before RNA 
isolation.  
The absence of  gene expression effects of  expected chemokines and cytokines at day 1 in the 
present in vivo study and the larger gene expression effects in vitro and ex vivo are in line with 
differences in phenotypic, physiological observations. Where in vitro systems show massive cell 
death at 24 hours and ileal loop models show epithelial detachment after 8 hours of  exposure to 
Salmonella63, no inflammatory changes are seen at the first day after oral infection with 
Salmonella in vivo44. This late in vivo response is also seen in our study, where NOx  a marker of  the 
a-specific immune response, increased from day 3 onward. It should be noted that at day 1 day 
p.i. high Salmonella numbers were observed in the MLNs in the present and previous studies4,5, 
demonstrating translocation of  Salmonella at this early time point.  
That translocation of  this pathogen did not provoke extensive early gene expression changes in 
vivo may indicate that Salmonella infection is a targeted and controlled process. In living 
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organisms gut epithelial cells are in continuous and intimate contact with gut bacteria. It is known 
that these host-microbe interactions are important for keeping inflammatory processes in check. 
The inflammatory response can be repressed by the microflora,9,19,24, Also, the surrounding host 
cells suppress signals, e.g. epithelial cell-derived factors influence dendritic cell responses which 
may regulate the generation of  an inflammatory response to bacteria41. Communication and 
feedback mechanisms between different mucosal cell types help to maintain mucosal 
homeostasis. Cell lines in vitro miss contact with other cell types and the modulating effect that 
commensal bacteria may have.  
Another possible, but less likely, explanation for the small gene expression changes observed in 
this in vivo study could be related to host specificity of  Salmonella-induced responses. The 
pathogenicity of  Salmonella serovars can be animal species-specific18,46,55 and Salmonella in vitro 
studies are mostly performed in human cell lines20. However, many aspects, such as time-course 
effects of  Salmonella colonization and translocation, are largely similar in this rat model 
compared with humans 3,5,15. 
 
Site of Salmonella invasion, mucosal glucose metabolism and defense 
Based on the number of  genes altered by Salmonella, the IM showed an earlier response than the 
PP. This may indicate that in rat the IM, and not PP, is the first site of  interaction or invasion. 
Within this early response, we newly identified that Salmonella changed genes related to glucose 
metabolism. These glucose metabolism-related genes, sodium-dependent glucose transporter 
(Sglt1), fructose transporters Glut5 and Glut2, and sucrase-isomaltase (SI) (fold change 2.9 in IM 
at day 1 p.i.), are expressed in enterocytes, which implies that the enterocytes are the first contact 
or entry site of  Salmonella infection. The expression of  Sglt1, Glut,5 and Glut2 in the PP most 
likely originates from enterocytes overlying the PP45. The upregulated glucose transport may be 
triggered by a higher glucose need of  infected cells, which has been reported in cells infected by 
chlamydia and viruses34,47. Altered cell metabolism may also explain the differential expression of  
other transporters (e.g. lipid transports Apob, Apoa1 and 4, E-Fabp, SLC10a2, peptide transporter 
Pept-1 and organic anion transporter Oat2). Salmonella decreased the expression of  genes 
important for host defense against bacterial intruders [(defensin 5 (Def5), lysozyme (Lys), 
matrilysin (Mmp7) and secretory phospholipase A2 (Pla2g2a)] at the early time point. Reduced 
expression of  α-defensin and lysozyme was also reported in mice inoculated with S. typhimurium42. 
Defensin, lysozyme and matrilysin are expressed by Paneth cells located in the bottom of  the 
mucosal crypts. These early changes suggest that, among the different cell types lining the IM 
(enterocytes, Paneth cells, goblet cells, and neuro-endocrine cells), the Paneth cells and 
enterocytes are a target for Salmonella. Based on these results it seems that the IM is at least as 
important as the PP as the major site of  early Salmonella invasion. This enterocyte-targeted 
invasion of  Salmonella has also been reported in experiments with calves 14, pigs 27, and rabbits 57.  
 
Detoxification 
Phase I and phase II detoxification enzymes in both IM and PP showed decreased expression, 
coinciding with increased expression of  inflammatory genes. This was not caused by dilution of  
epithelial cells, since the expression of  I-Fabp, a control for epithelial content31, showed no 
significant differential expression. One explanation for the decreased expression of  detoxification 
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genes might be that this allows optimal defense by immune cells. Down-regulation of  
cytochrome P450 gene expression is known to be induced by inflammatory mediators such as 
reactive oxygen species, nitric oxide, IFN, or cytokines (Il-1, transforming growth factor β)29,40 
and is also observed in mucosal biopsies from IBD patients 26. Alternatively, the expression may 
be actively reduced by Salmonella, especially since the Ah receptor nuclear translocator (Arntl), 
which is the transcription factor regulating Cyp1a1, Ugt1a6 and Gsta261, shows decreased 
expression at day 1 (fold change -2,1 in IM).  
 
Innate immune response 
Despite clear translocation of  Salmonella from the intestinal lumen to the MLN (table 1), no 
increased expression of  immune response genes was seen at day 1 p.i., neither in the PP nor in 
the IM (tables 2 and 3). So far, most of  the studies focusing on host gene expression responses 
on exposure to micro-organisms have been performed in vitro 20. At later time points, we observe 
in vivo some genes (Il-1α, Il-1β, Groα, Groγ, iNos) that are a confirmation of  former in vitro 
infection studies20, but we also observe that some genes well known to be upregulated by 
Salmonella in in vitro studies62, such as Tlr5 and the Nf-кb subunits RelA and P105, were not 
found to be affected based on array data. To exclude that the absence of  differential gene 
expression was due to a technical issue, we examined the differential expression of  Tlr5 by Q-
PCR analysis in individual samples and confirmed the absence of  differential expression (figure 
3). Also the main downstream signaling molecule, NF-кB p105 subunit, was not regulated (figure 
3). This was also the case for the NF-кB relA subunit (data not shown). 
 Despite the absence of  gene expression changes, this pathway seems to be activated, since we 
observed differential expression of  targets of  TLR and NF-кB activation such as cytokine, 
chemokine and inflammatory response genes (Il-6, Groα, β, γ, iNos, Cox2, Sod2)22,52, at the later 
time points. That the immune response genes could not be observed at day 1 may result from 
induction in a limited number of  cells or specific cell types, which are diluted in the 
heterogeneous cell population of  the mucosal scrapings and PP.  Another explanation might be 
modulation at posttranscription level, which escapes detection at transcription level. 
 
Recruitment 
Salmonella invasion is characterized by recruitment of  monocytes, neutrophils and dendritic cells 
to the infected area60. Indeed, later time-points showed a prominent increase in the expression of  
genes involved in chemotaxis, including several CC-chemokines (CCL3, CCL4) and several CXC 
chemokines (CXCL1, MIP-2, MIP-2B, Cinc-5, Cinc-10, Cinc-11). These genes were among the 
most highly differentially expressed genes in this study, particularly in the PP. Another prominent 
group of  genes in PP are inflammation related genes. The stronger induction of  genes involved 
in chemotaxis and inflammation in PP compared with IM suggests either a higher Salmonella 
invasion of  the PP at later time points or a stronger secondary response induced by more 
recruitment of  leukocytes to this tissue.  
 
Damage control 
Protective mechanisms against epithelial barrier disruption show differential expression at later 
time points. This late induction is most likely stimulated to limit inflammation-induced damage to 
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the mucosa. This is best reflected in the increased expression of  Daf  and Cd59. These are 
inhibitors of  the complement cascade and aid restoration of  blood flow in the microvasculature.  
 
Markers 
At days 3 and 6 on Salmonella infection, expression of  the general inflammatory mediators Cox2, 
iNOS and Sod2, Pap3, Lcn and calprotectin (S100A8 and S100A9) was strongly increased. 
Calprotectin, Pap3 and Lcn, are all highly expressed in the chronically inflamed mucosa of  
inflammatory bowel disease (IBD) patients and in animal models of  this disease6,12,23,33,58. 
Obviously, generic mechanisms are involved in acute inflammation due to Salmonella infection 
and chronic inflammation in IBD, despite different pathologies. Possibly, Pap, Lcn2 and 
calprotectin could serve as general markers for gastrointestinal inflammation. Since these markers 
are all secreted into stool, resistant to degradation by intestinal contents, and easily measured 
6,11,30, they might be very useful to follow the course of  an inflammatory period by non-invasive 
means. 
 
Responses driven by Salmonella 
The present study focused on Salmonella-induced changes in intestinal processes. Some 
identified processes such as defense and immune response are a confirmation of  known effects 
of  pathogens on the host. But others, such as changes in detoxification and transporter genes, are 
not related to infection before. We cannot discriminate whether these induced changes are 
directly caused by Salmonella or secondary effects of  infection-induced inflammation. Induction 
by Salmonella itself  cannot be excluded, since it is known that microbes are able to induce host 
gene expression for their own benefit. Salmonella uses its own type III secretion system to alter 
host cell processes, including apoptosis, cytoskeletal function and cytokine production1,25,28. Other 
than pathogens,  commensals can also actively induce host gene expression and thus affect 
important physiological functions8,9. Most of  these results originate from in vitro studies. The in 
vivo relevance for (intestinal) host resistance and gut barrier functioning should be addressed in 
future studies.  
 
Technical aspects 
Microarray analysis provided an overview of  processes in rat ileum that are affected by oral 
infection of  Salmonella. The processes that were obtained were not selected using random sets 
of  187 genes (data not shown), indicating that these processes are truly affected by Salmonella 
and not selected by chance. To further confirm the selection of  processes, selected genes, 
representative of  various physiological processes, were investigated by Q-PCR in individual rats. 
The individual genes showed a statistically significant change within the group (n = 8 rats), 
indicating that these genes are truly affected by Salmonella and not purely by chance. These 
analyses revealed a high variation in expression among different rats within a treatment group, a 
finding most likely resulting from the genetic heterogeneity of  the outbred Wistar rats used in the 
present study. Use of  inbred animals likely reduces heterogeneity but has the disadvantage that 
observed effects may be specific for a particular genetic background59 and thus hamper 
translation to humans. The large interanimal variation observed has implications for future 
studies. Using the same setup, it will be difficult to identify differential responses below twofold. 
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Such a twofold differential response may already constitute a relevant and large physiological 
response, especially if  this occurs in several genes in the same pathway simultaneously. Despite 
the relevance of  relatively small changes in gene expression, it will be technically difficult to study, 
e.g., the preventative effects of  dietary components or the therapeutic effects of  new drugs on 
infection-induced processes by current PCR- or array-based methods. To deal with this limitation 
and to confidently identify smaller effects, it would be best to include more animals per treatment 
group and to perform array hybridization of  individual samples. This allows identification of  
differentially expressed genes, not only based on magnitude of  change but also on statistical 
power. 
 
 
Conclusion 
 
In conclusion, the present in vivo study reveals that Salmonella enteritidis induces small gene 
expression changes in the ileum of  Wistar rats. Especially at day 1 p.i. a very limited response in 
gene expression was observed despite marked translocation of  Salmonella to the MLNs. 
Remarkably, the few early changes observed occurred in the IM. This may indicate that IM but 
not PP is the primary target for Salmonella translocation, at least in rats. The more various gene 
expression changes at days 3 and 6 p.i. were mainly observed in the PP and were related to 
immune cell recruitment and inflammation. Infection-induced inflammatory genes overlap with 
those reported to be up-regulated in inflammatory bowel disease, and may thus be explored as 
general markers of  intestinal inflammation. Finally, we newly identified that mucosal glucose 
metabolism and detoxification capacity are affected by Salmonella infection in the rat. 
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Abstract 
 
Background 
Salmonella enteritidis is suggested to translocate in the small intestine. In vivo it induces gene 
expression changes in the ileal mucosa and Peyer’s patches. Stimulation of Salmonella 
translocation by dietary prebiotics fermented in colon suggests involvement of the colon as well. 
However, effects of Salmonella on colonic gene expression in vivo are largely unknown. We aimed 
to characterize time dependent Salmonella-induced changes of colonic mucosal gene expression 
in rats using whole genome microarrays. For this, rats were orally infected with Salmonella 
enteritidis to mimic a foodborne infection and colonic gene expression was determined at days 1, 3 
and 6 post-infection (n=8 rats per time-point). As fructo-oligosaccharides (FOS) affect colonic 
physiology, we analyzed colonic mucosal gene expression of FOS-fed versus cellulose-fed rats 
infected with Salmonella in a separate experiment. Colonic mucosal samples were isolated at day 
2 post-infection.  
Results 
Salmonella affected transport (e.g. Chloride channel calcium activated 6, H+/K+ transporting 
Atp-ase), antimicrobial defense (e.g. Lipopolysaccharide binding protein, Defensin 5 and 
Phospholipase A2), inflammation (e.g. calprotectin), oxidative stress related genes (e.g. Dual 
oxidase 2 and Glutathione peroxidase 2) and Proteolysis (e.g. Ubiquitin D and Proteosome 
subunit beta type 9). Furthermore, Salmonella translocation increased serum IFNγ and many 
interferon-related genes in colonic mucosa. The gene most strongly induced by Salmonella 
infection was Pancreatitis Associated Protein (Pap), showing >100-fold induction at day 6 after 
oral infection. Results were confirmed by Q-PCR in individual rats. Stimulation of Salmonella 
translocation by dietary FOS was accompanied by enhancement of the Salmonella-induced 
mucosal processes, not by induction of other processes.  
Conclusions 
We conclude that the colon is a target tissue for Salmonella, considering the abundant changes in 
mucosal gene expression.  
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Background 
 
Foodborne infections cause a major burden on public health services and represent significant 
costs in many countries. Salmonella infection is one of the most common and widely distributed 
foodborne diseases and can be severe in the young, the elderly and patients with weakened 
immunity. Salmonella enteritidis is the most frequently isolated serotype, causing gastroenteritis in 
most humans and systemic infection in a subpopulation4,23. The precise mechanisms of 
Salmonella-host interaction in vivo at early time points after infection are not well known. Insight 
in pathogen-induced host processes in vivo could help to design therapeutic or nutritional 
strategies for infection prevention. An approach to investigate the effects of a pathogen on host 
target cells is the use of microarrays that contain the whole genome of the host. This broad 
approach can reveal biological processes affected by the pathogen. The rat is a good model to 
study Salmonella enteritidis-induced host processes, since salmonellosis in the rat shares many 
features of human disease 21. Besides gastroenteritis, a self-limiting systemic infection is observed 
in rats. The ileum is thought to be the main site of Salmonella invasion in both humans and rats49. 
For this reason we have previously studied Salmonella-induced gene expression in the ileum of 
rats. This study showed that Salmonella affects only a small number of genes at early time points 
post-infection 58. Carbohydrate transport, antimicrobial defense and detoxification were the main 
affected biological processes. At later time points large numbers of inflammation genes were 
found to be up-regulated in the ileal mucosa. The colon mucosa is supposed to be protected 
from Salmonella colonization by the abundant intestinal microflora. Pathogens entering the colon 
have to compete for nutrients and binding places with the endogenous flora. However, biopsies 
taken from humans during an infection with nontyphoid Salmonella setorypes suggest that the 
colon is involved in Salmonella infections41,46,72. As most studies focus on the ileum, which is 
thought to be the most likely site of translocation, only little information is available on 
Salmonella translocation in the large intestine 24. Besides indications from studies on biopsies, we 
have another reason to suspect colonic involvement in Salmonella infection pathology. We have 
shown earlier that diets supplemented with prebiotics such as fructo-oligosaccharides (FOS), 
lactulose and inulin consistently increased intestinal Salmonella translocation in rats3,5,18,69. As 
fermentation of FOS, and other prebiotics, occurs in cecum and colon and is very limited in the 
ileum of humans 2 and rats 22, it is unlikely that prebiotics facilitated translocation of Salmonella at 
that particular site. This is supported by the absence of ileal inflammation in FOS-fed and 
Salmonella-infected rats in contrast to profound cecal and colonic inflammation 5.To extend the 
current limited evidence indicating colonic involvement in Salmonella  infection, we used 
transcriptional profiling to investigate genes and biological processes in the rat colonic mucosa 
affected by Salmonella. We first studied colonic mucosal gene expression responses at days 1, 3 
and 6 after oral Salmonella infection of rats using whole genome microarrays and Q-PCR. In a 
second infection experiment, we studied whether the increased translocation of Salmonella by 
dietary FOS was reflected by amplification of Salmonella-induced gene expression changes in the 
colon.  
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Methods  
 
Time course infection study 
Animals, diet and infection 
The experimental protocols were approved by the animal welfare committee of  Wageningen 
University (Wageningen, the Netherlands). Specific pathogen-free male outbred 9 weeks old 
Wister rats (WU, Harlan, Horst, the Netherlands, n=48 in total), were housed individually in 
metabolic cages. All animals were kept in a temperature (22-24 C) and humidity (50-60%) 
controlled room with a 12 h light/dark cycle (lights on from 6 AM to 6 PM). Rats were fed a 
purified diet during the whole experimental period. The diet contained (per kg) 200 g acid casein, 
502 g glucose, 160 g palm oil, 40 g corn oil, 50 g cellulose, 35 g mineral mix (without calcium) 
and 10 g vitamin mix according to AIN93 recommendations 56. Diets were low in calcium 
content (20 mmol CaHPO4.2H2O/kg) and high in fat content (200 g fat/kg)6 to mimic the 
composition of  a Western human diet. Food and demineralized drinking water were supplied ad 
libitum. The animals were acclimatized to the housing and dietary condition for 11 days, after 
which they were orally infected with S. enteritidis (clinical isolate, phage type 4 according to 
international standards; B1214 culture of  NIZO food research, Ede, the Netherlands). 
Salmonella infection was performed by gastric gavage with 1 mL of  saline containing 3x109 
colony forming units (CFU) of  S. enteritidis. Non-infected rats received saline only (control). S. 
enteritidis was cultured and stored, as described earlier 68. Fresh fecal samples were collected on 
days 1, 2, 3 and 6 post infection (p.i.) and analyzed for viable Salmonella by plating 10-fold 
dilutions in sterile saline on Modified Brilliant Green Agar (Oxoid, Basingstoke, UK) and 
incubating aerobically overnight at 37°C. Sulphamandelate (Oxoid) was added to the agar plates 
to suppress swarming bacteria, such as Proteus species. The detection limit of  this method was 
102 CFU/g fecal wet weight. Total 24 h urine samples were collected from the day before oral 
infection of  the rats until day 6 after infection. Urines were preserved by adding oxytetracycline 
to the urine collection vessels of  the metabolic cages, and analyzed for the nitric oxide 
metabolites nitrite and nitrate (summed as NOx) by a colorimetric method (Nr. 1746081; Roche 
diagnostics, Mannheim, Germany).  
Rats were sacrificed on day 1, 3 or 6 post infection and control (n=8 rats per treatment and per 
time point). Rats were killed by carbon dioxide inhalation. Blood was collected by orbita 
puncture. Blood was coagulated for 30 minutes at room temperature, cooled to 4°C and 
centrifuged 20 minutes by 3000 g. Serum was collected and frozen at -80°C. The mesenteric 
lymph nodes (MLN), spleen and liver were excised aseptically, weighed, homogenized 
(Ultraturrax Pro200, Pro Scientific Inc. Oxford, CT) in sterile saline, serially diluted, and plated to 
culture for Salmonella, as described above. The detection limit was 102 CFU/g tissue. To obtain 
colonic mucosa, the colon was taken out, longitudinally opened and colonic contents removed by 
a quick rinse in 154 mM KCl. The mucosa was scraped off  using a spatula. The scrapings were 
immediately frozen in liquid nitrogen and stored at -80°C for RNA extraction.  
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RNA isolation 
Colon scrapings were homogenized in liquid N2 using a mortar and pestle cooled with liquid 
N2.(Fisher Emergo, Landsmeer, The Netherlands). Total RNA was isolated from these 
homogenates using TRIzol reagent (Invitrogen, San Diego, CA) according to the manufacturer’s 
instructions. Total RNA was purified using Rneasy columns (Qiagen, Chatsworth, CA). Absence 
of  RNA degradation was checked on a 1% TBE/agarose gel after 1 hour incubation at 37°C. 
The purity and concentration were measured with the Nanodrop (Isogen Life Science, Maarssen, 
The Netherlands). OD A260/A280 ratios were all between 2.08 and 2.10 indicating RNA of  high 
purity. 
 
Analysis of mRNA expression by Oligo Arrays 
For microarray hybridization, equal amounts of  RNA of  each animal were pooled per treatment 
group. Arrays were performed in duplicate. For this, RNA pools were split and separately reverse 
transcribed and labeled with Cy5. A standard reference sample, consisting of  a pool of  all colonic 
RNA was labeled with Cy3. For each oligo array, 35 μg of  total RNA was used to make Cy5 or 
Cy3 labeled cDNA. Total RNA was mixed with 4 μg T21 primer, heated at 65°C for 3 min (RNA 
denaturation) followed by 25 C for 10 min (primer annealing). cDNA was synthesized by adding 
5x first strand buffer (Invitrogen), 10 mM DTT, 0.5mM dATP, 0.5 mM dGTP, 0.5 mM dTTP, 
0.04 mM dCTP, 0.04 mM Cy5-dCTP or Cy3-dCTP, 1.2U RnaseOUT and 6U SuperScript II 
Reverse Transcriptase to a total volume of  62.5 μL. The reaction was incubated at 42°C for 2 h. 
Purification, precipitation and denaturation of  the labeled cDNA were performed as described 
earlier 70. 
The 44K rat whole genome Agilent array (G4131A, Agilent Technologies, Inc. Santa Clara, CA) 
used consists of  44290 60-mer rat oligonucleotides, including ~3000 control spots. The Cy5 
labeled cDNAs of  the Salmonella infected groups and the non-infected groups were mixed 1:1 
with the Cy3 reference labeled cDNA, mixed with 2x hybridization buffer (Agilent Technologies) 
and 10x control targets (Agilent Technologies) and hybridized for 17 hours at 60°C in Agilent 
hybridization chambers in an Agilent hybridization oven rotating at 4 rpm (Agilent Technologies). 
After hybridization the arrays were washed with an SSPE wash procedure (Agilent Technologies) 
and scanned with an Agilent Microarray Scanner (Agilent Technologies). 
 
Data analysis 
Signal intensities for each spot were quantified using Feature Extraction 8.1 (Agilent 
Technologies). The data of the time course infections study are available in Additional File 5 at 
the BMC website (http://www.biomedcentral.com) and have been deposited in NCBIs Gene 
Expression Omnibus50 and are accessible through GEO Series accession number GSE7496. 
Median density values and background values of each spot were extracted for both the 
experimental samples (Cy5) and the reference samples (Cy3). Quality check was performed for 
each microarray using both LimmaGUI package in R from Bioconductor 73 and Microsoft Excel. 
Data was exported into GeneMaths XT (Applied Maths, Sint-Martens-Latem, Belgium) for 
analysis. We discarded spots with an average intensity, over all arrays, of Cy5 lower than 2-fold 
above average background. Then, the Cy5 intensities were normalized against the Cy3 reference 
as described before 54. The gene expressions of duplicate arrays were averaged. Array data of non-
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infected rats, killed on section day 1 and 6 were highly comparable and could therefore be 
considered as one group and were averaged. For unknown reason, arrays of non-infected rats 
killed on day 3 showed reduced expression of 14 mast cell protease genes when compared with 
non-infected rats of both days 1 and 6, which were highly comparable. Therefore, we decided not 
to include the non-infected rats of day 3. Cluster analysis and Principle component analysis were 
performed using GeneMaths XT. Infected/control ratio’s between 0-1 were expressed as the 
negative inverse (-1/value) for easier interpretation. Genes that changed more than 2-fold in 
comparison with controls at one of the time points studied were selected for pathway analysis. 
Pathway analysis was performed using two pathway programs, MetaCore (GeneGo Inc, St. 
Joseph, MI)16and ErmineJ 40, using Agilent gene annotation (Agilent Technologies, version 
20060331). Processes were identified using statistical over-representation in both pathway 
programs. Since only 40% of the genes were annotated to GO processes in both pathway 
programs, processes with a p-value<0.001 were manually supplemented with non-annotated 
genes with FC>2 using biological databases (BIOcarta, SOURCE, GenMAPP, KEGG) and 
scientific literature.  
 
Analysis of mRNA expression by Real-time Quantitative RT-PCR 
Real-time Quantitative RT-PCR (Q-PCR) was performed on individual samples (n=8 per group). 
1 µg of  RNA of  all individual samples was used for the cDNA synthesis using the iScript cDNA 
synthesis kit of  Bio-Rad Laboratories (Veenendaal, The Netherlands). Real-time reactions were 
performed by means of  the iQ SYBR Green Supermix of  Bio-Rad using the MyIQ single-color 
real-time PCR detection system (Bio-Rad). Each reaction (25 µl) contained 12.5 µl iQ SYBR 
green supermix, 1 µl forward primer (10 μM), 1 µl reverse primer (10 μM), 8.5 µl RNase-free 
water and 2 µl diluted cDNA. The following cycles were performed 1x 3 min at 95°C,  40 
amplification cycles (40x 10 s 95°C, 45 s 60°C), 1x 1 min 95 °C, 1x 1 min 62 °C and a melting 
curve (80x 10 s 55 °C with an increase of  0.5 °C per 10 s). A negative control without cDNA 
template was run with every assay. The optimal melting point of  dsDNA (Tm) and the efficiency 
of  the reaction were optimized beforehand. Data were normalized against the reference genes 
Ribosomal protein S29 (Rps29), ADP-Ribosylation Factor 1 (Arf1) and β-actin. Rps29 and Arf1 
were chosen on the basis of  microarray data which showed similar expression levels for all 
microarrays, β-actin was chosen as this is a well accepted reference gene. Primers were designed 
using Beacon designer 4 (Premier Biosoft International, Palo Alto, CA). For sequences see 
supplemental table 3.1. A standard curve for all genes including reference genes was generated 
using serial dilutions of  a pooled sample (cDNA from all reactions). mRNA levels were 
determined from the appropriate standard curve. Samples with mRNA levels below the lowest 
standard value, and thus below detection level, were given half  the value of  this lowest standard. 
Analysis of  all individual samples was performed in duplicate.  
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Serum Interferon Gamma 
The serum Interferon Gamma (IFNγ) concentration of individual rats was determined by an 
enzyme-linked immunosorbent assay (ELISA) specific for rats (Biosource International, 
Camarillo, CA) according to the manufacturer’s protocol.  
 
Dietary infection study 
Animals, diet and infection   
A dietary intervention was performed to study the effect of  FOS on S. enteritidis-induced gene 
expression. Specific pathogen-free male outbred Wister rats (8 weeks old, mean body weight of  
253 g; n=48 in total) were housed as described above (time course infection study). Rats were fed 
the same diet as described above. The experimental diets both contained 20 g/kg cellulose and 
were supplemented with either 60 g/kg FOS (purity 93%; Raftilose P95, Orafti, Tienen, Belgium) 
or additional 60 g/kg cellulose as described earlier 68. Animals were fed restricted quantities (14 
g/day) of  the purified diet. Restricted food intake was necessary to prevent differences in food 
consumption and hence differences in vitamin and mineral intake as observed earlier in FOS 
interventions 5. After an adaptation period of  14 days, rats were orally infected with 4x108 CFU 
of  S. enteritidis or control-treated as described above. On day 2 p.i., 12 infected FOS-fed rats, 12 
infected rats fed the cellulose diet, and 12 control-treated non-infected rats fed the cellulose diet 
were sacrificed to obtain colonic mucosal RNA. Two additional groups of  rats fed either FOS 
(n=6) or the cellulose diet (n=6) and infected with Salmonella were kept until day 8 p.i. for 
determination of  urinary NOx excretion in time as described above. 
 
Analysis of mRNA expression by Oligo Arrays and Real-time Quantitative RT-PCR 
RNA isolation and analysis of  mRNA expression by microarray (pooled samples) and Q-PCR 
(n=12 per treatment group) were performed as described above. Arrays were scanned with a 
Scanarray Express HT scanner (Perkin Elmer). Signal intensities for each spot were quantified 
using ArrayVision 8.0 (GE Healthcare life sciences). Data analysis was performed as described 
above. The data of  the dietary infection study available in Additional File 6 at the BMC website 
(http://www.biomedcentral.com) and have been deposited in NCBIs Gene Expression Omnibus 
50 and are accessible through GEO Series accession number GSE7472. 
 
Statistical analysis 
Results are expressed as median or mean depending on normality of distribution as indicated. We 
used Prism 4 for all statistics (Prism 4, GraphPad software Inc., San Diego, CA). Data was 
analyzed using the Student’s t-test (two-sided). Non-normally distributed data was analyzed using 
the non-parametric Mann-Whitney U test (two sided). Differences were considered statistically 
significant when p<0.05. 
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Results 
 
Time course infection study 
General infection characteristics  
In agreement with previous studies, food consumption and growth of the Wistar rats were not 
affected by Salmonella infection6. Salmonella translocation to mesenteric lymph nodes was 
observed at days 1, 3 and 6 (table 1). This implies that at day 1, Salmonella has already crossed 
the intestinal barrier. In agreement with previous studies6,53 , Salmonella was detected in the 
spleen at days 3 and 6 and in the liver at day 6 (table 1). Urinary NOx excretion, a parameter of 
systemic infection, was found to be increased from day 3 onwards (figure 1a).  
 
Table 1. Viable Salmonella counts in feces, mesenteric lymph nodes, spleen, and liver of rats 1, 3 and 6 days post infection. 
   Salmonella (logCFU/g)a
 Control Day 1 p.i. Day 3 p.i. Day 6 p.i. 
Feces N.D. 7.22±0.19 5.92±0.24 6.04±0.32 
MLN N.D. 3.38±0.43 5.85±0.13 5.44±0.05 
Spleen N.D. N.D 3.20±0.33 3.49±0.05 
Liver N.D. N.D N.D 2.45±0.12 
 
 
 
 
 
 
 
a The rats were orally infected with 3 x 109 colony-forming units of S. enteritidis or control treated. Salmonella counts are 
expressed in log values as means ± SEM (n=8). N.D. = not detected. 
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Figure 1. Sum of urinary nitrate and nitrite (NOx) excretion in the non-infected (o), infected (■) groups of the time course 
infection study (A). And the urinary NOx excretion in the cellulose infected (■) and in the fructo-oligosaccharide (FOS) infected 
(▲) groups in the dietary infection study (B). Infected rats were orally challenged with S. enteritidis on day 0. Results are 
expressed as mean ± SEM (n=8 in the time course infection study and n=6 in the dietary infection study). * p<0.05. 
 
Salmonella-induced processes in colon mucosa 
To identify Salmonella-regulated processes, microarray-based gene expression profiling of colonic 
mucosa at days 1, 3 and 6 days p.i. was performed. The arrays contained 44000 spots of which 
32783 spots exceeded >2 times the background value and were included in the analysis. 
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Salmonella changed the expression of 330 genes >2-fold at least at one of the three time points 
studied. At days 1 and 3 p.i. comparable numbers of genes (70 and 57 genes, respectively) were 
affected by Salmonella infection in comparison with non-infected rats, while at day 6 
approximately four times more genes were affected (figure 2). This corresponded with 
progression of the infection as observed by the organ cultures and urinary NOx excretion as 
mentioned above. At all time points studied, most genes showed increased expression upon 
Salmonella infection, whereas only a small percentage of total regulated genes were down-
regulated (10% at day 1, 27% at day 3, 5% at day 6 figure 2). The genes that changed more than 
2-fold at any time point (FC> 2 infected/ non-infected) were classified into biological processes 
according to gene ontology terminology 16,40. Not all genes are annotated to GO processes. Forty 
percent of the genes on the array were annotated to GO processes. Therefore we manually 
supplemented the significant processes (p<0.001) with the remaining significant genes using 
biological databases and scientific literature. To prevent the occurrence of false positive genes, 
and over-interpretation of biological processes affected by Salmonella, we focused on biological 
processes with at least three genes exceeding the cut-off FC>2.0. Additionally, we observed that 
the genes within one biological process showed comparable patterns of expression (table 2), 
which strongly indicates that these processes are truly affected by Salmonella. 
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Figure 2. The number of differentially 
expressed genes with a fold change 
greater than 2 in colon mucosa of rats at 
days 1, 3 or 6 after oral infection with 
Salmonella or control treatment. 
We focused on the early Salmonella-induced gene expression changes occurring at days 1 and 3 
p.i. Presumably, these early modulated genes are more related to Salmonella-induced primary 
changes than gene expression at day 6 which is a secondary result of Salmonella-induced 
inflammation. Genes affected >2-fold on day 1 and/or day 3 p.i. that could be related to a 
biological process are shown in table 2. The biological processes that contained 3 or more 
modulated genes were transport, oxidative stress, immune response, antimicrobial defense, 
inflammatory response, interferon pathways and proteolysis. For more insight into these 
processes, genes that changed >2-fold at day 6 p.i. and also showing a >1.5-fold induction at day 
1 or 3 p.i. were also added to this table. Genes that changed >2-fold on day 6 p.i. only are 
available in Additional File 1 at the BMC website (http://www.biomedcentral.com). The gene 
most affected by Salmonella infection in the colon was pancreatitis associated protein (Pap), 
showing 11, 45 and 114 fold induction at days 1, 3 and 6 respectively.  
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Table 2. Processes regulated in colon by Salmonella at days 1, 3 and 6 after oral Salmonella infection.  
Fold Change infected vs non-
infected rats on different days p.i. 
Gene Name 
Gene 
symbol Sequence ID 
Time course infection 
studya
Dietary 
infection 
studyb
     Day 1 Day 3 Day 6 Day 2 
Transport       
Chloride channel calcium activated 6 Clca6 NM_201419 2,3 2,2 3,7 2,3 
Calcium channel, voltage-dependent, alpha 1I subunit  Cacna1i NM_020084 2,2 1,5 - 1,2 
Solute carrier family 4, member 1 (Slc4a1) , anion exchanger Slc4a1 NM_012651 2,0 1,7 - 1,0 
Atp-ase, H+/K+ transporting, nongastric, alpha polypeptide  Atp12a NM_133517 2,8 - 2,0 1,1 
Solute carrier family 20 (phosphate transporter), member 1  Slc20a1 NM_031148 2,1 - - -1,2 
Solute carrier family 15 (oligopeptide transporter), member 1 Slc15a1 NM_057121 2,0 1,5 1,6 0,9 
Transporter 1, ATP-binding cassette, sub-family B  Mdr/ Tap1 NM_032055 - 1,8 2,8 1,4 
Oxidative stress       
Dual oxidase 2  Duox2 NM_024141 1,9 2,4 2,8 1,6 
Glutathione peroxidase 2  Gpx2 NM_183403 - 2,3 3,0 2,2 
Xanthine dehydrogenase  Xdh NM_017154 - 1,8 2,5 1,4 
Immune response       
Rat class III Fc-gamma receptor  Fcgr3 M64368 2,1 1,6 - ND 
Immunoglobulin superfamily, member 4 Igsf4d XM_340958 2,1 1,6 1,4 1,1 
Rat MHC class I truncated cell surface antigen  RT1-Aw2 M10094 2,0 - 1,9 1,0 
Interleukin enhancer-binding factor 1  Ilf1 XM_221212 2,0 1,5 - 1,1 
Colony stimulating factor 2 (granulocyte-macrophage)   Csf2 XM_340799 2,0 1,6 - 1,2 
Interleukin 1 alpha  Il1a NM_017019 1,8 2,0 2,3 1,4 
Interleukin 1 beta  Il1b NM_031512 - 2,1 4,0 2,6 
TRAF2 binding protein T2bp NM_001014044 1,8 2,8 4,4 2,4 
Toll-like receptor 2   Tlr2 NM_198769 - 1,5 2,3 1,3 
Antimicrobial defense       
Lipopolysaccharide binding protein  Lbp NM_017208 1,9 1,8 2,2 1,3 
Defensin 5 precursor  (Enteric defensin)  Rd5 XM_214386 -1,9 -1,6 -1,6 ND 
Phospholipase A2, group IIA (platelets, synovial fluid)  Pla2g2a NM_031598 3,4 5,2 10,5 7,3 
Inflammatory response       
Pancreatitis-associated protein   Pap NM_053289 11,4 44,6 114,2 17,7 
Tissue-type transglutaminase   Tgm2 NM_019386 - 2,3 4,9 1,8 
Regenerating islet-derived 3 gamma   Reg3g NM_173097 - 2,3 4,3 1,9 
Nitric oxide synthase 2, inducible   Nos2 NM_012611 - 1,6 4,0 ND 
S100 calcium binding protein A8  S100a8 NM_053822 - 1,8 2,4 1,4 
S100 calcium binding protein A9  
Calprotectin   
S100a9 NM_053587 - 1,7 1,9 1,3 
Interferon       
Interferon-induced guanylate-binding protein 1  Gbp1 XM_221883 2,4 1,9 2,2 1,3 
Interferon gamma inducible protein  Ifi47 NM_172019 1,7 2,7 7,3 2,6 
Guanylate binding protein 2, interferon-inducible  Gbp2 NM_133624 1,6 2,4 3,1 1,7 
Interferon-induced protein Ifit2 NM_001024753 1,5 1,7 3,4 1,3 
Interferon-stimulated protein  G1P2 XM_216605 - 1,6 4,1 1,5 
Immunity-related GTPase family, M Irgm NM_001012007 - 1,8 3,7 1,4 
Signal transducer and activator of transcription 1  Stat1 NM_032612 - 1,7 3,6 1,8 
Interferon regulatory factor 7  Irf7 XM_215121 - 1,5 2,6 ND 
Alpha-interferon  Ifna XM_233145 - 2,0 - ND 
Proteolysis       
Ubiquitin D  Ubd NM_053299 1,7 2,5 15,2 3,4 
Proteosome (prosome, macropain) subunit, beta type 9 Psmb9 NM_012708 - 2,0 3,7 2,0 
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Protease, serine, 22  Prss22 XM_220222 - 2,0 2,6 1,6 
Potential ubiquitin ligase Herc6 XM_342700 - 1,7 3,3 1,5 
Proteasome (prosome, macropain) subunit, beta type 10  Psmb10 XM_214687 - 1,5 2,1 1,5 
a Values in bold exceed cut-off value FC>2 or FC<-2. Values -1,5 <FC< 1,5 are indicated by (-).  
b Fold Change infected vs non-infected rats fed a cellulose diet at day 2 p.i (obtained from the dietary infection study). All fold 
changes are shown. Genes not detected in this independent study are indicated by ND. 
 
Seventy genes changed>2-fold at day 1 p.i., of these genes 7 encoded for transporters and 5 
genes encoded for immune response proteins (table 2). At day 3 p.i., 57 genes showed FC>2, 
again including genes encoding for immune response proteins. Induced expression of Interleukin 
1β and 1α indicates activation of an inflammatory response. Induction of dual oxidase 2 and 
glutathione peroxidase 2 suggest oxidative stress in the colonic mucosa. At day 6 more than 200 
genes were induced more than 2-fold in infected mucosa compared with non-infected mucosa 
(Additional File 1 at BMC website). Most of these genes were related to immune and 
inflammatory responses. Processes related to inflammation-induced damage and repair, such as 
connective tissue remodeling and chemo-attraction also showed clear induction at day 6 p.i. To 
exclude the possibility that the observed changes were due to cellular changes of the mucosa, we 
analyzed expression differences of cell-type specific genes 26,37 (supplemental table 3.2). As 
transporters are most likely expressed by enterocytes 1, we examined expression of enterocyte 
specific genes (Fabp2, Vil2, Alpi2). These genes showed diverse regulation, indicating that the 
increased expression of transporters at day 1 is not due to altered enterocyte composition in the 
mucosal samples. A similar observation was found for Goblet cell specific genes (Muc2, Muc3, 
Tff1, Tff3) and Paneth cell specific genes (Rd5 and Pla2g2a). Expression of leukocyte specific 
genes was not altered at early timepoint, a mild increase was observed at day 6 p.i. Together this 
indicated that the observed Salmonella induced gene expression changes did not result from 
changes in cellular composition of the mucosa. This is in agreement with histology results from 
earlier Salmonella infection experiments, showing no or only minor deviations in intestinal 
mucosal architecture from healthy control slides (data not shown). This is further supported by 
the relatively constant expression of a group of well known housekeeping genes (supplemental 
table 3.2). The largest group of related genes induced by Salmonella infection in colon mucosa is 
related to interferon pathways as more than 20 IFNγ-regulated genes showed increased 
expression at at least one time point studied. The IFNγ-induced gene expression was most 
prominent at day 6 p.i, but already from day 1 onwards induction of several IFNγ-inducible 
GTPases (Gbp1, Gbp2, Ifi47, Ifit2) was seen (table 2). Furthermore at day 3 p.i. (table 2) induction 
of two members of the IFNγ- signaling pathway (Stat1 and Irf7) was observed. Despite induction 
of many interferon-related genes, increased expression of IFNγ mRNA itself could not be 
detected (changed 1.1-fold at days 1 and 3, and 1.3-fold at day 6 p.i.). IFNγ protein 
concentrations were measured in individual serum samples. IFNγ was not detected in serum of 
non-infected rats (all timepoints) and at the first day after Salmonella administration to rats. 
However, from day 3 p.i. serum IFNγ increased (figure 3). The serum IFNγ most probably 
originated from peripheral immune activation, as the increase in serum IFNγ followed the same 
trend as the increase in Salmonella CFU’s in peripheral organs (table 1). In the time course 
infection study, the kinetics of urinary NOx excretion are reflected by Nos2 gene expression in 
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colonic mucosal with a small 1.6-fold induction at day 3 p.i. and a 4 fold induction at day 6 p.i. 
(table 2). 
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Figure 3. Serum IFNγ levels before and after 
infection (days 1, 3 and 6 p.i.). Each dot 
represents an individual rat. Group medians are 
presented by a black line. * p<0.05, ***p<0.001. 
 
Q-PCR confirmation of Salmonella-induced gene-expression 
To determine inter-individual variation in gene expression within treatment groups, RNA from 
the colon of individual animals was analyzed by Q-PCR. We chose individual confirmation of 
Stat1 and Ifi47 to gain insight in inter individual interferon response as we also focused on the 
individual protein levels of IFNγ. Confirmation of Pap was chosen to obtain insight in the 
individual kinetics of the most strongly induced gene in colon mucosa at all time points. Q-PCR 
analysis showed rather large inter-individual variation among the outbred rats. Pap expression 
levels in the non-infected colonic mucosa were near detection level, which made it difficult to 
determine precise fold changes. Nevertheless, the Q-PCR analysis of the three genes examined 
clearly confirmed the gene expression changes observed in the microarray analysis (figure 4). To 
further validate the array data of the time course infection study we compared the gene 
expression changes of day 1 and 3 p.i. with gene expression data obtained from the independent 
dietary infection study at day 2 p.i. (table 2). Similar biological processes were induced at early 
timepoints in both studies. At individual gene expression level several transporter genes (Cacna1i, 
Slc4a1, Slc15a1) and immune response genes (Igsf4d, Ilf1, Csf2) showed no overlap possibly due to 
infection kinetics. However gene expression results of day 3 and day 2 p.i. largely overlapped 
(table 2). 
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Figure 4. Individual expression of two interferon-related genes and Pap in the colon mucosa at different time points after 
Salmonella infection or control treatment. Genes expression is quantified by Q-PCR, using Rps26 as reference gene (using Arf1 
as reference gene showed similar results; data not shown). Each dot represents an individual rat. Dotted line indicate lowest 
mRNA standard. Medians are presented by a black line. The median value of the uninfected group was set at 1.0. Y-axis is at 
log10 scale. * p<0.05, **p<0.01, ***p<0.001. 
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Dietary infection study  
General infection characteristics 
Food consumption and growth of the Wistar rats on both cellulose and FOS diet were similar, 
before and after infection. The section was performed on day 2 p.i. because similar effects on 
gene expression at days 1 and 3 were observed in the time course infection study. Furthermore 
we were interested in the primary responses as we expect that diet will mainly influence early 
events such as attachment to the mucosa and translocation of the pathogen. These events occur 
for the most part luminal where direct interaction between dietary components, pathogens and 
mucosa take place, while later phases merely reflect secondary infection and inflammation 
responses. At day 3 p.i. the serum IFNγ concentration and the amount of translocated 
Salmonella in the spleen are already high, which indicates systemic infection. At day 1 p.i. no 
serum IFNγ or Salmonella translocation to the spleen was observed. We chose day 2 p.i. as this 
seems the appropriate time point to study the effects of FOS on early Salmonella-induced 
changes. Salmonella colonization was quantified by determination of colony-forming units 
(CFU/g) in fresh fecal samples with time. At day 1 Salmonella levels were not significantly 
different between cellulose and FOS-fed animals (7.23 ± 0.11 and 7.10 ± 0.22, respectively). At 
day 2 FOS-fed rats had more Salmonella in feces than their cellulose counterparts (7.25 ± 0.25 
and 6.53 ± 0.25, respectively; p<0.05). Salmonella translocation to mesenteric lymph nodes and 
spleen was not significantly different in the FOS group compared to the cellulose group when 
quantified by CFU. Viable Salmonella counts in MLN were 5.96 ± 0.08 in the cellulose group 
and 6.19 ± 0.10 log10 CFU/g in the FOS group. Numbers in spleen were 2.85 ± 0.14 (cellulose) 
and 2.98 ± 0.16 log10 CFU/g (FOS). Counts in liver were under the detection limit of 102 CFU/g 
tissue in the cellulose and FOS group. These numbers are comparable to those observed in the 
time course infection study at day 3 and highly similar to numbers observed in earlier studies 
which showed increased translocation in FOS-fed rats at later time points after infection 68. To 
observe long term effects of FOS on Salmonella translocation in this study, urinary NOx 
excretion with time was determined in additional groups of rats. Urinary NOx excretion of FOS-
fed rats increased to 132 μmol/d at day 6 p.i. and started to decline towards baseline levels 
thereafter (figure 1B). Peak urinary NOx excretion of infected rats fed the cellulose diet was just 
one third of the level reached by the infected rats fed the FOS diet, i.e. 41 μmol/day (figure 1B). 
The NOx values for the cellulose diet are similar to those obtained in the time course infection 
study (figure 1A). The kinetics of urinary NOx excretion were similar in both diet groups, but 
total infection-induced urinary NOx excretion was higher in the FOS group indicating enhanced 
Salmonella translocation.  
 
Effect of dietary FOS on Salmonella-induced mucosal genes in colon mucosa 
The rats of the time course infection study and the rats in the dietary infection study on cellulose 
diet showed a comparable urinary NOx excretion and thus Salmonella translocation response. 
Despite the fact that the two studies were separately performed and different time points were 
studied, the identified biological processes affected by Salmonella at day two p.i. were comparable 
to processes observed at days 1 and 3 p.i. Furthermore both studies showed that more genes 
were up-regulated than down-regulated by Salmonella. For detailed analysis, we focused on the 
most robust genes, i.e. genes that showed similar Salmonella induced regulation in the two 
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independent studies. We choose a threshold of FC<1.5 for both studies, which is less stringent 
than the threshold we choose for analysis within one study (FC<2.0). We feel that this is 
legitimate, as genes with small but similar regulation in two completely independent studies are 
less likely to be selected by chance. Thirty-one genes fulfilled this criterion, 26 were up-regulated 
and 5 down-regulated. Eighteen of the up-regulated genes were categorized to the same 
processes found to be modulated by Salmonella in the colonic mucosa in the time course 
infection study, i.e. the transporter Clca6, the oxidative stress genes Gpx2 and Duox2, the immune 
response genes Il1b and T2bp, the antimicrobial defense gene Pla2g2a the inflammatory response 
genes Pap, Tgm2 and Reg3g, the interferon related genes Ifi47, Gbp2, Iigp2, P47Iigp, Stat1, G1p2 and 
the proteasome related genes Psmb9, Prss22, Psmb10, Ubd (Table 2). The other 8 up-regulated 
genes which could not be grouped to a specific process were Palmitoyl-protein thioesterase, 
Schlafen 3 (Slfn3), Tripartite motif protein 15 (Trim15), Aquaporin 3 (Aqp3) and four unknown 
genes. The 5 down-regulated genes were Heat shock protein 70kD 1A (Hspa1a), Resistin like 
alpha (Retnla), Resistin like gamma (Retnlg), Collectin sub-family member 10 (Colec10) and 
Mammalian suppressor of Sec4 (Mss4). Not all processes that were identified in the time course 
infection study at both days 1 and 3 p.i. were confirmed in the dietary infection study at day 2 p.i. 
(table 2). This was the case for two processes, namely transport (Cacna1i, Slc4a1, Atp12a, Slc15a1) 
and immune response (Igsf4d, RT1, Ilf1, Csf2, Il1a). Furthermore the antimicrobial defense gene 
Lbp and two interferon pathway genes (Gbp1, Ifit2) were not confirmed.  
To examine whether our choice for FC>1.5 was legitimate, we studied whether application of 
threshold FC>1.3 and FC>1.7 resulted in identification of the same processes as identified with 
FC>1.5. The general picture of processes affected was the same for FC>1.5 and FC>1.7. 
However, with FC>1.3 more genes could be included in processes identified with FC>1.5, such 
as the interferon response and proteolysis (data not shown). However, many other genes could 
not be grouped into (new) specific biological processes, indicating that a cut-off FC>1.3 might be 
too flexible and results in introduction of false positive processes, probably not related to the 
treatment. Therefore, we choose FC>1.5 for further analysis. To investigate the effects of FOS 
on Salmonella infection in the colon, we studied the expression of Salmonella-induced colonic 
mucosal genes in infected rats fed the cellulose diet versus infected rats fed the FOS 
supplemented diet. The five genes that were consistently downregulated by Salmonella in both 
studies (Hspa1a, Retnla, Retnlg, Colec 10 and Mss4) were not further influenced by FOS (equal gene 
expression in cellulose- and FOS-fed infected rats). For initiating early mucosal events after 
Salmonella infection (e.g. chemo attraction of inflammatory cells) increases in epithelial gene 
expression may be more important than decreases15,34. We focused on the 26 genes which showed 
a consistent increase in gene expression after Salmonella infection of FC>1.5 in both studies. All 
26 genes consistently induced by Salmonella infection in the colon mucosa showed a further up-
regulation in colon mucosa of Salmonella infected rats fed FOS (figure 5). The effect of FOS on 
the cluster of Salmonella affected genes was statistically significant. To asses the inter-individual 
gene expression in the dietary infection study we selected genes from several Salmonella 
modulated process for individual Q-PCR confirmation: Clca6, Gpx2, Il1b, Pla2g2a, Pap, Tgm2, 
Stat1, Gbp2 and Ifi47. Q-PCR of the selected genes in individual samples showed high inter- 
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Figure 5. Expression level of the most consistent 
Salmonella-target genes in the colon mucosa of rats 
fed a cellulose diet or a FOS diet. The gene 
expression is obtained from micro array analysis of 
pooled colonic mucosa samples collected at day 2 
post-infection. Each dot represents a gene. The 
median value of each gene in the uninfected group is 
set to 1.0. Y-axis is at log2 scale. ***p<0.001. 
 
individual variation but confirmed the fold changes of the microarray study using pooled samples 
(table 3). The confirmed Salmonella induced gene expression changes were significant (p<0.05) 
for 7 of the 9 genes, except for Tgm2 (p =0.09) and Stat1 (p=0.08). Examination of FOS-fed 
versus cellulose-fed infected groups on individual gene level showed a significant increase of 
Clca6 and Pla2g2a. Expression of Gpx2, Il1β and Tgm2 was >1.5-fold increased by FOS feeding in 
comparison to cellulose feeding but this was not statistically significant. The genes Pap, Stat1, 
Ifi47 and Gbp2 showed non-significant and small increases of 1.1-1.4 fold.  
 
Table 3. Q-PCR analysis of Salmonella-induced colonic mucosal gene expression of rats on a cellulose or a FOS diet (day 2 
p.i.). 
 Relative gene expression a
 Non-infected b                             Infected 
Gene symbol   Cellulose FOS 
Clca6 1  (0.9-1.3)  1.6  (1.4-2.2) 3.7  (2.8-4.1) 
Pla2g2a 1  (0.8-1.3)  4.6  (2.3-7.1) 8.8  (6.1-21.1) 
Gpx2 1  (0.8-1.2)  2.1  (1.7-2.4) 3.2  (1.3-4.8) 
Il1b 1  (0.6-1.1)  2.0  (1.3-3.4) 3.8  (0.6-5.4) 
Tgm2 1  (0.5-1.2)  1.6  (0.7-4.4) 10.2 (0.8-20.6) 
Pap 1  (0.4-2.4)  236 (68-326) 288 (13-1162) 
Stat1 1  (0.7-1.2)  1.2  (1.1-2.2) 1.5  (0.7-4.0) 
Ifi47 1  (0.8-1.2)  3.9  (2.1-6.4) 5.6  (1.6-18.4) 
Gbp2 1  (0.8-1.4)  2.0  (1.1-3.2) 2.1  (0.5-9.7) 
a The expression of genes is analyzed by Q-PCR, using Rps26 as reference gene (using Arf1 as reference gene gave similar 
results; data not shown). Data are represented as median (25% percentile- 75% percentile). 
b The median value of the non-infected group is set to 1.0. 
 
In t-testing each gene is tested independently, the FOS vs cellulose effect was not statistically 
significant for each independent gene. However, FOS significantly increased expression of the 
cluster of the 26 Salmonella induced genes (see figure 5 and supplemental table 3.3). We also 
looked at overall gene expression differences between cellulose- and FOS-fed rats at day 2 after 
Salmonella infection (supplemental table 3.3). This was done to determine whether the stimulated 
translocation in FOS-fed rats resulted in additionally affected genes or biological processes not 
induced by Salmonella in the cellulose groups. Twenty genes were induced by Salmonella >2-fold 
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in cellulose-fed infected rats. In the FOS-fed infected rats 72 genes were induced by Salmonella 
>2-fold. Seventeen genes overlapped between these two diet groups. Detailed analysis of the 
genes exclusively induced (>2-fold) in the FOS-fed group showed that those could be 
categorized in the same processes identified earlier (table 2 and supplemental table 3.3). 
Obviously, the induced translocation of Salmonella by FOS supplementation did not affect other 
processes than those already identified in Salmonella infected rats on a cellulose diet. However, 
more genes of the same processes and higher fold-changes were noticed in the colonic mucosa of 
infected rats on the FOS diet. 
Nos2 gene expression in colonic mucosa was below detection levels in the dietary infection study. 
As significant differences in NOx excretion between infected cellulose- and FOS-fed rats were 
observed from day 5, no differences at Nos2 gene expression were expected at day 2 p.i. Serum 
IFNγ was not detected at day 2 p.i., neither in infected cellulose-fed rats nor in infected FOS-fed 
rats.  
 
 
Discussion 
 
Colon is an infection target 
This study shows quick and profound gene expression changes in the rat colon mucosa upon oral 
S. enteritidis infection, which implicates that not only the ileum, but also the colon, is a target for 
Salmonella infection. The earliest responses were noticed on mucosal transport and antimicrobial 
defense. The most responsive gene is Pap, which showed an 11-fold induction in colon mucosa 
on the first day after infection and increased to over 100 fold at day 6. At later timepoints, the 
most notable process affected is interferon-related. Colonic genes consistently induced by 
Salmonella infection in two independent studies, were all further enhanced by FOS 
supplementation, a known stimulus of  colonic bacterial fermentation. Salmonella, ingested with 
contaminated foods or drinks, is thought to colonize the distal small intestine and to translocate 
through ileal Peyer’s patches to extra-intestinal organs 48,49. Several observations suggest that other 
parts of  the intestine are also involved in Salmonella infection. High numbers of  Salmonella are 
found in the cecum and colon of  orally infected rats 48,49 as well as pigs 20. In humans Salmonella 
commonly affects the small intestine, but colonic involvement of  S. enteritidis has been reported 
in humans 41,46,60 and may play an important role in induction of  diarrhea 41. Studies describing 
mucosal invasion via the paracellular and transcellular route 27,38 also suggest that translocation of  
Salmonella species to the systemic circulation is not restricted to the ileal Peyer’s patches. Our 
studies on the effects of  prebiotics on resistance of  the host to Salmonella infection also point to 
the colon as invasion site 5. Together results from literature and those presented here indicate that 
the colon is one of  the targets for Salmonella infection.  
 
Interferon-gamma response 
The increase of many IFNγ-regulated genes in the Salmonella-infected colon in the present in vivo 
study actually confirms the earlier suggested role of IFNγ in relation to host defense against 
Salmonella. Serum IFNγ levels increase in mice infected with Salmonella by oral or 
intraperitoneal route 9,14,31,32. IFNγ is produced by natural killer cells, CD4 Th1 cells and CD8 
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cytotoxic lymphocytes 44,45,71. IFNγ most likely exerts its function in host defense by activation of 
macrophages which can kill Salmonella 33. In our Salmonella time course infection study, more 
than 20 IFNγ-related genes were up-regulated (table 2). This did not coincide with an increased 
IFNγ mRNA level at any of the time points studied. In addition, we could not detect IFNγ 
protein in Salmonella-infected colons (data not shown). Serum levels of this pro-inflammatory 
cytokine were undetectable at day 1 p.i. but rose steadily from day 3 p.i. with large inter-individual 
variation in the magnitude of response (figure 3). Despite the lack of detectable IFNγ protein in 
colonic mucosa and in serum at day 1, we did observe increased expression of genes in the IFNγ 
induced pathway at that timepoint. These genes are most likely activated by IFNγ 66. We can not 
fully exclude that dilution of IFNγ-producing cells in the heterogeneous cell population of 
mucosal scrapings has lead to undetectable levels of this regulatory cytokine in the present study. 
At the later timepoints, serum IFNγ is strongly increased, whereas mucosal IFNγ remained below 
detection levels at all timepoints. This may suggest that systemic rather than colonic IFNγ seems 
to be the trigger for the later activation of IFNγ-related genes and -processes in colonic mucosa 
upon Salmonella infection. However, dilution of IFNγ-producing cells in colonic tissue to 
undetectable levels could also account for this later time point.  
As many as 1200 genes are known to be regulated by IFNγ. Their gene products are mediators 
of  the immune response essential for host defense against pathogens. One group of  clearly 
regulated IFNγ-induced genes is the GTPase family, which modulates survival of  pathogens 
residing in phagosomes or vacuoles 63,66. They are defined into three classes: Guanylate-binding 
proteins (Gbp’s), the p47 GTPases and the Mx proteins. We found Salmonella-induced up-
regulation of  the first and second group, i.e. Gbp1, Ifi47, Gbp2, Iigp and Irgm (Table 2). IFNγ 
induces expression of  p47 GTPases via activation of  Stat1 which was also increased by 
Salmonella at days 2 and 3 p.i. Mutant mice with gene disruptions in IFNγ or Stat1 are 
significantly compromised in their immune response to microbial infections, including 
salmonellosis 43. Thus the increased expression of  IFNγ-related genes in colonic mucosa in the 
present study confirms the earlier proposed role of  this cytokine in Salmonella infection.  
 
Pancreatits associated protein  
The colonic mucosal gene most highly induced by Salmonella infection on the array was Pap, 
which was confirmed by Q-PCR of individual rat samples. Pap is a member of the Reg III gene 
family, which includes Regenerating islet-derived 3 gamma (Reg3g) which was also increased in 
our study. Pap expression is also increased in the rat ileal mucosa infected with S. enteritidis 58 and 
in the gastrointestinal tract of pigs infected with Salmonella typimurium 51. Furthermore, significant 
up-regulation of intestinal mucosal Pap expression is described in IBD patients, whose bowel is 
chronically inflamed 12,19,52. This suggests that PAP is a marker for acute as well as chronic 
inflammation. Biological functions of PAP in the intestine are not fully uncovered. Recently, it 
was proposed to function in innate immunity 8,19. PAP was shown to have direct antimicrobial 
properties as it was able to bind and kill Gram-positive bacteria, but not Gram-negative Salmonella 
typhimurium 8. Additional research will be needed to answer whether PAP is able to inhibit the 
growth of Salmonella enteritidis. Pap and Reg3g are expressed in several tissues and organs, but the 
small intestine has the highest expression under normal conditions. Only very low levels can be 
found in colon 29. Indeed, Pap mRNA expression for most non-infected rats was below detection 
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level (figure 4). Three rats did not express Pap at timepoint day 3 p.i. (figure 4), whereas at day 6 
p.i. all rats expressed increased levels of Pap. Variation in infection kinetics between (outbred) rats 
is obviously reflected in Pap expression. We are currently investigating which mucosal cell types 
contain PAP and whether it is secreted to the intestinal lumen or to the serosal (blood) site. If 
secreted, PAP might be used as a non-specific marker to follow and quantify intestinal infection 
or inflammation in humans. 
 
Calprotectin 
Calprotectin (S100a8/a9), a heterodimer of  the two calcium-binding proteins S100A8 and 
S100A9, was up-regulated in the colonic mucosa by Salmonella (Table 2). Both subunits were 
increased in colon. Calprotectin is a 36 kDa calcium and zinc binding protein and constitutes 
approximately 60% of  soluble cytosolic proteins in neutrophil granulocytes. Therefore, 
calprotectin is a marker of  neutrophil influx and is elevated in a number of  inflammatory 
conditions. In agreement with our results, Naughton et al (1996) also found increased levels of  
this marker in Salmonella- infected animals. Fecal calprotectin is emerging as a useful marker to 
quantify mucosal inflammation, not in the least because it appears to be stable in feces which can 
be obtained by non-invasive means 55. 
 
Differences between colon and ileum 
Ileum and colon are both targets for Salmonella. Remarkably, the number of  genes showing 
increased expression is larger than the number of  genes showing decreased expression upon 
Salmonella infection in both ileum and colon. However, this is more extreme in colon than in 
ileum mucosa 58. Technical bias is unlikely as in a flavonoid intervention study with rats and using 
the same array system and data handling the number of  down-regulated genes was similar to the 
number of  up-regulated genes 11. In an in vivo Salmonella infection study in pigs only up-regulated 
and no down-regulated genes were observed 51. 
The extent of the early response to Salmonella is similar for both intestinal segments: From all 
genes expressed above background level on the arrays, 0.21% of the genes expressed in the colon 
and 0.26% of genes expressed in the ileum 58 were affected at day 1 p.i. The colonic response is 
less than the ileal response at day 3 p.i., as 0.15% of colonic mucosal genes were affected versus 
0.67% of ileal mucosal genes. The smaller colonic response could be due to differences in crypt-
villus architecture of the ileal and colonic mucosa. Furthermore, the colonic mucosa, which is 
constitutively exposed to bacteria, might be more efficient in repressing host- or more specifically 
immunological responses to bacteria, including pathogens 10,30,35.  
Ileum and colon show overlapping as well as distinct processes affected upon oral infection 58. At 
early time points after oral infection i.e. transport processes and antimicrobial defenses were 
regulated in both intestinal segments, but the process-related genes did not fully overlap. At day 1 
p.i., glucose transporters were increased in the ileum, whereas in colon ion transporters were 
induced. The role of  ion transporters in water absorption support involvement of  the distal part 
of  the gut in diarrhea development during salmonellosis as reported earlier in humans 41. The 
gene coding for antimicrobial defensin 5 was down-regulated by Salmonella in both ileum and 
colon. Other genes coding for antimicrobial proteins (Pla2g2a and lysozym) were clearly 
enhanced in the infected colon in contrast to ileal tissue 58. At day 3 and 6 p.i. Salmonella reduced 
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the expression of  several phase I and II detoxification genes in the ileum, which was not 
observed in the colon. The downregulation of  cytochrome P450 genes in ileum coincided with 
increased expression of  inflammatory genes. It is known that inflammatory mediators can down-
regulate cytochrome P450 genes47,57,58. This might suggest that the inflammatory response 
induced by Salmonella in colon, at later time-points, is smaller than in ileum. Nevertheless, both 
tissues showed signs of  an inflammatory response at later time-points, but responsible genes 
were not the same. Mainly cytokines and chemokines were induced in the ileum, whereas in colon 
many interferon-related genes were up-regulated. No interferon response was observed in the 
ileum.  Apparently, the immune response in the two intestinal segments is differentially regulated. 
 
Finally, the in vivo transcriptional response of  intact mucosa to invasion by Salmonella is 
represented by a limited number of  regulated genes compared to in vitro studies with HT-29 
cells15. In vitro models provide insight in complex mechanisms of  Salmonella-host interaction. 
However, results should be interpreted with caution as in vitro systems show massive cell death at 
24 hours, whereas only minor inflammatory changes are observed in the intestine 24 hours after 
infection with Salmonella in vivo 17. Several genes like Toll like receptors, Nf-кb or Il-8 that are 
regulated by Salmonella in vitro, were not found to be regulated by Salmonella infection in the 
present in vivo study. Possibly, transcription of  these genes is highly specific for particular cell 
types in the colonic mucosa. Identification of  cell type-specific responses of  potential target cells 
could be addressed in vivo using laser microdissection. 
 
FOS and mucosal barrier function 
We consistently observed that diets supplemented with rapidly-fermentable prebiotics (such as 
FOS) increased translocation of S. enteritidis in rat infection studies despite stimulation of 
Bifidobacteria and Lactobacilli 68. In other words, FOS decreases the resistance of the rat intestinal 
mucosa to intestinal pathogens. Because fermentation of FOS hardly occurs in the ileum of 
humans2 and rats22, it is unlikely that prebiotics facilitated translocation of Salmonella in the 
ileum. This is supported by the absence of ileal inflammation in FOS-fed and Salmonella-infected 
rats in contrast to profound cecal and colonic inflammation5. The precise mechanism underlying 
the effects of FOS on the colon mucosa is not known. FOS itself, the changed intestinal 
microflora or its fermentation products (e.g. SCFA) could play a role. Prebiotics, such as FOS 
resist enzymatic hydrolysis by digestive enzymes secreted in the small intestine and reach the 
colon intact. The resident colonic microflora ferments these carbohydrates to lactic acid and 
short-chain fatty acids (SCFA). This results in lowering of the pH of intestinal contents and 
stimulation of e.g. Bifidobacteria and Lactobacilli67,68. These lactic acid bacteria are assumed to 
enhance resistance 18 but we found opposite effects 5,68. As shown earlier, dietary FOS increases 
intestinal permeability in non-infected rats and even more in infected rats69. At present it is 
unknown whether intestinal permeability is increased in ileum or colon, nor whether it is induced 
by the presence of FOS or by its fermentation metabolites. It has been shown that SCFA can 
induce colonic mucosal injury and increase permeability 3. Furthermore, in vitro studies showed 
that SCFA can enhance expression of virulence (e.g. invasion) genes of Salmonella typhimurium 13,39, 
but data on in vivo consequences have not been reported. Preliminary experiments of our lab 
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showed no evidence for increased expression of virulence genes of Salmonella enteritidis in infected 
rats fed a FOS-diet (unpublished results).  
From two independent rat infection studies we identified 26 colonic mucosal genes consistently 
affected by Salmonella. These ‘robust’ Salmonella target genes were all further induced by the 
FOS diet. The pronounced effects of FOS on Salmonella translocation were reflected by a 
modest but highly consistent increase of all Salmonella target genes. Moreover, the total number 
of genes induced by Salmonella is nearly 3 times higher in FOS-fed rats than in cellulose-fed rats. 
However, biological processes identified to be affected by Salmonella in colon of FOS-fed rats 
were not different from those observed in cellulose-fed rats. So, the quality of the colonic 
response was the same, but clearly the magnitude of the response was increased by FOS feeding. 
Based on the physiological effects, larger gene expression differences might have been expected. 
The modest responses observed might be due to our focus on Salmonella-induced gene 
expression. It can not be totally excluded that FOS targets other genes and processes related to 
barrier function (in absence of infection) than Salmonella. However, the genes affected by 
Salmonella in FOS-fed rats did not show involvement of additional processes in comparison to 
their cellulose-fed counterparts. In our view, the enhanced expression of colonic Salmonella 
target genes in FOS-fed animals concomitant with stimulated translocation of this invasive 
pathogen indicates that infection and related inflammation is worsened by FOS supplementation. 
Histological analyses of intestinal samples from previous FOS intervention studies of our lab did 
not show presence of intestinal mucosal inflammation in non-infected FOS-fed rats in contrast 
to post-infection samples (data not shown). Therefore, we feel that the observed aggravation of 
the intestinal response is due to interaction of FOS and Salmonella. 
It should be stressed, that genes identified as Salmonella target genes in the present study are not 
necessarily Salmonella specific, but may well result from colonic inflammation in general and thus 
be similar in other enteric infections. Furthermore, effects of dietary FOS on gut barrier function 
may not be restricted to changes in mRNA expression, but exist on the translational or functional 
level of proteins. For instance, internalization of the tight-junction proteins occludin, claudin and 
junctional adhesion molecule-A, caused by IFNγ, results in profound mucosal barrier changes 7. 
This cellular translocation can occur without concomitant changes in mRNA gene expression. 
Detection of such effects would require a different approach from transcriptomics. Many studies 
report on possible therapeutic effects of FOS on intestinal disease such as IBD and pathogenic 
infection. In addition to an increase in ‘’beneficial’’ bacteria, the potential beneficial effects of 
FOS are based on the effects on surrogate markers, e.g. increase of mucin production 61, increase 
of the size and cytokine production of Peyer’s patches and increased faecal or ileal IgA25,59,65. 
Changes in these markers are often presumed to reflect increased barrier function or resistance to 
pathogenic bacteria, but concomitant actual measurements of these functional effects are missing. 
In our study, genes involved in antimicrobial defense, immune response and inflammation were 
all induced by Salmonella infection and further enhanced by dietary FOS, but concomitantly 
translocation of Salmonella was evident and stimulated by FOS. Therefore, these surrogate 
markers should be interpreted with caution and always correlated with functional effects or 
clinical endpoints. 
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In this study we compared Salmonella-induced gene expression changes of two independent rat 
infection experiments at early time points after oral infection. The gene expression results were 
analyzed at two levels, at the level of gene expression itself and at the level of biological 
processes. Analysis at the level of gene expression showed some variation in the expression of 
individual genes between the two studies (table 2, supplemental table 3.3). This variation between 
two studies can be due to the different time-points studied and the use of outbred rats showing 
inter-individual differences in infection kinetics. Rats did not all respond to Salmonella at the 
same time p.i. which is e.g. shown by individual gene expression levels of PAP (figure 4) and by 
serum IFN  levels (figure 3). Variation in infection kinetics and inter-individual variation are 
expected features of infection studies in outbred species 28. It can be argued that differences 
between studies, due to differences in time points measured or infection kinetics, will result in 
more pronounced variance at the level of individual genes than at the level of physiological 
processes 62,64. Indeed, analysis of gene expression at the level of biological processes showed that 
both studies gave highly comparable Salmonella-induced effects at early time points. 
In the dietary infection study, we were interested whether the FOS-stimulated Salmonella 
translocation was reflected in colonic gene expression changes. We observed an overlap in gene 
expression changes observed in the two experimental diets, and an additional set of 58 genes 
which were only significantly affected in the FOS-fed rats. Although the list of altered genes was 
different in FOS-fed rats, this was not the case at the process level as exactly the same processes 
were observed for both dietary groups. This indicates involvement of similar underlying 
biological processes in cellulose and FOS-fed infected rats and no obvious role for other 
processes. 
Comparison at the level of biological processes is a powerful tool to interpret microarray 
experiments and enables comparison of different microarray datasets42. Comparison at gene level 
has some drawbacks, one is redundancy in gene function, which means that different genes can 
provide the same physiological effect. In addition, the homeostatic condition as well as the 
precise nature of the stimulus will determine how individual genes within a process are controlled 
to provide the necessary physiological response. Differences in responses of individual genes are 
filtered out when they are analyzed at the level of pathways or processes. However, the 
translation of differentially expressed genes into biological processes also suffers from limitations 
36. The most important limitation is that annotations to pathways and processes are incomplete. 
Therefore it is important that results from pathway analysis are manually supplemented with the 
remaining significant genes using biological databases and scientific literature. 
 
 
Conclusions 
 
In conclusion, our results show that, in addition to the ileum, the colon mucosa is clearly a target 
for Salmonella infection. Early Salmonella-induced changes were observed in transport and 
oxidative stress, while at later stage, most likely secondary, infection and inflammation responses 
were observed. Some findings confirm expected results, such as induction of an immune and 
inflammatory response. However, the Salmonella-induced immune response in colon is clearly 
different from that in ileum. We newly identified that colonic transport processes and proteolysis 
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are affected by Salmonella infection and that pancreatitis associated protein was the most 
responsive gene in Salmonella infected rat colon.  
An important observation is that FOS-stimulated Salmonella translocation (as measured by 
urinary NOx), does not induce other processes than those observed in cellulose-fed and 
Salmonella infected rats. So, the quality or diversity of the colonic host response to Salmonella is 
not affected by colonic FOS fermentation in contrast to the magnitude of response. As far as we 
know, there are no literature data pointing to a functional effect of FOS in the ileum. Therefore, 
the FOS effects on Salmonella translocation are most likely due to colonic effects. Understanding 
the changes caused by FOS alone may provide insight in processes that ultimately result in the 
observed weakening of the barrier.      
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ABSTRACT  
 
Background  
Microbial infection and increased microbial-epithelial contact induce ileal pancreatitis associated 
protein/regenerating gene III (PAP/RegIII) mRNA expression. PAP/RegIII is suggested to 
function as a stress protein with anti-inflammatory or antimicrobial functions. Up to now in vivo 
PAP/RegIII protein expression has been poorly studied. Therefore we aimed to study 
PAP/RegIII protein levels in the ileal mucosa and faeces of rats infected with Salmonella. Rats 
were fed a diet relatively low or high in calcium to decrease or improve intestinal resistance to 
infection, respectively.  
Design 
Rats on a Western-type diet containing 30 or 120 mmol/kg calcium were orally infected with 
Salmonella enteritidis. At days 3-4 post infection, the ileal mucosa was isolated to determine 
PAP/RegIII mRNA and protein expression. Parallel groups were studied until days 7-8 post-
infection to determine Salmonella colonisation and translocation and to assess PAP/RegIII 
excretion in faeces with time. 
Results 
Salmonella infection significantly increased ileal mucosal PAP/RegIII expression on mRNA and 
protein level in comparison with non-infected controls. Immunohistology showed that 
PAP/RegIII was present in epithelial cells located at the crypt-villus junction. Faecal PAP/RegIII 
excretion increased after infection. Inhibition of Salmonella colonisation and translocation by 
dietary calcium was associated with lower mucosal and faecal PAP/RegIII concentrations.  
Conclusion 
PAP/RegIII protein is increased in epithelial cells of the ileal mucosa during Salmonella infection 
and is associated with infection severity. This supports its proposed role as an intestinal stress 
protein. PAP/RegIII is excreted in faeces and might be used as infection marker. 
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Introduction 
 
Pancreatitis associated protein (PAP) is a type III member of the regenerating (Reg) gene family 
and was originally identified as a lectin-related secretory protein present in rat pancreatic juice 
during experimental pancreatitis19. Since then, considerable attention has been given to the Reg 
family and its structurally related molecules. Recently, the complex terminology of the Reg family 
and its isoforms was elegantly reviewed15 and a combined term of PAP/RegIII was coined, to 
foster a concerted effort in the investigation of PAP and the isoforms. In this study we focused 
on ileal PAP/RegIII, represented by the genes PAP1 and PAP3. Expression of PAP/RegIII 
mRNA has been shown in the pancreas of human,37 mouse35 and rat17. Moreover, PAP/RegIII 
was described as constitutively expressed in the rat18 and human9 small intestine and this 
expression was not altered during acute pancreatitis.18 Interestingly, increased levels of intestinal 
PAP/RegIII mRNA have been detected during active inflammatory bowel disease (IBD), Crohn’s 
disease and ulcerative colitis, in humans11,23 and in animal models of IBD14,23,32. We recently 
reported a time dependent increase in intestinal PAP/RegIII mRNA, represented by the genes 
PAP1 and PAP3, in Salmonella infection studies in rats.27,28 These results are supported by studies 
that showed increased PAP/RegIII mRNA upon bacterial colonisation of the porcine small 
intestine with Salmonella22 and enterotoxigenic Escherichia coli.21 Hence, it is suggested that 
PAP/RegIII expression is triggered by increased microbial-epithelial contact and reflects a state 
of enhanced host defence8. Hitherto, few studies focus on PAP/RegIII protein levels and it was 
not investigated whether a more severe infection or increased host defence status would result in 
a higher PAP/RegIII expression. 
Furthermore, data about the site of ileal PAP/RegIII expression is controversial. PAP/RegIII 
mRNA is reported to be present in epithelial cells of the lower villus part,18 other studies limit 
expression to Paneth cells8. 
Although several functions have been proposed for PAP/RegIII, the physiological relevance of 
PAP/RegIII mRNA upregulation under conditions of infection and inflammation is unknown at 
present. In a search of a functional role for PAP/RegIII, the mouse RegIIIγ isoform showed in 
vitro binding to carbohydrates present on the surface of bacteria8. Moreover, mouse and human 
RegIIIγ were shown to have anti-bacterial activity against Gram-positive bacteria.8 Other studies 
suggested that PAP/RegIII may have anti-inflammatory functions by blocking NF-кB 
activation12,14. These anti-inflammatory effects were shown for experimental pancreatitis36,38, but 
whether the same function can be extrapolated to the intestine remains to be explored.  
To investigate intestinal localisation and protein levels of PAP/RegIII we investigated 
PAP/RegIII expression in the rat small intestine upon infection with Salmonella enteritidis, which is 
a common foodborne pathogen. We focussed our study on the distal ileum, since this was shown 
to be the main site of PAP/RegIII expression (genes PAP1 and PAP3) upon Salmonella 
infection27,28. In addition, we assessed whether ileal PAP/RegIII expression is sensitive to dietary 
modulation of infection severity. We have shown that dietary calcium has profound resistance-
enhancing effects and protects against infectious diarrhoea in rats4,5 and humans2. Calcium 
supplementation inhibits colonisation and translocation of invasive S. enteritidis.5 Studying rat 
intestinal PAP/RegIII expression in a dietary calcium intervention and correlating its protein 
levels with well-established markers of infection severity may extend insight in PAP/RegIII 
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functionality in the gut. Moreover, we determined its presence in faeces and assessed its proposed 
anti-microbial function. 
 
 
Materials and Methods 
 
Diets, infection and dissection of the rats 
The experimental protocol was approved by the animal welfare committee of Wageningen 
University (Wageningen, the Netherlands). Specific pathogen-free male outbred Wistar rats (WU, 
Harlan, Horst, the Netherlands), 8 weeks old and with a mean body weight of 245 g, were housed 
individually in metabolic cages as described.3 Rats were fed purified diets containing per kg: 200 g 
acid casein, 326 g cornstarch, 174 g glucose, 160 g palm oil, 40 g corn oil, 50 g cellulose and 
vitamin and mineral mix (without calcium) according to AIN-93.26 To mimic the composition of 
a Western human diet, the prepared diets were relatively low in calcium and high in fat content in 
comparison with recommendations for rodent diets of the AIN-93. Diets were supplemented 
with CaHPO4.2H2O (Merck, Darmstadt, Germany), at the expense of glucose, to a final 
concentration of 30 mmol/kg (control diet) or 120 mmol/kg (calcium diet). Food, intake 
recorded daily, and demineralised drinking water were supplied ad libitum. Body weight was 
measured every two days before infection and daily after infection. Two groups were fed the 
control diet and another two groups were fed the calcium-supplemented diet (n=9 per group). In 
addition, five rats were fed the control (n=3) or calcium (n=2) diet and served as non-infected 
controls. 
Animals were acclimatised to housing and dietary conditions for 14 days, after which they were 
orally infected with 0.5 ml of saline containing 3.109 colony-forming units of S. enteritidis (clinical 
isolate, phage type 4; strain B1214 NIZO food research, Ede, the Netherlands) as described 
elsewhere.3 Animals in the non-infected group received orally 0.5 ml saline only.  
On day 3 or 4 after oral infection, one control and one calcium-supplemented group were 
randomly selected and killed by carbon dioxide inhalation. The non-infected control rats were 
also killed by this procedure. During the dissection, the distal 12 cm of the ileum was excised. 
From this a 2 cm piece, identical location in each sample, was cut out and preserved in 10% 
formalin (Sigma-Aldrich, St Louis, Missouri, USA) and embedded in paraffin for histological 
analysis. The remaining parts were cut open longitudinally and, after flushing with saline, the 
mucosa was scraped off and immediately frozen in liquid nitrogen for RNA isolation and protein 
analyses. 
The other infected control and calcium groups were followed until day 7 after infection to collect 
fresh faecal samples for Salmonella quantification, as described elsewhere.6 In addition, 24 h 
faeces (pooled per animal per 2 days) and urines were collected one day before infection and 
seven consecutive days after oral infection. All faeces and urine were stored at -20°C until further 
analysis. Oxytetracycline (Sigma-Aldrich) was added to the urine collection vessels of the 
metabolic cages to prevent bacterial deterioration. Bacterial translocation was quantified by 
measuring urinary NOx (sum of nitrate and nitrite) excretion by using a colorimetric enzymatic kit 
(Roche Diagnostics, Basel, Switzerland), as described elsewhere33.  
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Myeloperoxidase analysis in ileal mucosa 
Frozen mucosal scrapings of the ileum were pulverized under liquid nitrogen. Approximately half 
of the pulverized tissue was suspended in a 0.2 M sucrose buffer of pH 7.4 containing 20 mM 
trishydroxymethylaminomethane (Tris), 1 mM dithiothreitol (DTT) and Complete Protease 
Inhibitor Cocktail (Roche Diagnostics). After mixing and centrifugation at 14000 g for 20 min the 
pellet was resuspended in acetate-HETAB buffer (0.5% hexadecyltrimethylammonium bromide 
(HETAB) at pH 6.0, 50 mM sodium acetate, 10 mM ethylenediaminetetraacetic acid (EDTA) and 
0.25 M sucrose) and sonicated on ice for 30 s at level 2-3 (Sonicator XL2020, Heat Systems, 
Farmingdale, NY, USA). The protein concentration of the samples was determined using BC 
Assay (Omnilabo, the Netherlands) according to the manufacturer’s protocol. A mouse 
myeloperoxidase (MPO) ELISA test kit (Hycult biotechnology, Uden, the Netherlands), which is 
cross-reactive with rat MPO, was used according to the manufacturer’s guidelines to determine 
the concentration of MPO in mucosal scrapings.  
 
Quantitative real-time PCR analysis of PAP/RegIII, represented by PAP1 and PAP3 mRNA, in 
ileal mucosa 
The other half of the pulverized ileal mucosal scrapings was dissolved in TRIzol reagent 
(Invitrogen, Carlsbad, California, USA) to isolate  and purify total RNA as described before.27 By 
using TaqMan Reverse Transcription reagents (Applied Biosystems Inc., Foster City, California, 
USA) cDNA was created from 1 µg of RNA on a Perkin Elmer DNA Thermal Cycler 480, 
followed by SYBR Green-based real-time PCR on a 7500 Fast Real-Time PCR system (Applied 
Biosystems). PCR conditions used were 95 °C for 10 min, followed by 40 amplification cycles 
(95°C for 15 s, 60°C for 1 min). Data were normalised against β-actin and aldolase. Controls, 
methods and primerdesign were performed as described27. The primer sequences are listed in 
table 1. 
 
Table 1.  Sequences of primers used for quantitative real-time PCR analysis. 
Gene Acc nr forward primer (5'→3') reverse primer (5'→3') 
PAP1 NM_053289 GACTCCATGACCCCACTCTTG GCAGACGTAGGGCAACTT CAC 
PAP3 NM_173097 GCTTCCTTTGTGTCCTCCTTGATT TACTCCACTCCCATCCACCTCTG 
β-actin NM_031144 CTTTCTACAATGAGCTGCGTGTG GTCAGGATCTTCATGAGGTAGTCTGTC 
aldolase NM_012495 ATGCCCCACCCATACCCAGCACT AGCAGCAGTTGGCGGTAGAAGCG 
 
Analysis of PAP/RegIII protein in ileal mucosa 
Ileum paraffin sections were immunostained with a goat polyclonal antibody against rat 
PAP/RegIII (1:50) (PAP/ RegIII #AF 1996; R&D Systems, Minneapolis, MN, USA). This 
antibody can not discriminate between PAP1 and RegIII (PAP3), but since both PAP1 and 
PAP3 fall within the PAP/RegIII group, this discrimination is not essential for our 
investigation.15 Localisation of Paneth cells was confirmed by immunostaining for lysozyme with 
ready to use anti-lysozyme (N1515; Dako). DAB peroxidase substrate kit (Dako) was used for 
signal detection of the HRP labelled secondary antibody, according to the manufacturer’s 
protocol.  
PAP/RegIII protein expression in the ileal mucosa was semi-quantified by light microscopy as 
follows: total length of (bottom) crypt to villus (tip) and part of this length stained positive for 
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PAP/RegIII were measured. The length stained positive for PAP/RegIII was expressed as 
percentage of total crypt-villus length. For each tissue section three completely visible crypt-villus 
axes were analysed, scored and averaged for that particular rat. All histological slides were 
recoded before microscopy to ensure blind scoring and to prevent observer’s bias. 
 
Analysis of PAP/RegIII protein in faeces 
Total 24 h faeces were lyophilized in a manifold freeze dryer (FD5515; Ilshin Laboratory Co Ltd, 
Seoul, South Korea) and pooled per treatment group on the basis of individual daily faecal dry 
weight excretion. Proteins were isolated from lyophilized faeces pools as described elsewhere16 
with a few modifications. Briefly, 100 mg of faeces pool was homogenised in 500 µl buffer 
containing 50 mmol/L Tris-HCl (pH7.5), 100 mmol/L NaCl, 1 mmol/L EDTA and Complete 
Protease Inhibitor Cocktail (Roche). After centrifugation (2 min at 15000 g), the supernatant was 
taken and its protein concentration was determined using DC protein assay kit (Bio-rad 
Laboratories, Veenendaal, the Netherlands) according to the manufacturer’s protocol. 45 µg 
protein was denatured at 100°C for 3 min in Tricine sample buffer (Bio-rad Laboratories), 
subjected to SDS-PAGE gel (4% stacking-gel, 14% separation-gel) and transferred to a PVDF 
membrane (Bio-rad Laboratories). After blocking, the membranes were incubated with the 
PAP/RegIII antibody (1:100). The signal of the secondary HRP-conjugated antibody was 
detected using the ECL Plus chemiluminescent detection kit (GE Healthcare, Den Bosch, the 
Netherlands). 
To evaluate recovery of PAP/RegIII protein in faeces, 3x 50 mg of the pre-infection faeces pool, 
from animals fed the control diet, was homogenized in PBS. Of these three samples one was 
spiked with 1 µg recombinant rat PAP (recPAP; pre-release reagent from R&D Systems Inc.). 
The second sample was heat inactivated by incubation at 75°C for 10 min, then cooled down to 
room temperature and identically spiked with the recombinant protein. Just PBS was added to 
the third sample and used as negative control. Subsequently, the three samples were incubated at 
37°C for 1 h and protein was isolated and analysed by immunoblotting as described above.  
To assess in vitro bactericidal activity of PAP/RegIII against S. enteritidis  and Listeria monocytogenes, 
analysis was performed as described8 with few modifications. To mimic the natural environment 
were PAP/RegIII could function as antimicrobial peptide, we performed the assays in (sterile) 
faecal water extracts from non-infected animals fed the control diet, prepared as described.34 
Purified recPAP was added to incubates to a final concentration of 3.3 µM and viable pathogens 
were quantified after 0, 2, 4, 8 and 24 hours of incubation. 
 
Statistical analysis 
Data from the non-infected rats fed the control or calcium diet were pooled as no diet-induced 
differences were observed. All data are expressed as means ± SE, except for PCR results, which 
are individually plotted in addition to indication of groups’ mean. Data were tested for normality 
by the Kolmogorov-Smirnov test. If normally distributed, differences of the means were tested 
for significance using one-way ANOVA, followed by Student’s t-test (two sided). For non-
normally distributed data, differences between means were tested for their significance using 
Kruskall-Wallis ANOVA, followed by the non-parametric Mann-Whitney U test (two sided). 
Statistical significance was set at p<0.05. 
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Results 
 
Animals and food intake 
All data from one animal in the calcium group (followed until day 7-8 after infection) were 
excluded from the study results because that rat suffered from pneumonia due to oropharyngeal 
reflux of the S. enteritidis suspension. At the start of the experiment, mean body weight of the 
animals was 245 g. Average body weight gain (mean before infection 5 g/d, after infection 3.3 
g/d) and food intake (mean 17 g dry wt/d; not affected by Salmonella infection) were not 
affected by dietary treatment (data not shown).   
 
Faecal excretion and translocation of Salmonella 
As expected, no Salmonella could be detected in faeces collected before infection of the animals. 
The first days after Salmonella infection, rats fed the calcium diet had approximately 10-fold less 
Salmonella in their faeces than rats fed the control diet (fig 1A; p<0.05). This result indicates 
much better colonisation resistance in rats fed the calcium diet.6 The impaired colonisation 
resistance of rats fed the control diet coincided with a progressive increase in urinary NOx 
excretion (fig 1B), which was shown to reflect differences in magnitude of bacterial 
translocation.5 Total infection-induced urinary NOx excretion (area under the curve) of the 
calcium group was significantly lower than that of the control group: 25±5 versus 73±14 µmol 
per 7 days, respectively.   
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Figure 1. Effect of dietary calcium on (A) faecal Salmonella excretion and (B) infection induced urinary NOx (sum of nitrate and 
nitrite) excretion with time.  Rats fed the control (●) or calcium (▲) diet were orally infected with 3.109 colony-forming units S. 
enteritidis on day zero. Faeces and urine collected on day zero was prior to infection. Results are expressed as means +/- SE. 
An asterisk indicates a significant difference from the control group (p<0.05). 
 
Ileal mucosal inflammation 
On days 3-4 after Salmonella infection, compared to non-infected animals MPO levels increased 
by factor 11.5 and 5.4 in the control and calcium group, respectively (fig 2). Although post-
infection MPO levels in the calcium-supplemented rats were half of those detected in the control 
group, this difference did not reach statistical significance (p=0.3). This was likely due to the 
relatively large inter-individual variation observed in the Salmonella-infected control group.  
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Figure 2. Myeloperoxidase (MPO) levels in the ileum mucosa of non-infected (n=5) and Salmonella infected rats fed either the 
control (n=9) or calcium-supplemented (n=9) diet. Results are expressed as means ± SE. Different letters indicate significant 
differences (p<0.05). Standard additions with MPO, provided by the manufacturer, were included in each assay to confirm the 
absence of inhibiting factors in the ileal mucosal samples. 
 
Effect of infection and dietary calcium intervention on PAP/RegIII mRNA and protein 
expression in ileal mucosa 
During infection ileal PAP1 is 3 fold higher expressed than PAP3 (PAP1/actin was 0.8 and 0.7 
and PAP3/Actin was 0.29 and 0.27 in control and calcium groups, respectively). Salmonella 
infection of rats fed the control diet increased PAP1 mRNA 2.4-fold, whereas no up-regulation 
was observed in calcium-supplemented infected rats (p<0.05, fig 3A). Furthermore, compared to 
non-infected rats a 3.6-and 1.8-fold induction of PAP3 mRNA was observed in infected rats fed 
the control and calcium diet, respectively (fig 3B).  
PAP/RegIII protein was detected in the ileum mucosa of non-infected rats (fig 4). Infected 
animals showed an increased number of cells staining positive for PAP/RegIII protein (fig 4). 
PAP/RegIII protein was detected specifically in epithelial cells at the crypt-villus junction, 
however after infection the number of PAP/RegIII-positive cells increased towards both the 
villus tip and the crypt bottom. So, a larger area of the surface epithelium was stained positive for 
PAP/RegIII after infection.  
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Figure 3. Relative pancreatitis associated protein 1 (PAP1, A) and pancreatitis associated protein 3 (PAP3, B) mRNA 
expression in ileal mucosa due to Salmonella infection of rats fed the control or calcium-supplemented diet. Individual values 
were first normalized to β-actin expression. These normalised data were used to calculate relative expression levels by setting 
the mean expression level of non-infected rats fed the identical diet at one. The mean of each diet group (n=9) is indicated by a 
line. The asterisk indicates p<0.05. Identical results were found when signals were normalised by comparison with aldolase 
mRNA (data not shown). 
 - 82 -
                                                Pancreatitis associated protein is associated with infection severity
  
  
 A 
           
B  
       
                     non-       control               calcium                         
       infected         
              infected 
12.5x 
40x 
 
Figure 4. Pancreatitis associated protein/regenerating gene III (PAP/RegIII) protein expression in the ileal mucosa of non-
infected and Salmonella infected rats fed either the control or calcium-supplemented diet. PAP/RegIII protein was present in 
epithelial cells at the crypt-villus junction (A, 12.5x; B, 40x). Immunostaining for lysozyme precisely identified paneth cells at the 
base of the crypts were PAP/RegIII staining was absent (data not shown). The number of PAP/RegIII positive cells increased 
after infection, especially in the direction of villus tips (A). Dietary calcium reduced PAP/RegIII expression in infected animals. 
No staining was observed in sections incubated without primary antibody (data not shown). All sections were counterstained 
with haematoxylin to visualise nuclei. (For full colour figure, see page 170). 
 
Semi-quantification revealed that the percentage of total crypt-villus length stained positive for 
PAP/RegIII protein increased 34% after Salmonella infection in the control group (p<0.05; fig 
5). In contrast, no significant increase in PAP/RegIII protein was observed in calcium-
supplemented infected animals (fig 5). PAP/RegIII protein was not detected in the ileal Paneth 
cells, which was confirmed by specific staining of Paneth cells (data not shown).  
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Figure 5. Pancreatitis associated protein/regenerating 
gene III (PAP/RegIII) protein expression in the ileum 
mucosa of non-infected (n=5) and Salmonella infected 
rat fed either the control (n=9) or calcium-supplemented 
(n=9) diet. Immunohistochemical slides (representative 
images are shown in fig 4) were used to quantify the 
percentage of total crypt-villus length stained positive for 
PAP/RegIII. Total crypt-villus length was not affected by 
infection or calcium. Results are expressed as means ± 
SE. Different letters indicate significant differences 
(p<0.05). 
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Presence and anti-microbial activity of PAP/RegIII in faeces 
Immunoblotting revealed the presence of PAP/RegIII protein in faeces (fig 6A, lanes 1-10). 
Similar to the PAP/RegIII levels in the ileum mucosa, PAP/RegIII protein in faeces of rats fed 
the control diet was considerably increased from 3-4 days and remained steady until day 7 after 
infection. This infection-induced increase in PAP/RegIII was clearly less in calcium-
supplemented infected animals. Although, the basal faecal PAP/RegIII level of the non-infected 
group was slightly higher in the calcium group in comparison with the control group.  
Purified recPAP protein showed a single band of 15 kDa, which is identical to the size of 
PAP/RegIII detected in ileum mucosa (fig 6B, lanes 4 and 5). However, a second band of 
approximately 14 kDa was also apparent in the mucosal samples. When recPAP was added to 
faeces it was hydrolysed into two smaller forms. Adding recPAP to heat inactivated faeces largely 
prevented subsequent hydrolysation and merely preserved the 15 kDa band.  
RecPAP in faecal water showed no bactericidal activity against the Gram-negative S. enteritidis or 
Gram-positive L monocytogenes (data not shown). Only growth of the latter was slightly inhibited (1 
 
log CFU after 8 hrs incubation).  
igure 6. Effect of Salmonella infection and dietary calcium on pancreatitis associated protein/regenerating gene III 
iscussion 
n this study, we have shown that both PAP/RegIII mRNA and protein levels are upregulated in 
rt of findings reported by Iovanna et al7,18, our experiments clearly showed that 
 
F
(PAP/RegIII) excretion in faeces with time. Lyophilized faeces was pooled per group (n=9) per two days. SDSpage gels were 
loaded with equal quantities of faecal protein and analyzed for PAP/RegIII (A, lanes 1-10) by using specific PAP/RegIII anti-
serum. Recombinant rat pancreatitis associated protein (recPAP) showed a single band (B, lane 5), similar to PAP/RegIII 
detected in the ileum mucosa of animals fed the control diet (B, lane 4). RecPAP incubated with pre-infection faeces from rats 
fed the control diet was hydrolysed into two smaller fragments (B, lane 2). Heat inactivation of faeces before addition of recPAP, 
largely prevented hydrolysis of the protein (B, lane 3). Non-spiked faeces (from non-infected rats) was added to lane 1 and 
served as negative control. No signal was detected when immunoblots were incubated without primary antibody (data not 
shown). 
 
 
D
 
I
the ileal mucosa after oral Salmonella infection in rats. This upregulation was shown in parallel 
with infection severity as quantified by determination of intestinal Salmonella colonisation and 
translocation of this invasive pathogen. Furthermore, we demonstrated that the concentration 
PAP/RegIII protein present in faeces reflects abundance of this protein in the infected ileal 
mucosa. 
In suppo
PAP/RegIII protein was present in epithelial cells at the crypt-villus junction of the ileal mucosa. 
In contrast, others did report expression of RegIII  in mouse ileal Paneth cells isolated by laser 
capture microdissection before mRNA analysis.8 In that study possible production of RegIII  by 
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as not only 
II is of most interest. Studies suggesting anti-microbial functions of 
other mucosal cell types was not investigated or at least not described. Moreover, the latter study 
was performed in (ex-)germ-free animals, whereas, Iovanna’s and our studies were performed in 
animals exposed to a conventional flora. When germ-free animals are exposed to micro-
organisms for the first time this initiates a period of intensive contact between microbes and the 
gut mucosa, until their naïve immune system (for example  secretion of sIgA) has evolved into a 
more mature one29. Therefore, results obtained in germ-free animals should be extrapolated with 
caution as those might not be relevant for the normal host with a conventional flora. 
The increase of intestinal PAP or Reg mRNA expression after bacterial colonisation h
been reported by our group27. Niewold et al identified PAP1 mRNA upregulation by 
enterotoxigenic E. coli21 and Salmonella typhimurium in a pig model.22 These and our results indicate 
that PAP/RegIII expression is triggered by increased microbial-epithelial contact at mucosal 
surfaces. In order to establish infection, foodborne pathogens like S. enteritidis and 
enterotoxigenic E. coli bind to the small intestinal mucosa by using adhesins or colonisation 
factors which are known virulence factors10,24,25. Situations of increased host epithelium-microbial 
contact often coincide with gut mucosal inflammation, especially when pathogenic bacteria are 
involved1. Inflammation in general, is also suggested as causative agent of PAP/RegIII 
upregulation, as increased mRNA levels have been documented in inflamed colonic mucosa from 
patients with active inflammatory bowel disease11,23 as well as in experimental models of colitis23,32. 
It should be realised that during active inflammation the mucosa might be damaged, its barrier 
function impaired, and mucosal cells are likely more exposed to micro-organisms from the gut 
lumen in comparison to healthy non-inflamed mucosa20,30,31. Hence, it is difficult to point out 
whether it is the inflammation or the microbe-host contact that induces PAP/RegIII 
upregulation. In a previous study we have shown that PAP/RegIII mRNA is not upregulated till 
day 3 after oral Salmonella infection27. As translocation of Salmonella has already occurred 
then5,27, initial bacterial contact is less likely the main driver for PAP/RegIII upregulation. Here, 
we show that faecal PAP/RegIII, probably originating from mucosal cells, increased from day 3-
4 after infection. Together these results suggest inflammation as trigger for PAP/RegIII increase. 
A study in which SPF animals are inoculated with an organism known to bind the gut mucosa 
without causing inflammation can show whether inflammation is indeed necessary for 
PAP/RegIII upregulation.  
The function of PAP/RegI
PAP/RegIII have shown that mouse RegIIIγ was able to bind to Gram-positive bacteria in vitro8. 
Analogous to defensins, PAP/RegIII is a small protein (± 15 kDa) and has a secretion signal plus 
a carbohydrate-binding motif. Carbohydrates are present in the gut mucosa (for example 
mucines) and on the surface of bacteria. Up to now, actual excretion of PAP/RegIII to the gut 
lumen has only been slightly mentioned without showing data18. The results of our infection 
study clearly showed that PAP/RegIII is present in faeces and is upregulated in the same 
timeframe as the mucosal levels of this protein. This does not only suggest that faecal 
PAP/RegIII reflects ileal mucosal levels, but also suggests the gut lumen as functional site. In 
order to examine possible anti-microbial function, we investigated the bactericidal properties of 
PAP/RegIII as found by Cash et al,8 however we studied this function in faecal water. The 
concentration of recPAP used in our experiments was 3.3 µM as this was approximately the 
concentration detected in faeces after Salmonella infection (estimated from immunoblots). 
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Moreover, this concentration fits well in the range applied in experiments of Cash et al.8 We 
found that recPAP only slightly inhibited growth of Gram-positive Listeria monocytogenes, but 
absolutely no bactericidal activity was noticed against this pathogen, in contrast to studies 
described,8 or against S. enteritidis. In the present study, we have shown that the protein was 
enzymatically hydrolysed in faeces with unknown effects on (anti-microbial) functionality. As 
hydrolysis is obviously relevant for the in vivo situation, we feel that our experiments using faecal 
water, including its enzyme activity, might be more relevant than experiments in clean buffers or 
media8,14. In view of the anti-microbial function, it is also remains unexplained why Gram-
negative bacterial pathogens, like S. enteritidis (our present and previous27,28 studies) and 
enterotoxigenic E. coli21 are the most potent inducers of intestinal PAP/RegIII, whereas this 
mucosal protein has no anti-bacterial effect whatsoever against its inducers. Firstly, this might 
indicate that PAP/RegIII has this function at the mucosal interface only, where most of the 
protein could be intact. Secondly, it cannot be excluded that hydrolysis of PAP/RegIII in the 
intestinal lumen rather reflects activation than inactivation of a function yet to be discovered. 
Furthermore, if mucosal PAP/RegIII is secreted by epithelial cells it will face a myriad of 
carbohydrates associated with the mucosa. In that respect, binding of PAP/RegIII to mucins is 
an area to be investigated. 
In conclusion, this study demonstrates that PAP/RegIII expression is significantly upregulated in 
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Abstract  
 
In whole genome microarray studies major gene expression changes are easily identified, but it is 
a challenge to capture small, but biologically important, changes. Pathway based programs can 
capture small effects, but may have the disadvantage to be restricted to functionally annotated 
genes. A structured approach towards the identification of major and small changes for 
interpretation of biological effects is needed. 
We present a structured approach, a framework, that addresses different considerations in 1) the 
identification of informative genes in microarray datasets and 2) the interpretation of their 
biological relevance. The steps of this framework include gene ranking, gene selection, gene 
grouping and biological interpretation. Random forests (RF), which takes gene-gene interaction 
into account, is examined to rank and select genes.   
For human, mouse and rat whole genome arrays, less than half of the probes on the array is 
annotated. Consequently, pathway analysis tools ignore half of the information present in the 
microarray dataset. The framework described takes all genes into account. RF is a useful tool to 
rank genes by taking interactions into account. Applying a permutation approach, we were able to 
define an objective threshold for gene selection. RF combined with Self-organizing maps 
identified genes with coordinated but small gene expression responses that were not fully 
annotated, but corresponded to the same biological process. 
The presented approach provides a flexible framework for biological interpretation of microarray 
datasets. It includes all genes in the dataset, takes gene-gene interactions into account and 
provides an objective threshold for gene selection. 
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Introduction 
 
Transcriptome analysis using whole genome microarrays is an elegant and widely used approach 
to identify the molecular mechanisms underlying dietary induced cellular or physiological 
changes. Both major effects as well as a wide overview of more subtle changes can be obtained. 
While the major differences are important for classification and identification of individual 
response genes, the smaller changes are an integral part of the physiological response and are 
essential for the identification of the physiological processes that are affected by the challenge or 
intervention. This is especially true in nutrition, where dietary interventions result in modest, but 
biologically important gene expression changes1,12,32. Also in the medical field it is increasingly 
recognized that the more subtle changes contribute importantly to outcome29,30,37. 
 
To translate microarray data into functional physiological information, a set of genes with the 
maximum amount of information and a minimum of noise is needed. Although a large number 
of methods exist to select genes from microarray datasets, most methods aim to identify the 
smallest possible set of genes that still can discriminate, for example to classify malignancies, 
predict therapeutic outcomes or diagnose physiological responses7,37. These methods may not 
always be appropriate to select larger set of genes for biological interpretation, that includes the 
smaller changes. These smaller changes are part of the response to medication or disease, which 
occurs through the interactions of multiple genes, via signaling pathways or other functional 
relationships. Small changes, variability among individuals and the often small samples sizes on 
the one hand and the large number of genes tested on the other, make it difficult to distinguish 
true differences from noise29,48. Careful planning and execution of microarray experiments 
nowadays offers technically high quality data, with a minimum of noise. However, the 
combination of small gene expression changes and the needed selection of a largest informative 
set of genes demands sophisticated selection methods. A structured framework that incorporates 
the different considerations in the identification of informative genes and the interpretation of 
their biological relevance is needed. Here, we describe the steps of such a framework and address 
the following considerations: gene ranking, gene selection, gene grouping and biological 
interpretation. 
 
Gene ranking  
To identify genes of relevance within the total dataset, genes are ranked by a measure of 
importance. As such, fold change has often been used. However, fold change is not a reliable 
measure, as this measure does not take variability in the data into account2,46. Therefore, other 
measures that do take variability into consideration should be used. The most commonly used 
approach for gene selection in two-class microarray studies that takes variability into account is 
the conventional t-test, while ANOVA is used for multi-class studies. Genes are tested 
independently and a p-value is assigned to each gene, which can be used to rank genes by their 
importance. However, by ranking genes by a univariate test-statistic such as the t-statistic, all 
genes in the dataset are assumed to be independent and gene-gene interactions are not taken into 
account. In biological responses, gene-gene interactions will take place as these responses often 
result from co-regulation of genes4,39. Consequently, by testing each gene independently, weak to 
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small genetic effects that only in interaction make an important distinction between different 
study groups will not be detected by using a univariate test. 
 
Gene selection 
For functional interpretation the total ranked gene set can be used, but this will include noise and 
selection of the most important genes is needed. The difficulty in gene selection is how to define 
the threshold. The threshold to select the differentially expressed genes influences the functional 
interpretation. Selection of genes is to some extent subjective, as there are no clear thresholds for 
existing methods. For t-test, the threshold choice is flexible and the significance level is chosen 
by the researcher3,8. However, a threshold should preferably be defined in an objective way. 
Procedures can be applied to correct for multiple testing, such as the family-wise error rate 
(FWER) or the false discovery rate (FDR)19,44. However, these procedures can be overly stringent, 
resulting in identification of only the most important changes and possibly discarding other 
relevant genes30.  
 
Gene Grouping 
Each probe on a microarray corresponds to a specific nucleotide sequence, which represents a 
specific gene. Most genes known to be involved in a functional category are annotated in 
annotation databases, such as the GO-database16, KEGG21 or Entrez Gene22. Whole genome 
microarrays contain annotated genes as well as non-annotated genes. Although the extent to 
which spots on whole genome microarrays are annotated has not exactly been established, many 
known genes are not annotated in functional analysis tools, for example GO-annotated, and are 
thus lost for biological interpretation when a pathway program uses the GO-database as source 
14,22. However, the non-annotated genes may provide important new targets. Clues on the 
function of these genes can be obtained by establishing similarities in expression behavior to 
known genes. Genes with similar gene expression can be identified using self-organizing maps 
(SOM) and hierarchical clustering34,43,45. Grouping based on similarity in expression behavior is 
also useful for functional interpretation of known genes.  
 
Biological interpretation 
Biological interpretation is the final step in this framework. A useful way to interpret microarray 
data is pathway analysis. In pathway analysis the effect of treatment on biological processes or co-
regulated gene sets are studied, rather than effects on individual genes22,47. A commonly often 
used approach is to import a list of genes, that meets the threshold criteria, into a pathway 
program, such as freely available ErmineJ, GeneMapp, David/EASE or commercially available 
ones like Metacore or Ingenuity. These programs search through public or private databases to 
link related genes that are grouped in biological processes.  
Recently, new methods have been developed for functional interpretation which circumvent the 
need to preselect genes36. One of these methods is Gene Set Enrichment Analysis (GSEA)42. This 
method enables detection of important pathways where all genes in a predefined set (for instance 
a GO-category) change in a coordinated manner28,29. This is highly relevant for studies where 
subtle, but coordinated changes in expression can be expected.  However, GSEA may have the 
disadvantage that it is restricted to, and therefore only informs about, functionally annotated 
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genes. Thus, not all information that is available in the dataset is used. Nevertheless, the 
application of GSEA has shown that small effects can be captured when coordinate gene 
expression changes are taken into account29. 
 
In this study we describe a framework for functional interpretation of microarray based 
expression studies using two real gene expression datasets. For gene ranking and selection, we 
have examined the usefulness of Random forests (RF)6. RF is one of the statistical methods that 
have been developed to select genes from large datasets containing many variables in small 
sample sizes. RF and other supervised methods like Support Vector Machines (SVM) and 
Discriminant Analyis (DA) have mainly been used to select genes that provide the best 
classification performance for diagnostic purposes (e.g.20,38). In a simulation study, RF performed 
better than an univariate test26. In microarray studies, RF was shown to outperform other 
classification methods, especially when the number of classes is moderate13,24. RF could also be a 
suitable tool to rank and select a larger subset of genes for further interpretation, as it is has many 
advantages13. One major advantage of RF is that it provides an importance measure for each 
gene, which can be used to rank the genes. Furthermore, the advantage of this importance 
measure is that it takes gene-gene interactions in the ranking of genes into account. In this way, 
RF is able to capture not only the main effects in a dataset, but also the variables with weak to 
small genetic effects that mainly contribute by interactions with other genes. Interaction between 
genes increases the importance of the individual interacting genes, making them more likely to be 
given high importance relative to other genes. Genes with a higher importance index are more 
associated with differences resulting from the treatment. As RF takes gene-gene interactions into 
account in the ranking of genes, this method was applied within this framework as a tool to rank 
genes at the first step. However, RF does not provide a threshold to define which genes should 
be selected for further interpretation. Therefore, after applying RF to rank genes by their 
importance index, we examined an approach to define a threshold for the genes ranked by RF to 
select biologically important genes in an objective way. After selection, genes were clustered by 
self-organizing maps (SOM) which clusters genes with similar gene expression in ordered profile-
groups. The advantage of combining results obtained with SOM and information obtained at 
previous steps is that insight can be obtained whether genes within the same profile contribute by 
their main effect and/or that interaction effects are present. Finally, for each gene expression 
dataset, the selected genes obtained by RF were incorporated in pathway programs (Metacore 
and ErmineJ) and compared to the results obtained with GSEA. Together this provides a 
stepwise framework focusing on the different considerations in the identification of informative 
genes and the interpretation of their biological relevance.  
 
 
Methods 
 
Datasets  
To illustrate and examine the framework considerations, we have used two whole genome gene 
expression datasets obtained from the same dietary study. In this study, two groups of Wistar rats 
were fed different diets for 2 weeks. One group of rats received a control diet (n=12) and the 
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other an experimental diet (n=12). The experimental diet is identical to the control diet, but 
additionally contains fructo-oligo saccharides. Detailed analysis of the effects of the diet is subject 
of another paper. The two datasets are obtained from two different tissues, colon and cecum. 
RNA from colon mucosa and cecum mucosa was isolated, reverse transcribed into cDNA, 
labeled and individually hybridized to Agilent-Whole Rat Genome Microarrays (G4131A). 
Labeling was performed by incorporating Cy5 for individual samples and Cy3 for pooled RNA. 
Hybridization and washing were carried out according to Agilent protocols. A total of 24 arrays 
for colon were analyzed, one array did not pass the quality controls based on MA plot and signal 
intensity distribution 2,40. Therefore, the colon dataset contained 23 arrays in total. The cecum 
dataset contained 22 arrays in total, since two cecum RNA samples were excluded based on poor 
quality of RNA.We preprocessed the microarray datasets as described 33. Only genes with an 
average signal 1.5 times above the background were taken into account for further data analysis, 
equal to 28180 genes for colon and 21049 genes for cecum. Gene expression values were log-
transformed before performing statistical analyses. The data have been deposited in NCBIs Gene 
Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and are accessible through 
GEO Series accession number GSE5943.  
 
Statistical analyses 
T-test 
T-tests to obtain t-statistics and corresponding p-values for the differences in mean gene 
expression between the two treatment groups were performed using the program GeneMaths XT 
(Applied Math, Sint-Martens-Latem, Belgium). Within the same program FDR analyses according 
to the Benjamini and Hochberg procedure 19 were performed.  
 
Random forests 
In RF a group of tree-based models (the forest) can be used to rank genes with an important 
contribution to the treatment variable. Each tree starts with the total dataset, which is recursively 
splitted into smaller and more homogeneous groups to fit models for predicting the different 
treatment groups from the selected genes. Within the forest, different trees are obtained by 
bootstrapping and random subset selection. In more detail, each tree is constructed from a 
bootstrap sample of the total dataset. A bootstrap sample is a sample of observations (for 
example rats) from the original dataset with replacement. The bootstrap sample therefore 
contains the same number of observations as the original dataset, but some observations are 
sampled more than once, while others are left out. The sampled observations are used to 
construct the tree, whereas each left-out sample is used to obtain a prediction of that tree to what 
extent the left-out sample can be appointed to one of the groups based on their genes. A 
prediction for the forest is obtained by aggregating the predictions over all trees for which the 
sample was left out. The prediction error of the forest is then the proportion of misclassified 
samples and is a quantitative measure of the quality of the prediction. For each split in a tree, the 
gene that gives the best split is not selected from the total set of genes, but from a random subset 
of genes. The number of randomly selected genes that is used to be searched through for the best 
split is referred to as mtry. RF performance is usually not sensitive to this parameter and it is 
suggested to use genes of nr total as a default value for mtry 6,25. Comparing the default value and 
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values lower and higher than the default for both colon and cecum, we obtained similar 
prediction errors for different mtry values (data not shown). Therefore, default values for mtry 
( genes of nr total ) were chosen for both colon (167 genes) and cecum (145 genes) to perform 
the RF analyses. 
More important genes will discriminate better between the treatment groups and will therefore be 
present in most of the trees and more often selected at a split close to the total sample. On the 
other hand, less important genes will be less present in the different trees and selected at splits 
farther from the total sample. Importance of genes is defined by a measure referred to as the 
importance index (Im). This Im is obtained by comparing the predictive performance of the forest 
for all genes with the predictive performance of the forest in which the values of one gene are 
randomly permuted in the trees for the left-out samples. For more important genes this will 
results in larger differences in the predictive performance as these genes are selected at splits 
close to the total sample while less important genes that are selected at splits farther from the 
total sample. The more important genes will therefore be given a larger importance index. By 
permuting the values for one gene, not only the effect of this gene is taken into account, but also 
all possible interactions of this gene with other genes. Interactions between genes increase the 
importance index for each of the genes that are part of the interaction. In this way random 
forests takes interactions between genes into account. Genes are ranked according to their 
importance. To obtain stable estimates of the Im, large numbers of trees in the forest are needed 
25,26. Since one tree will only be able to capture the interactions between the genes present in that 
tree the use of large numbers of trees allows capture of many interactions. Therefore we set the 
number of trees grown in the forest to 40000. We used all genes in the dataset in the analysis and 
the Im values for each gene was used as measure to rank the genes. 
To obtain a threshold for selection of genes for subsequent interpretation, the permutation test 
9,27 was applied. We used 100 permutation datasets, in which the group labels are randomly 
permuted. For each permutation dataset, RF analysis was performed using the same parameter 
settings as for the observed dataset. Next, for each permutation dataset Im’s for the genes were 
obtained and genes were ranked. The distribution of the Im values derived from the permutation 
datasets indicates how the Im’s of the genes behave in the absence of a true association with the 
treatment. To define the threshold for selecting genes, two approaches were taken. The first 
approach was to determine the value of Im where the Im of the observed dataset was equal to, or 
lower than the Im for at least one of the 100 permutation datasets. This corresponds to a 
significance level of p<0.01. The second approach to define the threshold (explained and 
illustrated at the GeneSrF website17) was to determine the number of genes with Im larger than 
the mean value of Im for the first ranked gene obtained from the 100 permutation datasets. 
However, this second approach yielded a very small number of genes, 11 for colon and 19 for 
cecum, which was very unlikely compared to the results of other methods (corresponding p-value 
for these threshold were p=7·10¯7 for colon and 9·10¯6 for cecum). Therefore, we only used the 
results of the first approach. 
To examine whether RF provides reproducible results over different analyses, we performed 
several analyses (runs), each time using the same parameter settings, but a different seed value. 
The seed value controls the random number generator and different seed values generate 
different forests. The results can be repeated if the same seed value is used. We examined the 
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reproducibility of RF by comparing the Im of the genes for different runs. Each run can return 
slightly different results as in RF each tree is constructed on a bootstrap sample of the 
observations (rats), and at each split of the tree the best discriminating gene is selected from a 
random subset of genes (mtry).  
The permutation test that was used to determine the threshold of the Im was also used to obtain 
the significance of the prediction error of the random forest model. For each permuted dataset, a 
prediction error was obtained by random forests. The proportion of permutation datasets with a 
prediction error equal to or lower than the prediction error of the random forest model of the 
observed dataset provided the significance of the model. 
Software for Random Forests (RF) is freely available, including R-packages10,25,35,41, and the 
original Fortran code5. For analyses with RF we have applied the R-package RandomForest to 
obtain the Im for the different genes. 
 
Gene grouping: SOM 
For the gene sets selected with the obtained RF threshold (935 genes in colon, 165 genes in 
cecum), self-organizing maps (SOM) analyses were performed. SOM was chosen because this 
method clusters genes with similar expression into ordered groups, rather than random groups, 
of genes with similar expression profiles. The number of SOM-profiles was set to 90 for colon 
and 16 for cecum, corresponding to an average of approximately 10 genes per profile-group. To 
distinguish between genes that mainly contribute by their interaction effect or their main effect, 
genes selected by RF were compared to the same number of genes ranked by t-test. We explored 
whether profiles consisting of genes only selected by RF were present, which indicate profiles 
consisting of gene-gene interaction effects.  
To perform SOM-analysis, both commercial (e.g. GeneMaths XT) and free open-source software 
packages (e.g. Orange machine learning software11 at http://www.ailab.si/orange) are available. 
In this study we used GeneMaths XT (Applied Math, Sint-Martens-Latem, Belgium) to obtain 
the SOM-profiles.   
 
Biological interpretation: Pathway analysis 
For the genes selected by RF, we performed pathway analyses for biological interpretation. The 
pathway results obtained for genes selected by RF were compared with pathway results obtained 
for the same number of genes selected by t-test, to assure comparability. For pathway analysis we 
used the freely available software ErmineJ 23 and the commercial program Metacore15. ErmineJ is 
a web-based application for identification of Gene Ontology (GO) processes on input gene sets. 
Metacore is a package of GeneGo (GeneGo Inc, St. Joseph, MI). 
In ErmineJ we used over-representation-analysis (ORA), in Metacore GO-processes were used 
for pathway analysis. For both ErmineJ-ORA analysis and Metacore-GO processes, gene sets 
existing of 5-250 genes were tested. In both analyses, gene lists selected by RF or t-test were 
classified into GO processes. These processes were ranked according to their p-value, which 
represents the probability that a particular process is selected by chance. Each pathway program 
uses different statistical tests to calculate these probabilities, this is beyond the scope of this paper 
and is discussed in Goeman et al18. For both programs we selected pathways with two selection 
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criteria i) the pathways should have a p<0.001 and ii) the pathways should include at least three 
selected genes.  
We also analyzed which biological pathways were enriched using GSEA42. In GSEA, enrichment 
of genes in a gene set is based on the ranking of the genes within the whole dataset36. We 
included functional c2 gene sets originated from KEGG, GenMapp and BioCarta with 5-500 
genes with FDR q-value <0.25 and ranked on NES score and nominal p-value. 
 
 
Results 
 
Whole genome arrays are not fully examined in pathway analysis programs 
Whole genome microarray analysis combined with pathway analysis is an attractive approach to 
identify effects of an intervention, but the analysis is limited to those genes that are annotated in 
database used by the program. To assess completeness of annotation, we examined first the 
extent to which genes were incorporated in the analysis in three different pathway programs, 
Metacore (GeneGo), ErmineJ and GSEA. This was performed for the two most widely used 
array platforms, Agilent and Affymetrix, and for three different species: human, mouse and rat. 
Only 23-48% of the probes on whole genome microarrays are translated to functional categories 
by these programs (Table 1). Ermine J is not included as it does not provide the number of 
incorporated genes. Annotation in this program is based on the specific GO-term(s) linked to the 
gene, which for the Agilent 44k Rat array applies to 7437 genes (18%). Altogether, analysis only 
based on functional annotation and co-occurrence in genesets, leaves out at least half of the 
microarray data, and thereby potential new targets. 
 
Table 1. Percentage of probes from whole genome microarrays identified by the pathway programs Metacore and GSEA. 
Number of probes linked to program database 
Metacore*  GSEA†
Number of probes imported 
Number  Percentage Number Percentage 
Agilent      
Human 41675 12976 31 17517 42 
Mouse 41534 13714 33 19589 47 
Rat 41372 9489 23 14631 35 
Affymetrix      
Human 54675 22792 42 20606 38 
Mouse 45102 18105 40 21891 48 
Rat 44761 12259 39 13342 43 
* Spots linked to a GO-term 
† Spots linked to a gene symbol 
 
Information content of gene expression datasets 
In both gene expression datasets (p=28180 for colon, p=25049 for cecum) the extent of 
differential gene expression induced by the dietary treatment was small; in colon, 179 genes were 
differentially expressed with a change of more than 1.5 fold, while in cecum the number of 
differentially expressed genes was 164. Based on fold change the datasets are similar in number of 
expressed genes and magnitude of differential expression (fold change). However, the two 
datasets differed in the significance of expression, with the colon dataset containing substantially 
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more significantly differentially expressed genes (table 2). With a t-test threshold of p<0.001, 803 
genes were differentially expressed in the colon dataset, while 123 genes were differentially 
expressed in cecum. Application of FDR using a threshold of q<0.01 resulted in selection of 231 
genes in colon and 19 genes in cecum. RF models were found to be significant in both colon 
(p<0.02) and cecum (p<0.01), indicating that gene expression differences were present. 
 
Table 2. Characteristics of the colon and cecum dataset 
 Fold change T-test FDR 
 
Total number of genes in 
dataset >1.5 fold* p<0.001 q<0.01 
Colon 28180 179 803 231 
Cecum 25049 164 123 19 
*Fold change experimental diet/control diet. 
 
Gene ranking: taking gene-gene interactions into account 
Genes were ranked according to their Im obtained using RF. To obtain insight in the ranking of 
genes by RF, we compared the results from RF with the ranking of genes by the commonly used 
t-test. For the genes present in the dataset  the absolute values for the t-statistics are plotted 
against the Im of RF (see Figure 1). In both datasets, Im obtained from RF does show a similar 
trend with t-statistics. Both RF and t-test rank genes in common (Figure 1, box A), indicating 
strong gene effects related to the treatment. Genes ranked high by RF, compared to t-test (Figure 
1, box B), are indicative of weak gene effects that are likely to be related to the treatment in 
interaction with other genes. 
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Figure 1. Plot of absolute value of t-statistics against Im for colon (left) and cecum (right) dataset. Box A: Genes highly ranked 
by both RF and t-test. Box B: Genes highly ranked exclusively by RF. 
 
Gene selection: defining an objective threshold 
We aimed to define an objective threshold for Im by using a permutation approach (see method 
section). This permutation test provides an indication where noise starts to interfere with real 
gene effects. For both colon and cecum the highest ranked genes from the observed dataset had 
higher Im values than the ranked Im values obtained from the permuted datasets (see Figure 2). To 
define the threshold, we determined the Im value where genes in the observed dataset have equal 
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or higher Im values relative to the genes in the permuted datasets. The point where the Im values 
of the observed dataset equaled that of at least one of the 100 permutated datasets was chosen as 
threshold, which is equal to a significance level for the Im of p<0.01.  
Ranking of genes
Im
po
rta
nc
e
in
de
x 
(Im
)
Ranking of genes
Im
po
rta
nc
e
in
de
x 
(Im
)
A B
Im
po
rta
nc
e
in
de
x 
(Im
)
Im
po
rta
nc
e
in
de
x 
(Im
)
Im
po
rta
nc
e
in
de
x 
(Im
)
Im
po
rta
nc
e
in
de
x 
(Im
)
Im
po
rta
nc
e
in
de
x 
(Im
)
Im
po
rta
nc
e
in
de
x 
(Im
)
Figure 2 a and b. Genes, of 100 random sets (black lines) and real sets with different seed values (colored lines), ranked by the 
Im values. For colon (A) and cecum (B) datasets. (For full color figure, see page 171). 
 
We performed 15 runs (each with a different seed value) resulting in very similar thresholds 
(results not shown). For colon a mean threshold of Im=0.906 and for cecum a mean threshold of 
Im= 1.753 was obtained.  For each run, the genes with Im values above the threshold were 
determined. Genes with higher Im values were always selected over the different runs. However, 
genes with ranking close to the threshold (lower Im values) were not selected over all runs, thus 
the selection of these genes varied between different runs. We chose to include all genes that 
were selected in at least one run, and not only the overlapping genes, because the number of 
genes that were additionally selected over increasing numbers of runs decreased rapidly (figures 
3a and b, tables 3a and 3b, for colon and cecum, respectively). This likely indicates that 
additionally selected genes are truly affected by the treatment and not randomly selected noise. 
After 10 runs for colon and 11 runs for cecum, the proportion of genes additionally selected 
became and remained less than 2%. Therefore, more runs were not performed. Combining the 
results of different runs resulted in the selection of 935 genes above the threshold for colon and 
165 genes above the threshold for cecum. These genes were selected as the set of genes being 
related to the treatment.  
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Figure 3. Genes selected by RF thresholds Im> 0.906 for colon and Im>1.753 for cecum. The total number of selected genes is 
plotted against the number of runs. 
 
 
Table 3. Selection of genes by RF threshold. 
B: Cecum 
Genes added 
Run 
Number 
of 
genes* 
Total 
number of 
genes† Number Percentage 
1 110 110 - - 
2 109 120 10 9.1 
3 118 131 11 9.2 
4 112 138 7 5.3 
5 111 144 6 4.3 
6 108 147 3 2.1 
7 112 150 3 2.0 
8 108 154 4 2.7 
9 112 158 4 2.6 
10 115 161 3 1.9 
11 111 165 4 2.5 
12 114 166 1 0.6 
13 108 167 1 0.6 
14 115 168 1 0.6 
15 108 170 2 1.2 
* Number of genes selected with threshold Im>1.753.  
† The number of genes selected after each additional run. 
A: Colon      
Genes added 
Run 
Number 
of 
genes* 
Total 
number of  
genes† Number Percentage 
1 558 558 - - 
2 552 665 107 19.2 
3 558 740 75 11.3 
4 558 791 51 6.9 
5 557 825 34 4.3 
6 562 849 24 2.9 
7 542 873 24 2.8 
8 557 891 18 2.1 
9 564 911 20 2.2 
10 549 935 24 2.6 
11 560 945 10 1.1 
12 554 955 10 1.1 
13 540 966 11 1.2 
14 573 977 11 1.1 
15 547 985 8 0.8 
* Number of genes selected with threshold Im>0.906.  
† The number of genes selected after each additional run. 
 
Comparison of gene selection by RF, t-test and fold change 
Genes selected based on the RF threshold (935 genes in colon and 165 genes in cecum) were 
compared with an equal number of genes selected by t-test. For t-test this resulted in inclusion of 
genes with p<0.0014 (q<0.04) for colon and p<0.0018 (q<0.23) for cecum. In colon 679 genes 
(72.6%) and in cecum 112 genes (67.9%) overlapped between RF and t-test. As shown in the 
volcano plots (figures 4a and b), gene sets selected by RF include the most significant genes 
based on t-test, as was also seen in figure 1. Furthermore, the volcano plots show that RF and t-
test also differ in selection of genes. Several genes with high fold change, that would not have 
been selected based on t-test alone, are also selected by RF.   
For both datasets, the set of selected genes by RF were used for subsequent gene grouping and 
biological interpretation. 
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Figure 4. Volcano plots for colon (A) and cecum (B). Fold change is plotted against p-value. All genes are shown, genes 
selected by RF are shown in black (935 for colon, 165 for cecum).  
 
Gene grouping: obtaining gene expression profiles by SOM 
For grouping of the genes selected by RF, we applied self-organizing maps (SOM)-analysis, to 
find groups of highly correlated genes. While SOM is mostly used to identify patterns in time or 
as a result of multiple treatments 43, it will also identify patterns of coordinate changes over a 
number of animals. In figure 5, the groups of genes with similar expression are shown for colon 
and cecum respectively. For both colon and cecum, profiles are present that consist mainly of 
genes that are selected exclusively by RF (light gray). SOM analyses for genes selected by the t-
test did not result in profiles consisting of genes exclusively selected by t-test (data not shown). 
Apparently, RF selects genes with main effects similarly to the t-test, but additionally selects 
genes (not selected by t-test) that can be grouped in profiles, which are likely to be related to the 
treatment by gene-gene interaction effects. 
Figure 5. SOM profiles for colon (a) and 
cecum (b). The total number of SOM-
profiles was arbitrarily set to 90 for colon 
and 16 for cecum, corresponding to an 
average of approximately 10 genes per 
profile. The size of the circles 
corresponds to the number of genes 
included in the group (range of genes per 
profile: colon 1-19, cecum 2-27). Within 
each profile, genes that overlap between 
RF and t-test are shown in dark gray, and 
genes exclusively selected by RF are 
shown in light gray. Genes in profiles 1, 2 
and 3 were analyzed in more detail. 
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We examined whether the genes exclusively selected by RF and highly enriched within one 
profile shared similar biological functions. Herefore we selected profiles consisting of mainly RF 
selected genes. For colon two profiles and for cecum one profile was selected (figure 5 white 
squares). The first colon profile (profile number 1) consisted of nine genes, four genes with 
unknown function (ESTs) and  five genes which were annotated but not classified to a known 
GO-process. After literature and database search these five genes could not be linked to a single 
biological process (table 4a). The second colon profile (number 2) consisted of 13 genes, of 
which 12 were only selected by RF. Five genes were annotated in a GO-process (bold gene 
names in table 4b), of which four are part of the same GO-process: cellular component 
organization and biogenesis. The remaining eight genes consisted of two ESTs, and six genes 
which are presently poorly understood, as further database and literature mining did not reveal a 
relation to a known biological process. One of these 6 (palladin) was recognized to play a role in 
maintaining normal actin cytoskeleton architecture 31, indicating a possible role in the same 
biological process as the 4 annotated genes within this SOM profile.  
The cecum profile consisting of exclusively RF selected genes (profile number 3) consisted of 13 
genes, comprising ten unique genes. Three of the ten genes were annotated by GO, of which two 
are part of the GO-process immune response. Further database and literature mining revealed 
that six of the seven other genes had a function related to immune response (table 4c). This 
confirms the notion that genes with a similar expression profile selected from a micorarray 
dataset exclusively by RF may be enriched in the same biological process. It further indicates that 
this is a strategy to hunt for biological function of genes and to reveal new biological processes 
related to treatment 
 
Table 4. Genes mainly selected exclusively by RF, grouped in SOM profiles (white boxes figure 5).  
A: Colon SOM profile number 1. 
Gene name* Sequence ID Gene symbol† FC‡ p-value q-value 
3222401M22Rik protein (LOC363231) XM_343571 - 1.39 0.005 0.08 
2410024A21Rik protein (LOC314415) XM_234506 - 1.21 0.014 0.13 
Rattus norvegicus cDNA clone UI-R-A1-dv-f-02-0-UI 5' BF558849 - 1.20 0.007 0.10 
Uronyl-2-sulfotransferase XM_341728 Ust 1.12 0.074 0.31 
Ring finger protein 10  XM_213797 Rnf10 1.21 0.026 0.18 
Midnolin TC480469 Midn 1.31 0.002 0.05 
Mitsugumin 29  XM_342316 Mg29 1.16 0.012 0.13 
Carbonic anhydrase I (Carbonate dehydratase I)  XM_226922 Ca1 1.28 0.007 0.10 
Polyglutamine-containing protein BF546374 - 1.22 0.001 0.04 
* None of these genes were annotated by GO.  
† Genes without official gene symbol are indicated with -.  
‡ Fold change experimental diet/control diet. 
 
B: Colon SOM profile number 2. 
Gene name* Sequence ID Gene symbol† FC‡ p-value q-value 
Hypothetical protein FLJ32871  XM_219819 - 1.26 0.025 0.18 
GCD14/PCMT domain containing protein NM_001007706 - 1.23 0.015 0.14 
Telomeric repeat binding factor 2 XM_341683 Terf2 1.26 0.002 0.05 
Probable nocturnin protein  XM_344988 - 1.11 0.184 0.48 
cGMP-dependent protein kinase 1, beta isozyme  XM_219807 Prkg1 1.21 0.010 0.11 
High mobility group nucleosomal binding domain 1  BI303604 Hmgn1 1.11 0.156 0.44 
Cyclin-dependent kinase 5  NM_080885 Cdk5 1.18 0.021 0.16 
- 102 - 
                                                                                           Biological interpretation of microarray datasets
  
 - 103 -
Beta-sarcoglycan  XM_223355 Sgcb 1.11 0.096 0.35 
Phosphodiesterase isoform  AF053097 Pde 1.18 0.005 0.08 
Palladin, cytoskeletal associated protein  XM_214338 Palld 1.20 0.010 0.11 
splA/ryanodine receptor domain and SOCS box containing 3  XM_220230 Spsb3 1.20 0.003 0.07 
Kinesin family member 5B  XM_341538 Kif5b 1.24 0.001 0.03 
Acyl Transferase  XM_235527 Mct 1.13 0.010 0.11 
* Genes annotated by GO are presented in bold.  
† Genes without official gene symbol are indicated with -.  
‡ Fold change experimental diet/control diet. 
 
C: Cecum SOM profile number 3. 
Gene name* Sequence ID Gene symbol† FC‡ p-value  q-value 
Anti-NGF30 antibody light-chain , variable and constant regions U39609 - 2.65 0.005 0.31 
Ig germline kappa-chain gene C-region M12981 Igkc 2.63 0.007 0.34 
Immunoglobulin joining chain  XM_341195 Igj 2.11 0.009 0.35 
Immunoglobulin rearranged κ-chain mRNA variable (V) region CO562777 Igkv 1.92 0.005 0.31 
Anti-acetylcholine receptor antibody gene, κ-chain, VJC region L22655 - 2.25 0.013 0.39 
Ig germline kappa light chain joining (J) segments J00746 Igkjca 1.72 0.009 0.35 
Periostin, osteoblast specific factor  XM_342245 Postn 1.93 0.002 0.23 
Immunoglobulin kappa light chain variable region  AF217591 Igkv 1.73 0.009 0.35 
Chemokine (C-X-C motif) ligand 12  NM_022177 Cxcl12 1.63 0.020 0.46 
2.20 0.004 0.28 
1.56 0.008 0.35 
1.56 0.008 0.34 
Ig active kappa-chain mRNA VJ-region from immunocytoma 
IR162 
 
M15402 
 
 
 
Igkac 
Igkac 
Igkac 
Igkac 1.58 0.004 0.29 
* Genes annotated by GO are presented in bold.  
† Genes without official gene symbol are indicated with -.  
‡ Fold change experimental diet/control diet. 
 
Biological interpretation: Pathway analysis to obtain biological processes 
To examine whether pathway programs are able to identify differences between RF selected 
genes and t-test selected genes, we applied pathway analysis for the set of genes selected by RF 
and compared this with the same number of genes selected by t-test (935 genes for the colon 
dataset, and 165 for the cecum dataset). To ensure that we covered different pathway analysis 
methods, we used two pathway programs, Metacore and ErmineJ. For both colon and cecum the 
comparison between RF and t-test based selection showed highly comparable results per pathway 
program (Metacore table 5a and 6a, EmineJ table 5b and 6b). However, the ranking of processes 
was somewhat different and each selection method (RF or t-test) identified some unique 
processes. 
GSEA does not require preselection of genes, although information may be lost due to 
incomplete annotation. GSEA is especially suited to identify processes based on interaction. To 
see whether similar or complementary information is obtained, we analysed the complete colon 
and cecum datasets with GSEA. We focused on pathway related GSEA genesets, obtained from 
GO, GenMapp and Biocarta, to allow for comparison. Only few genesets were found to be 
significantly enriched (FDR<0.25 according to GSEA), 12 in colon and 6 in cecum. The small 
number of processes identified by GSEA analysis suggests that information is lost. The program 
does give some overlapping pathways in colon, but in cecum other processes are selected. In 
both cases no overlap with processes only selected with RF was found.  
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Discussion 
 
We described a framework for physiological interpretation of gene expression data. This 
framework (see BOX 1) consists of the following steps: genes are first ranked, the relevant genes 
are selected, the selected genes are grouped according to their expression profile and then 
biologically interpreted. The considerations underlying the different steps are illustrated using two 
real gene expression data sets. We show several features of Random Forest (RF) that should be 
part of any data-analysis framework. These are 1) all genes in the dataset are included in the 
analysis, 2) interaction between genes is taken into account and, 3) a well-defined gene set can be 
selected using an objective threshold.  
 
 
BOX 1. A framework for identification of physiological responses in microarray based gene expression studies. The  framework 
is composed of the following steps: Gene ranking, gene selection, gene grouping and biological interpretation. Essential 
features of the data-analysis framework are that 1) all genes (annotated and non-annotated) in the dataset are included in the 
analysis, 2) interaction between genes is taken into account and, 3) an objective threshold is used for selection of a well-defined 
gene set. Random forest has these features. Gene grouping can provide information on new targets and add information above 
pathway analysis. Despite loss of information due to incomplete annotation of the complete dataset, Gene set enrichment 
analysis can provide additional information on related genes with small differences.  (For full color figure, see page 171). 
Ranking Selection Gene grouping
Biological interpretation
Im
portance
m
easure
Based
on
interaction
O
bjective
threshold
Annotated genes
Non-annotated genes
Gene set enrichment analysis (GSEA) GSEA
Im
portance
m
easure
Based
on
interaction
O
bjective
threshold
 
For human, mouse and rat whole genome arrays, the number of annotated genes is less than half 
of the genes present on the array. Consequently, analysis only based on functional annotation and 
co-occurrence in gene sets filters out half of the information present in the microarray dataset. 
Well studied biological processes are better represented in pathway databases22. Therefore, 
conclusions obtained from data analysis based only on pathway programs are biased towards the 
well annotated biological processes. By including all genes from a whole genome dataset, it is 
possible to find genes or processes less defined in databases, but which could be attractive new 
targets for drug development or nutritional intervention. For both colon and cecum, genes 
exclusively selected within one SOM profile belonged to the same biological process: cellular 
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component organization and biogenesis (colon) and immune response (cecum) respectively. As 
only a few genes within these profiles were GO-annotated, these processes were not selected by 
the different pathways programs. By literature and database search we could clearly identify these 
genes as part of this process. 
 
A major strength of whole genome microarray studies is that the expression levels of all genes are 
displayed, allowing for identification of gene-gene interactions. RF was chosen to rank genes, as 
its measure of importance takes possible interactions between genes into account. Compared 
with the results obtained by t-test, RF selected genes with main effects but additionally was able 
to capture weak effects. In studies with small gene expression changes which are independently 
not significant, but occurring in one group may be of large relevance, this is an advantage. For 
example, it enables identification of possible side effects in drug studies, or expected subtle 
differences in nutritional studies. In our study, application of RF in combination with SOM 
indeed showed enriched profiles containing mainly genes selected exclusively by RF and not by t-
test. Genes within these profiles are therefore contributing by gene-gene interactions.  
 
By applying a permutation test we defined a threshold for RF to select genes in an objective way. 
Comparison of different runs showed that the most important genes were consistently selected. 
However, selection of genes ranked closely above the threshold varied between different runs. 
We chose to include genes that were additionally selected over different runs in the total selected 
gene set. By including genes selected additionally by different runs there is a chance that more 
false positives were included in the selection. If we would have chosen to select the set of genes 
that overlapped in all runs, we might discard truly relevant genes (false negatives). We reasoned 
that the increased information available for pathway analysis outweighed the potential 
disadvantage of including some noise, especially since in dietary studies gene expression changes 
of interest are usually small. Furthermore, the results show that the number of additionally 
selected genes decreased rapidly for each additional run. As there was large overlap, it is less likely 
that many of the additionally selected genes were noise. Thus, within this framework, RF is a 
useful tool to select a well-defined set of genes for further interpretation. 
 
SOM was applied to find groups of genes with similar gene expression profiles. Other 
approaches to find gene groups, such as hierarchical clustering, can be used with the same 
objective34. SOM has the advantage that clustering is organized in profile-groups and therefore 
provides a more ordered output than that of other cluster programs. While individual genes may 
have small gene expression differences, groups of similarly behaving genes can be biologically 
significant. When SOM analysis is applied to whole genome datasets, unrelated data will also 
produce clusters, without any physiological relevance34. This can be overcome by selecting a 
subset of genes and to examine whether biological valid clusters are obtained. For both colon and 
cecum, genes selected by RF and analyzed by SOM provided profiles consisting of genes with 
similar biological function. In the colon dataset, a SOM profile consisted of genes belonging to 
the same GO-process, and genes with poorly identified functions. This could be a starting point 
to identify possible biological function of the non-identified genes. Using SOM within this 
framework can provide information on genes with unknown function and help to identify 
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biological processes not captured by pathway analyses. Therefore SOM is a useful tool for 
identification of biological processes in addition to pathway analysis. 
 
The pathway analysis based on the subset of genes obtained by RF and t-test shows overlap for 
the selected processes, however different processes were additionally obtained by RF.  
Remarkably, GSEA only returned a few gene sets connected to public databases that were 
significantly enriched in colon or in cecum. The small number of processes identified by GSEA 
analysis suggests that information is lost. On the other hand, GSEA did provide biological 
processes not found in the other pathway programs. Although only a few processes were found 
by GSEA, these are worth exploring as these may consist of related genes with small differences. 
Thus, in the context of the framework discussed in this paper, GSEA may additionally be 
applied.  
 
The advantage of this framework is that different methods can be applied at different steps, for 
example a Bayesian method, depending on the aim and preferences of the researcher. This study 
used two real datasets with subtle gene expression changes and showed that RF can be used to 
extract a biologically meaningful group of genes, such as the set of immune response genes in the 
cecum dataset that would be discarded with univariate tests such as the t-test. Previous studies on 
simulation datasets by Lunetta et al26 showed that RF outperformed other univariate methods. RF 
is not the only method available, however it has advantages to use RF within this framework to 
rank and select genes. As mentioned, it returns an importance factor for each gene (Im) in which 
gene-gene interactions are taken into account. Based on this Im, we showed an approach which 
can be used to define an objective threshold for selection of genes.  
Besides two classes RF can also be applied to multi-class problems. Furthermore, free software is 
available for RF whereby only a few parameters need to be defined. Also, users can easily obtain 
a gene list for further interpretation without the need to understand the finer details of the 
method thoroughly. Therefore, within this framework RF is a suitable and practical tool to rank 
and select genes. Combined with gene grouping by SOM and pathway programs, this framework 
is helpful to obtain insight in the biological processes. These physiological effects are the main 
focus for further confirmatory and mechanistic studies.  
 
In conclusion, in this study we have examined the application of a framework in which all genes 
in a microarray dataset are analyzed. Within this framework, application of RF has the advantage 
that it takes gene-gene interactions in the ranking of genes into account. Also, selection of genes 
by an objective threshold provides a well-defined set of genes for further interpretation. Groups 
of genes within this set are identified by SOM-analysis. It provides in combination with pathway 
analyses valuable information on biological processes involved in the treatment. 
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Abstract  
 
Background 
Dietary non-digestible carbohydrates stimulate the gut microflora and are therefore presumed to 
improve host resistance to intestinal infections. However, several strictly controlled rat infection 
studies showed that non-digestible fructo-oligosaccharides (FOS) increase, rather than decrease, 
translocation of  Salmonella towards extra-intestinal sites. In addition, it was shown that FOS 
increases intestinal permeability already before infection. The mechanism responsible for this 
adverse effect of  FOS is unclear. Possible explanations are altered mucosal integrity due to 
changes in tight junctions or changes in expression of  defense molecules such as antimicrobials 
and mucins. To examine the mechanisms underlying weakening of  the intestinal barrier by FOS, a 
controlled dietary intervention study was performed. Two groups of  12 rats were adapted to a 
diet with or without FOS. mRNA was collected from colonic mucosa and changes in gene 
expression were assessed for each individual rat using Agilent rat whole genome microarrays.  
Results 
Among the 997 FOS induced genes we observed less mucosal integrity related genes than 
expected with the clear permeability changes. FOS did not induce changes in tight junction genes 
and only 8 genes related to mucosal defense were induced by FOS. These small effects are 
unlikely the cause for the clear increase in intestinal permeability that is observed. FOS 
significantly increased expression of  177 mitochondria-related genes. More specifically, induced 
expression of  genes involved in all 5 OXPHOS complexes and the TCA cycle was observed. 
These results indicate that dietary FOS influences intestinal mucosal energy metabolism. 
Furthermore, increased expression of  113 genes related to protein turnover, including 
proteasome genes, ribosomal genes and protein maturation related genes was seen. FOS induced 
increase in the peptide hormone proglucagon gene, in agreement with previous studies, as well as 
three other peptide hormone genes; peptide YY, pancreatic polypeptide and cholecystokinin. 
Conclusion 
We conclude that altered energy metabolism underly barrier function disruption due to FOS 
feeding in rats. 
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Introduction 
 
Non-digestible carbohydrates like fructo-oligosaccharides (FOS) stimulate the gut microflora and 
are therefore presumed to improve host resistance to intestinal infections. For this reason non-
digestible carbohydrates are added to a growing list of  products, including baby-formula, bread, 
dairy products. Many studies, including our own, showed that non-digestible carbohydrates 
indeed affect intestinal microflora composition9,28,76. However, there is little evidence that these 
non-digestible carbohydrates strengthen intestinal resistance to infection and gut barrier function.  
For this reason, several strictly controlled rat infection studies were previously performed at our 
lab. These studies consistently showed that the non-digestible carbohydrates inulin, lactulose and 
FOS increase translocation of  Salmonella to extra-intestinal organs74,76,77. A dose-dependent 
increase in Salmonella translocation was observed in FOS-fed rats76. Stimulation of  Salmonella 
translocation by dietary FOS was reflected in transcriptional changes in colon. Genes involved in 
antimicrobial defense, immune response and inflammation were induced by Salmonella infection 
of  rats on a control diet and further upregulated in Salmonella infected rats on a FOS diet 61. 
Moreover, intestinal barrier parameters were already affected by FOS before infection. In 
particular intestinal permeability was increased by FOS before Salmonella challenge.  Also, 
luminal cytotoxicity and faecal mucin excretion were increased in FOS-fed rats and may indicate 
mucosal irritation77.  
 
The intestinal barrier is mainly formed by the mucosal epithelial lining. Disturbed barrier 
function can be monitored by measurement of  epithelial permeability using inert permeability 
markers such as different kind of  sugars or CrEDTA4,82. It has been shown that increased 
transport of  large molecules or antigens due to increased permeability may initiate inflammation7. 
Several mechanisms have been implicated in the mucosal barrier. Tight junctions tightly connect 
the epithelial cells and regulate paracellular transport of  fluids, electrolytes and small 
compounds44. Modification or cellular translocation of  the tight junction molecules ZO1 and 
several claudins have indeed been observed in inflammatory bowel disease (IBD) and chronic 
non-steroidal anti-inflammatory drugs (NSAIDs) use, both characterized by increased intestinal 
permeability46,85.  
In addition to changes in epithelial tight junctions, balance between apoptosis and proliferation, 
or regeneration, is also a major determinant of  an intact mucosal epithelial lining54. Increased 
apoptosis can induce epithelial leakage as shown in colonic epithelial cell lines and in intestinal 
biopsy specimens of  IBD patients68. 
Apart from tight junctions and apoptosis, secretory products of  intestinal epithelial cells are 
known to play a role in mucosal barrier. The different intestinal epithelial cells; enterocytes, 
goblet cells, Paneth cells and enteroendocrine cells, are equipped with defense mechanisms. For 
instance Paneth cells in the crypt base produce antimicrobials, such as defensins, lysozyme and 
Pla2g2a83, to regulate and restrict the bacterial load in the gut lumen. Goblet cells produce mucins 
to form a mucus layer, this layer functions as a physical barrier that protects the epithelial cells 
from harmful compounds73. Furthermore, the immune system plays an important role in mucosal 
integrity49. Whether other processes are involved and the relative importance of  these 
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mechanisms for intestinal barrier integrity is not known. Also it is not known if  any of  the above 
mentioned mechanisms or others are responsible for the effect of  FOS on gut permeability.  
Therefore, we analyzed colonic gene expression changes in individual rats fed a 6% FOS diet for 
2 weeks. Analyzing FOS induced gene expression using whole genome microrarrays allowed us 
to not only focus on the above mentioned mechanisms, but to obtain an unbiased view on 
processes affected by dietary FOS. This facilitates identification of  genes and processes currently 
unknown to be related to barrier function. The colon had our main interest as FOS and other 
non-digestible carbohydrates are exclusively fermented in the distal gut in humans2 and rats76. We 
aimed to identify the in vivo biological mechanisms involved in FOS-induced weakening of  the 
barrier in rats. 
 
 
Materials and Methods 
 
Animals and diet  
The animal welfare committee of  Wageningen University (Wageningen, the Netherlands) 
approved the experimental protocol. Specific pathogen-free male outbred Wister rats (8 weeks 
old, mean body weight of  253 g; n=36 in total), were housed individually in metabolic cages. All 
animals were kept in a temperature (22-24 C) and humidity (50-60%) controlled room with a 12 
h light/dark cycle (lights on from 6 AM to 6 PM). Rats (two dietary groups, n=18 each) were fed 
restricted quantities (14 g/day) of  a purified diet during the entire experimental period. Restricted 
food intake was necessary to prevent differences in food consumption and hence differences in 
vitamin and mineral intake as observed earlier in FOS interventions76. The diet contained (per kg) 
200 g acid casein, 502 g glucose, 160 g palm oil, 40 g corn oil, 20 g cellulose, 35 g mineral mix 
(without calcium) and 10 g vitamin mix according to AIN93 recommendations59. Diets contained 
20 g/kg cellulose at least and were supplemented with either 60 g/kg FOS (purity 93%; Raftilose 
P95, Orafti, Tienen, Belgium) or additional 60 g/kg cellulose as described earlier76. Diets were 
low in calcium (20 mmol CaHPO4.2H2O/kg) and high in fat content (200 g fat/kg) to mimic the 
composition of  a Western human diet. Demineralized drinking water was supplied ad libitum.  
To follow intestinal permeability, 6 of  the 18 rats of  each dietary group received their diet 
supplemented with the intestinal permeability marker chromium ethylenediamine-tetraacetic acid 
(CrEDTA). The CrEDTA solution added to the diet was prepared as described elsewhere77. After 
feeding the diets for 16 days, rats were killed by carbon dioxide inhalation. Rats fed diets 
containing the permeability marker CrEDTA (n=6 per diet group) were not included in the gene 
expression study, to exclude possible interaction of  CrEDTA on colonic gene expression. From 
the remaining 12 rats per dietary group, the colon was taken out, longitudinally opened and 
colonic contents were removed by a quick rinse in 154 mM KCl. Colonic mucosa was scraped off  
using a spatula. Scrapings were immediately frozen in liquid nitrogen and stored at -80 C. The 
scrapings were homogenized in liquid N2 using a mortar and pestle cooled with liquid N2 (Fisher 
Emergo, Landsmeer, The Netherlands). One third of  the pulverized samples was used for 
protein determination and the remaining part for RNA isolation. 
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Analysis of urine samples 
Total 24 h urine samples were collected on days 14 and 15 from rats fed the control and FOS diet 
(n=6 each) supplemented with CrEDTA. Urines were preserved by adding oxytetracycline (1 mg) 
to the urine collection vessels of  the metabolic cages, and analyzed for the intestinal permeability 
marker CrEDTA  as described elsewhere77. CrEDTA data were analyzed using the Student’s t-test 
(two-sided) using Prism 4 (GraphPad software Inc., San Diego, CA). 
 
RNA isolation 
Total RNA was isolated from colon scraping homogenates using TRIzol reagent (Invitrogen, San 
Diego, CA) according to the manufacturer’s instructions. Total RNA was purified using Rneasy 
columns (Qiagen, Chatsworth, CA). Absence of  RNA degradation was checked on a 1% 
TBE/agarose gel after 1 hour incubation at 37°C. RNA purity and concentration were measured 
with the Nanodrop (Isogen Life Science, Maarssen, The Netherlands). OD A260/A280 ratios were 
all between 2.08 and 2.10 indicating RNA of  high purity. 
 
Analysis of mRNA expression by Oligo Arrays 
For microarray hybridization, RNA of  each individual animal was labeled with Cy5. A standard 
reference sample, consisting of  a pool of  all colonic RNA was labeled with Cy3. For each oligo 
array, 35 μg of  total RNA was used to make Cy5 or Cy3 labeled cDNA. Total RNA was mixed 
with 4 μg T21 primer, heated at 65°C for 3 min (RNA denaturation) followed by 25°C for 10 min 
(primer annealing). cDNA was synthesized by adding 5x first strand buffer (Invitrogen), 10 mM 
DTT, 0.5mM dATP, 0.5 mM dGTP, 0.5 mM dTTP, 0.04 mM dCTP, 0.04 mM Cy5-dCTP or Cy3-
dCTP, 1.2U RnaseOUT and 6U SuperScript II Reverse Transcriptase to a total volume of  62.5 
μL. The reaction was incubated at 42°C for 2 h. Purification, precipitation and denaturation of  
the labeled cDNA were performed as previously described80. 
Each labeled cDNA sample was individually hybridized on the 44K rat whole genome Agilent 
array (G4131A, Agilent Technologies, Inc. Santa Clara, CA) consisting of  44290 60-mer rat 
oligonucleotide probes, including ~3000 control spots. The Cy5 labeled cDNAs of  the individual 
rats were mixed 1:1 with the Cy3 labeled reference cDNA, mixed with 2x hybridization buffer 
(Agilent Technologies) and 10x control targets (Agilent Technologies) and hybridized for 17 
hours at 60°C in Agilent hybridization chambers in an Agilent hybridization oven rotating at 4 
rpm. After hybridization the arrays were washed with an SSPE wash procedure (Agilent 
Technologies) and scanned with a Scanarray Express HT scanner (Perkin Elmer). 
 
Data analyses and functional interpretation of microarray data  
Spot intensities were quantified using ArrayVision 8.0 (GE Healthcare life sciences). Median 
density values and background values of  each spot were extracted for both the experimental 
samples (Cy5) and the reference samples (Cy3). Subsequently, quality control was performed for 
each microarray using both LimmaGUI package in R from Bioconductor and Microsoft Excel. 
One array in the dietary FOS group did not pass the quality control based on MA plot and signal 
intensity distribution 1. Therefore, the dataset contained 23 arrays in total. Data was exported into 
GeneMaths XT (Applied Maths, Sint-Martens-Latem, Belgium) for background correction and 
normalization. We discarded spots with an average intensity, over all arrays, of  Cy5 lower than 
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1.5-fold above average background. Then, the Cy5 intensities were normalized against the Cy3 
reference as described previously53. The data have been deposited in NCBIs Gene Expression 
Omnibus52 and are accessible through GEO Series accession number GSE5943. The complete 
dataset is available as supplemental table at www.foodbioactives.nl. Fold changes calculations 
were performed in Microsoft Excel, fold change equals ratio FOS/control in the case of  increase 
or equals -1/ratio in the case of  decrease. For statistical identification of  differentially regulated 
probes between the control and FOS group we used two complementary tests, the often used t-
test and Random Forest (RF). T-test was performed in GeneMaths XT, the generated p-values 
were used to obtain insight into significantly affected genes. To correct for multiple testing we 
used FDR-adjusted p-values (GeneMaths XT), so called q-values6. For t-test we choose a 
stringent threshold of  p<0.001. The corresponding q-value was 0.035, meaning that 3.5% of  the 
genes selected by this p-value could be false positive. The t-test tests each gene independently and 
therefore will miss genes that have no main effect but are related to the treatment in gene-gene 
interaction56. We therefore used RF, available as R-package17,57, as a complementary method as 
that method includes genes that in gene-gene interaction are related to treatment besides 
including genes with a main treatment effect. RF was recently successfully used in several 
microarray studies20,40. The method provides an importance index for each gene. This value is 
dependent on the main treatment effect of  a gene. In addition, gene-gene interaction related to 
the treatment increases importance index value of  genes40. For RF we defined a threshold where 
the importance index of  each gene in the real dataset exceeded the importance index of  genes 
obtained from analysis of  100 randomly permuted datasets, using randomly assigned class labels 
FOS or control. This indicates that these genes are truly related to the treatment41 (detailed 
method described in Chapter 5). We included the genes that were selected by the t-test threshold 
and the genes selected by the RF threshold. These genes were considered significantly changed 
by FOS. 
To interpret functional changes in the dataset, we applied two pathway analysis programs, 
Metacore and GSEA, with different complementary pathway-classification properties. Pathway 
analysis of  the selected genes was performed using MetaCore (GeneGo Inc, St. Joseph, MI). We 
used classification based on GO-term and classification based on GeneGo annotation. The 
GeneGo annotation database is a curated database of  gene networks based on several databases 
(KEGG, GO) and scientific literature24. We also performed a pathway analysis with GSEA 
(Broad Institute), a method that does not require preselection of  genes by a statistical threshold 
but uses the whole dataset. GSEA is thoroughly described by Subramanian et al72. This method 
prevents possible selection bias14,63. We used the c2 functional genesets based on publicly available 
and curated databases (GenMapp, Biocart and SigmaAldrich). Only processes with 5-500 genes 
were taken into account. Agilent gene annotation version 20060331 was used for both programs. 
We selected pathways with p<0.001 in metacore and q-value <0.25 in GSEA, in accordance with 
the recommendation of  the GSEA developers72. 
Since only about 30% of  the genes on the whole genome array were recognized in both pathway 
programs, we manually supplemented the significantly enriched biological processes with non-
annotated genes from the selected gene-set using biological databases (BIOcarta, SOURCE, 
GenMAPP, KEGG) and scientific literature. As processes overlap, we bundled some processes 
and renamed them. 
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Analysis of mRNA expression by Real-time Quantitative RT-PCR 
Real-time Quantitative RT-PCR (Q-PCR) was performed on individual samples (n=12 per 
group). 1 µg of  RNA of  all individual samples was used for cDNA synthesis using the iScript 
cDNA synthesis kit of  Bio-Rad Laboratories (Veenendaal, The Netherlands). Real-time reactions 
were performed by means of  the iQ SYBR Green Supermix of  Bio-Rad using the MyIQ single-
color real-time PCR detection system (Bio-Rad). Each reaction (25 µl) contained 12.5 µl IQ 
SYBR green supermix, 1 µl forward primer (10 μM), 1 µl reverse primer (10 μM), 8.5 µl RNase-
free water and 2 µl diluted cDNA. The following cycles were performed: 1x 3 min at 95°C,  40 
amplification cycles (40x 10 s 95°C, 45 s 60°C), 1x 1 min 95° C, 1x 1 min 62°C and a melting 
curve (80x 10 s 55°C with an increase of  0.5°C per 10 s). A negative control without cDNA 
template was run with every assay. The optimal melting point of  dsDNA (Tm) and the efficiency 
of  the reaction were optimized beforehand. Data were normalized against the reference genes 
Pleckstrin homology domain containing, family A member 6 (Plekha6), Nucleoporin 37 (Nup37) 
and β-actin. Plekha6 and Nup37 were chosen because our microarray data showed equal 
expression levels for all microarrays, and β-actin was chosen because it is a well accepted 
reference gene. Primers were designed using Beacon designer 7.00 (Premier Biosoft International, 
Palo Alto, CA). For primer sequences see supplemental table 6.1. A standard curve for all genes, 
including reference genes, was generated using serial dilutions of  a pooled sample (cDNA from 
all reactions). mRNA levels were determined using delta CT method (IQ5 software version 2.0, 
Bio-Rad version). Analysis of  all individual samples was performed in duplicate. Data were 
analyzed using Student’s t-test (two-sided) using Prism 4. Differences were considered statistically 
significant when p<0.05. 
 
Protein determination 
Mucosal scrapings of  individual rats or pools of  all rats per group (n=12) were lysed in a buffer 
containing 0.125 M TrisHCl pH 6.8, 2% SDS and 20% glycerol. Protein concentrations were 
determined using DC protein assay kit (Bio-rad Laboratories, Veenendaal, the Netherlands).  All 
samples were boiled in sample buffer (0.125 M TrisHCl pH 6.8; 2% SDS; 20% glycerol; 2% β-
mercaptoethanol; 0.04% coomassie briljant blue), and separated by 14% SDS-PAGE. The 
proteins were transferred onto a nitrocellulose membrane. Immunoblot analysis was performed 
with a 1:2000 dilution monoclonal antibodies against OXPHOS complexes, Complex IV subunit 
II (COXII) monoclonal antibody (MS601, Mitosciences, Eugene, OR, USA) or with a 1:200 
dilution of  monoclonal anti-GLP1 antibody (Abcam (Ab23468), Cambridge, UK) by incubation 
in 2.5% protifar/TBS-T for 1½ hr at RT.  After incubation, blots were washed in TBS-T and 
incubated 1 hr at RT with a 1:2000 dilution horseradish peroxidase-conjugated anti-mouse IgG 
(7076, Cell Signaling, Danvers, MA, USA) for detection GLP1 or a 1:2500 dilution of  horseradish 
peroxidase-conjugated anti-mouse IgG (W4021, Promega, Madison, WI, USA) for detection of  
Complex IV. The signal was detected using an enhanced chemiluminescence detection system 
(GE Healthcare, The Netherlands) according to the protocol of  the supplier. After washing the 
membranes thoroughly with TBS-T, they were subsequently incubated with the monoclonal anti-
Actin (1:100 dilution, Santa Cruz, sc-1615) and HRP anti-goat (1:10000 dilution, Promega. 
V8051). The intensities of  GLP1, COXII and Actin signals on the autoradiography films were 
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quantified using geldoc (Bio-Rad). GLP1 and COXII quantities were normalized to actin to 
correct for loading differences.  
 
 
Results 
 
Food intake, body weight gain, and intestinal permeability 
Rats on the control diet and FOS diet showed no significant difference in body weight gain. Both 
dietary groups consumed the provided 14 grams of  diet per day as intended and thus had a 
similar dietary CrEDTA intake. Intestinal permeability was examined by measurement of  
CrEDTA excretion in urine and showed that FOS fed rats had increased urinary excretion of  this 
inert permeability marker as compared to the control group (figure 1).  
 
Control FOS
0
2
4
6
8
10
***
C
rE
D
TA
 ( μ
m
ol
/d
ay
)
Figure 1. Average urinary CrEDTA excretion in the control 
and FOS group. Daily dietary CrEDTA intake was 54μmol. 
Urines were collected at days 14 and 15. Results are 
expressed as mean ± SEM (n=6 per diet group). The FOS 
groups significantly differed from the control group 
(***p<0.001). 
 
Gene expression profile  
28180 probes on the array had an expression value of  1.5 times above background. Of  these 123 
were induced and 56 were reduced more than 1.5 fold in FOS fed rats compared with rats fed the 
control diet. Only 19 probes were induced more than 2-fold. While gene expression changes 
induced by FOS supplementation were small, there were many significantly changed probes in 
the dataset: 803 had a p-value < 0.001, and 231 probes had a FDR derived q-value<0.01. This 
indicated that the gene expression response of  colon mucosa to FOS was small in magnitude, but 
highly significant. As each probe signal is tested independently in t-test and multiple testing 
increases the risk for finding false positives, we also applied Random Forest20,40. RF ranks genes 
based on an importance value taking main treatment effect as well as gene-gene interaction into 
account40. Using RF, we identified 935 probes with an importance value above threshold. 629 
were selected by both the t-test and RF. To prevent loss of  information, we used all genes 
selected by t-test and RF. This resulted in a list of  1109 probes. 112 corresponding genes were 
listed more than once. Therefore, duplicates with the highest p-values were removed, resulting in 
997 unique genes regulated by FOS 
Gene selection by t-test or RF alone substantially overlapped and did result in a highly 
comparable outcome in pathway analysis, showing that the main effects extracted by both 
methods were similar. However, the individual gene selection differed slightly between both 
methods. We choose to include all genes selected by either method. 
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Effect of FOS on the expression of barrier associated genes 
As FOS affects the mucosal barrier, we specifically analyzed genes that are known or assumed to 
play a role in barrier function. These include tight junction genes like Zo1, occludin and claudin, 
cell turnover/apoptosis genes such as caspases, Bak, Bcl2, and mucosal defense genes such as 
defensins, lipocalin, toll like receptors and IgA (supplemental table 6.2). Tight junction related 
genes were not affected by FOS. Several apoptosis (for example Bax, DNase1, Pdcd 6 and 8) and 
mucosal defense genes (for example phospholipase A2 and trefoil factor 1 & 3) were increased by 
FOS (supplemental table 6.2). However, no FOS effect was found on other mucosal defense 
genes like IgA, Mucin 2 & 3, defensins, lipocalin, calprotectin, and most toll-like receptors. In 
addition, some markers of  apoptosis were slightly affected (Bak, Caspase 7), while most 
(including Apaf, caspase 9, caspase 3, caspase 2, Bcl2 and Bad) were not affected by FOS.  
  
Genes most prominently affected by FOS 
We examined the top 10 of  genes most affected by the FOS diet (table 1). We choose the genes 
most prioritized by RF. These genes were characterized by extremely low p-values and relatively 
high fold changes. The genes were related to nutrient homeostasis (proglucagon), energy 
metabolism (NADH dehydrogenases (Ndufb6, Ndufa4 and Ndufb5) and ATP synthase (Atp5f1)), 
protein turnover (Proteasome subunit alpha type 3-like (Psma3l)), oxidative stress response 
(Metallothionein-2 (Mt2)) and retinol metabolism (cellular retinol-binding protein (Rbp7)). This 
top-10 list indicates that FOS especially affects cellular energy metabolism in rat colonic mucosa, 
this was supported by the pathway analysis results, as described below. 
 
Table 1. Top 10 of highest ranked genes by Random forest and by t-test.  
Gene name Sequence ID Gene 
Symbol 
Fold 
change* 
p value 
Glucagon gene, exon 6  K02813 Glc 2.6 5E-10 
Cellular retinol-binding protein 7 P02696 Crbp 4.0 2E-09 
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5 XM_215544 Ndufb5 1.3 3E-08 
Unknown (LOC295337)  XM_215660  1.6 4E-08 
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6 XM_216378 Ndufb6 1.5 7E-08 
ATP synthase, H+ transporting, mitochondrial  F0 complex, subunit b, 
isoform 1  
NM_134365 Atp5f1 1.4 3E-07 
Protein C11orf10, LOC309206 XM_219574 - 1.4 3E-07 
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4 NM_010886       Ndufa4 1.4 3E-06 
Metallothionein-2  BF556648 Mt2 1.9 4E-06 
Proteasome subunit alpha type 3-like  BN000326 Psma3l 1.4 7E-06 
*Fold change FOS/ control. 
 
Pathway analysis 
Pathway analysis identified processes most affected by dietary FOS in colonic mucosa. 366 Genes 
of  the 997 selected genes could be classified based on GO term or based on GeneGo annotation 
in the Metacore database24. The most significant processes were an entire range of  mitochondria 
related processes such as mitochondrial electron transport, oxidative phosphorylation, translation 
in mitochondria and proteins targeted to mitochondria (supplemental table 6.3). Another highly 
classified process was proteolysis (supplemental table 6.3). To prevent bias in biological 
interpretation due to gene selection (by t-test and RF), we also applied Gene Set Enrichment 
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Analysis (GSEA) which includes all genes in the dataset (28180 genes). We focused on curated 
gene-sets originating from GenMapp, Biocart, SigmaAldrich and Broad institute. Comparable 
biological processes were found by GSEA as observed in Metacore: again electron transport and 
oxidative phosphorylation were most significant, followed by proteasomal degradation 
(supplemental table 6.4). Thus the threshold based Metacore analysis and the threshold free 
enrichment analysis, GSEA, gave similar results for the most significantly changed processes by 
FOS. The results obtained by pathway programs consist of  many overlapping pathways. We 
combined pathways with overlapping genes such as mitochondrial electron transport (Metacore), 
electron transport (Metacore) and electron transport chain (GSEA) and categorized the 
processes. 
Analysis based on pathway programs is restricted to the well annotated genes34. As only 36% of  
the Agilent whole genome array is recognized by Metacore and only 35% by GSEA, we manually 
extended the significantly altered pathways with the non-recognized genes using literature and 
databases mining (using Biocarta, Source, Genecards). This strengthened the pathway outcome, 
as we were able to identify many additional genes affected by FOS that could be added to the 
processes already identified by the pathway programs. This was the case for transcription 
identified by Metacore as nucleosome assembly, cell turnover identified by GSEA as programmed 
cell death, cytoskeleton and vesicle related processes (muscle filament sliding and cytoskeleton-
dependent intracellular transport in Metacore) and oxidative stress (free radical induced apoptosis 
in GSEA) (figure 2). In addition, we identified FOS affected genes that were not grouped into a 
pathway by both programs but obviously belong to the same biological process, this was the case 
for mucosal barrier, transport, and peptide hormones (figure 2).   
Figure 2. Classification of the genes affected by 
FOS into biological processes. Analyzed by 
Metacore, GSEA and data mining. 
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Detailed analysis of  the mitochondrial processes showed an increased expression of  genes 
associated with al five complexes of  the OXPHOS complex, TCA-cycle and mitochondrial 
ribosomes and mitochondrial protein transport (table 2). In addition to protein degradation, 
which was found in the pathway programs, protein translation and maturation were also affected 
by FOS. From these 113 genes more than 90% showed increased expression upon FOS 
indicating increased protein turnover (table 2). Detailed gene expression data for all processes 
mentioned in table 2 is presented in Supplemental table 6.5 available at the website 
www.foodbioactives.nl. 
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Table 2. Detailed classification of biological processes affected by FOS. 
Biological process 
                                           Number of genes  
                                           affected by FOS* 
Mitochondria Complex I 27 
 Complex II 5 
 Complex III 2 
 Complex IV 13 
 Complex V 21 
 Metabolism and TCA cycle 53 
 Mitochondrial ribosomes 33 
 Protein transport 11 
 Miscellaneous 12 
Protein turnover Protein degradation  31 
 Translation 44 
 Protein maturation 32 
 Miscellaneous 6 
Transcription Chromatin related 22 
 mRNA metabolism 7 
 Transcription 26 
 Miscellaneous 6 
Cell turnover Apoptosis 19 
 Growth/ differentiation 16 
Mucosal barrier  30 
Cytoskeleton  26 
Transport  20 
Oxidative stress  16 
Vesicle related  10 
Peptide hormones  6 
Other†  503 
  997 
* genes with p-value<0.001 or selected by RF threshold. 
† genes with less than 5 other genes belonging to the same process, unknown genes and, genes not part of a known process.   
 
Confirmation of array results by Q-PCR 
Confirmation of  FOS induced processes was performed by Q-PCR. Genes from several FOS 
affected processes were analyzed by individual Q-PCR. We selected nine genes from 
mitochondria related processes: NADH dehydrogenase (ubiquinone) 1 beta subcomplex 9 
(Nduf9b) , succinate dehydrogenase complex subunit B (Sdhb), ubiquinol-cytochrome c reductase 
binding protein (UbiqcytC), cytochrome c oxidase subunit VIIb (Cox7b), ATP synthase H+ 
transporting mitochondrial F0 complex subunit G (ATP5g), aldo-keto reductase family 1 member 
B8 (Akr1b8), malic enzyme 1 (Me1), mitochondrial ribosomal protein S16 (RiboS16) , translocase 
of inner mitochondrial membrane 8 homolog b (Timm8b). In addition, one gene from protein 
degradation proteasome subunit alpha type 3-like (Psma3l), two genes related to mucosal barrier 
phospholipase A2, group IIA (platelets synovial fluid) (Pla2g2a) and trefoil factor 3 (Tff3) and one 
gene from the peptide hormones, proglucagon (Gcg) were analyzed. We additionally selected 
retinol binding protein 7 (Rbp7) as this gene was highest induced by FOS (4-fold). Q-PCR fully 
confirmed the microarray data (table 3). The p-value in the Q-PCR analysis reached significance 
(p<0.05) for 11 out of  13 genes. Two genes had a p-value>0.05 (ATP 5g and Timm8b).   
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Table 3. Q-PCR confirmation of microarray data.  
  
Micro-
array  
Q-PCR 
Gene name 
Gene 
symbol sequence ID Ratio*    Ratio* SEM± 
p-
value† 
Mitochondria        
Complex I        
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9  Nduf9b XM_216929 1.47  1.29 0.05 0.001 
Complex II        
Succinate dehydrogenase complex, subunit B, iron sulfur  Sdhb XM_216558 1.43  1.32 0.05 <0.001 
Comples III        
Ubiquinol-cytochrome c reductase binding protein Uqcrb XM_001074024 1.53  1.28 0.05 0.005 
Comples IV        
Cytochrome c oxidase subunit VIIb Cox7b NM_182819 1.61  1.36 0.06 0.001 
Comples V        
ATP synthase, H+ transporting, mitochondrial F0 complex, 
subunit G ATP5g XM_001075306 1.52  1.15 0.05 0.11 
Metabolism and TCA cycle        
Aldo-keto reductase family 1, member B8 Akr1b8 NM_173136 2.13  2.15 0.22 0.006 
malic enzyme 1 Me1  1.65  1.76 0.11 <0.001 
Mitochondrial ribosomes        
Mitochondrial ribosomal protein S16 Mrps16 XM_001064095 1.43  1.20 0.05 0.03 
Mitochondrial protein transport        
Translocase of inner mitochondrial membrane 8 homolog b Timm8b NM_022541 1.45  1.19 0.06 0.09 
Protein turnover        
Proteasome subunit alpha type 3-like Psma31 BN000326 1.39  1.24 0.04 0.002 
Mucosal barrier        
Phospholipase A2, group IIA (platelets, synovial fluid) Pla2g2a NM_031598 3.73  4.70 0.87 0.03 
Trefoil factor 3 Tff3 NM_013042 1.7  1.21 0.05 0.04 
Top 10 gene        
Retinol binding protein 7 Rbp7 XM_575960 2.06  3.72 0.36 <0.001 
Peptide hormone        
Proglucagon Gcg NM_012707 2.56  2.91 0.23 <0.001 
* Ratio FOS diet/ Control diet. 
± SEM of Q-PCR data is given (n= 12 per group). 
† p-value of Q-PCR data is given, the p-value of microarray data were all <0.001. 
 
Confirmation of gene expression results on protein level 
To substantiate the FOS induced transcriptional modulation of  mitochondrial genes at the 
protein level, we analyzed pooled mucosal scrapings of  all rats (n=12 per group). The small 
increase in mRNA levels of  complex IV subunits (~1.4 fold), was confirmed by a similar increase 
(1.5, 1.7 and 2.7 fold in independent pools, relative to actin) in protein levels of  complex IV 
subunit COX II in the FOS group compared with the control group in pooled (n=12) mucosal 
scrapings (figure 3). 
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Complex IV: COXII (26 kDa)
FOSControl
Actin (43 kDa)
Figure 3. Mucosal scapings (pool of n=12 per group) were examined for complex IV subunit COXII protein levels. The 
experiment was performed three times on separately prepared pools, showing a 1.5; 1.7 and 2.7 fold difference in COXII protein 
expression relative to actin, respectively. The 1.5 fold increase is shown. 
 
The relatively high and significant induction of  proglucagon gene by FOS was also examined at 
the protein level. Mucosal scrapings of  randomly sampled control and FOS-fed rats (n=7 per 
group) were analyzed for GLP-1 protein levels by western blot and normalized  to actin. FOS 
significantly increased GLP-1 protein levels in colonic mucosal tissue (Figure 4), substantiating 
the gene expression findings. 
The clear effects of  FOS on mitochondrial processes was not expected beforehand, therefore no 
precautions were taken at the time of  sampling and storage that would allow post-hoc analysis of  
ATP levels. Alternatively, we attempted to examine levels of  phosphorylated AMP-activated 
protein kinase (AMPK) which reflects the ADP/ATP ratio in cells30. Low levels of  total AMPK 
protein could be detected in colonic scrapings with no difference between control and FOS (data 
not shown).  AMPK phosphorylation could not be detected in mucosal scrapings, most probably 
due to the instable phosphorylations that require specific handling during the collection of  the 
samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
 
The CrEDTA results showed that dietary FOS increased intestinal permeability in rats in 
accordance with our previous study77. The FOS induced increase in intestinal permeability 
reduces intestinal barrier function as reported earlier77. Individual gene expression of  12 rats after 
≈2 weeks FOS versus control feeding were explored on whole genome level and showed that the 
increased permeability could not be explained by changes in genes belonging to the tight junction 
system. No significant changes were observed in claudin 2 and 4, cadherins or tight junction 
protein 1. With our focus on gene expression, possible changes in protein levels and cellular 
Figure 4. Relative expression of proglucagon mRNA  
(gray bar) and GLP-1 protein (black bar) in colonic 
mucosa of a random selection of control fed (n=7) 
and FOS fed (n=7) rats. mRNA and protein levels 
were normalized to actin levels. (**p<0.01, 
***p<0.001). 
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localization or modification cannot be excluded. 19 Genes related to apoptosis were affected by 
FOS with only modest fold changes.  Although some pro-apoptotic genes were mildly affected 
(eg Bax, Caspase 7), no changes were seen in many key pro-apoptotic genes such as Bad, Caspase 
3 and Apaf1. Therefore, we feel that apoptosis is not the main cause of  the increased intestinal 
permeability observed. Known mucosal defense genes such as defensins, mucins and calprotectin 
were also unaffected by FOS. These few and small transcriptional changes in potential barrier 
related genes cannot explain the profound and consistent effects of  FOS on intestinal 
permeability in rats.  
On the other hand, we identified multiple genes associated with energy metabolism (177 
mitochondria related genes) that were significantly modified by FOS. Protein turnover was also 
clearly affected by FOS (113 genes). Coincidence of  increased permeability and upregulation of  
these genes suggests that these processes play a major role in preservation of  intestinal mucosal 
integrity. 
 
The most striking observation was the induction of  a broad range of  mitochondrial genes. 
Increased expression of  mitochondrial genes is commonly observed during disturbed ATP 
homeostasis caused by increased energy demand or decreased mitochondrial energy supply84. 
ATP depletion by a wide range of  uncoupling agents induces mitochondrial genes such as cyclo-
oxidase, NADH dehydrogenase and 16S mitochondrial mRNA in rat colon58, cytochrome c 
oxidase subunit III (CoxIII) in rat heart84, Cytochrome c, CoxII and Atp-ase in fibroblasts and 
several mouse tissues and CoxIV and Adenine nucleotide translocator (Ant) and liver cell culture 
studies 19,62. FOS induced most of  the above mentioned genes (Ant, 24 NADH dehydrogenases, 
7 Cox subunits and 3 ATP-ases). This could be confirmed at protein level for complex IV subunit 
II. Together this strongly indicates that FOS caused ATP depletion in colonic epithelial cells.  
The next question is whether the increased expression of  mitochondrial genes by FOS, which 
probably reflects ATP-depletion, is responsible for the observed increase in intestinal 
permeability in FOS-fed rats. Many studies using epithelial cell lines have shown that ATP 
depletion is a cause of  paracellular hyperpermeability42,43,79. Another strong indication that 
mitochondria are important in maintaining intestinal permeability is derived from studies on 
chronic non-steroidal anti-inflammatory drugs (NSAIDs)69. Direct exposure of  rat intestine to 
the NSAID indomethacin or the mitochondrial uncoupler 2,4-dinitrophenol (DNP) increases 
epithelial permeability 51. Also, NSAIDs or DNP induced uncoupling of  intestinal mitochondria 
was shown to lead to increased bacterial translocation in rats and intestinal cell lines, and immune 
cell infiltration and ulceration in rats51,70. Enhanced bacterial translocation reflects impaired 
barrier function. The NSAID induced increased permeability is attenuated with co-administration 
of  glucose and citrate, substrates for tricarboxylic acid cycle and glycolysis, or ATP8,10. 
 
What could be the mechanism of  the FOS induced increase in intestinal mitochondrial gene 
expression and possible ATP-depletion, and the increased mucosal permeability? Previous studies 
in rats37,60,76 and humans75 showed rapid fermentation of  FOS in cecum and colon by the 
endogenous microflora resulting in lactic acid accumulation, SCFA production, and decreased pH 
of  luminal contents. Although luminal production of  modest quantities of  SCFAs is essential for 
normal colonic mucosal function64, overproduction or accumulation of  SCFA along with low pH 
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in the intestinal lumen has been shown to cause intestinal injury leading to increased intestinal 
permeability3,39,48. In vitro studies show that increased permeability of  intestinal epithelial 
monolayers caused by exposure to excess SCFA levels and reduced extracellular pH is associated 
with cellular ATP depletion36,45. The SCFA induced depletion of  cellular ATP coincided with a 
reduced intracellular pH (pHi) in perfused livers5. In an acidic luminal environment, a relatively 
larger portion of  SCFA becomes protonated, facilitating passive diffusion of  SCFA across the 
apical hydrophobic enterocyte membrane causing intracellular acidification13,15. The above 
mentioned studies were done in vitro or in perfused liver, but the concentrations applied can 
impair the pHi homeostasis in colonocytes in FOS fed rats37,47. Taken together, FOS reduces 
luminal pH and increases levels of  SCFAs, this likely leads to acidification of  the cellular 
cytoplasm (decrease in pHi) and subsequent ATP-depletion. ATP-depletion can occur because 
the decrease in pHi is compensated by H+ excretion in exchange for Na+ by the pHi regulating 
Na+/HCO3- cotransporter (NBC) and the Na+/H+ exchanger (NHE) in the basolateral 
membrane 18,23. This indirectly activates the Na+,K+-ATPase (ATP1) which is known to require 
~25% of  the cellular ATP turnover under basal conditions11. Long-term exposure of  enterocytes 
to high SCFA concentrations under low pH conditions might therefore disturb or exhaust plasma 
membrane pumps, leading to rapid ATP-depletion36(BOX 1). FOS diet significantly increased 
expression of  Atp1b1 (1.2-fold, p<0.001). No changes were found in the gene expression of  the 
transporters Nbc and Nhe possible increased activity of  these transporters can occur without 
concomitant changes in mRNA gene expression. A strong indication supporting SCFA and low 
luminal pH as inducers of  the observed effects, are results of  previous studies of  our lab 
showing that the adverse affects of  FOS on mucosal barrier, i.e. increased permeability and 
decreased resistance to pathogens, are absent when calcium is supplemented to the diets74. 
Calcium is known to increase the buffering capacity of  luminal contents by its precipitation with 
dietary phosphate. By preventing acidification during fermentation, SCFA will remain in the 
anionic form, for which the cellular plasma membrane is not permeable. 
 
Another possible, but less likely, mechanism of  FOS induced mitochondrial gene expression is 
SCFA induced accumulation of  Acyl-CoA in mitochondria. This can result in depletion of  ATP 
in the intramitochondrial compartment and accumulation of  AMP67. We observed induction of  
Acyl-Coa synthetase (FC1.3, p<0.001). Furthermore, SCFAs are reported to induce opening of  
mitochondrial inner membrane channels like the permeability transition pore complex resulting 
in loss of  membrane potential and consequently ATP depletion32,36. FOS significantly changed 
the expression of  pore complex member adenine nucleotide translocator (Ant) (FC 1.3, 
p<0.001). However no significant changes were observed in the expression of  other members 
such as voltage activated anion channel, Cyclophilin D and peripheral benzodiazipine receptor. 
Although the exact mechanism is not clear, the observed increase of  many mitochondria related 
genes in the present study seem to represent induced mitochondrial activity to compensate for 
SCFA -induced ATP depletion. This is supported by the fact that all five OXPHOS complexes, 
mitochondrial ribosomes and many other mitochondria related genes were induced, indicating an 
overall increase in mitochondrial capacity. We would like to add that although in vitro studies and 
studies performed in other tissues show ATP depletion due to SCFA exposure, this has to be 
confirmed for the colon in the intact animal, preferably by direct assessment of  ATP levels. 
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BOX 1. Proposed mechanism of dietary FOS induced intestinal permeability 
 
 
The second major process affected by FOS was protein turnover. FOS induced 27 ribosomal 
proteins and 30 proteasomeal genes, indicating increased protein turnover. Intracellular proteins 
are targeted to the proteasomal degradation system by ubiquitination50. FOS induced 9 ubiquitin 
related genes, including several isoforms of  the E2 ubiquitin carrier enzyme. Proteasomal 
degradation is tightly controlled and removes denatured, misfolded and damaged proteins. The 
clear increase in proteasomal gene expression might result from increased presence of  misfolded 
proteins. One common cause of  misfolding of  cellular proteins is mild oxidative stress33. FOS 
induced several genes related to oxidative stress, such as metallothionein-2 (Mt2) metallothionein-
1a (Mt1a), six glutathione S-transferases (Gst’s), heme oxygenase 1 (Hmox1), and superoxide 
dismutase 1 and 3 (Sod1 and Sod3). Mt2 is one of  the top-10 most regulated genes by FOS, it 
protects against oxidative stress by capturing harmful oxygen radicals by its cystein residues78. An 
increase in oxidative stress proteins is an indirect marker for production of  reactive oxygen 
species (ROS)65. It is well recognized that induced mitochondrial activity can increase production 
of  ROS. The increased expression of  oxidative stress genes and mitochondrial genes observed in 
the present study suggests increased mitochondrial activity, possibly associated with increased 
ROS production and increased in protein oxidation. Oxidized proteins are often misfolded, and 
directed to proteasomes for degradation. In support, the translocase Sec61 responsible for 
1 High levels of FOS fermentation products increase intestinal permeability in vivo 3,39,77. 
2 Excess SCFAs cause intracellular acidification of epithelial cells. When protonated-SCFA diffuse from the gut lumen 
into epithelial cells 15,29. The SCFA cause intracellular acidification and induce proton pump activity (NHE and NBC 
transporters) which may lead to ATP depletion 5,36 
3 Reduced ATP levels, by increased energy demand, chronic mitochondrial uncoupling or any other cause of disturbed 
energy metabolism, are compensated by increased mitochondrial gene expression and mitochondrial biogenesis 62,84.   
4 Disturbed energy metabolism leads to increased permeability. In agreement: ATP-depletion in epithelial cell lines 
causes paracellular hyperpermeability 42,43,79 and uncoupling of intestinal mitochondria leads to increased bacterial 
translocation, immune cell infiltration and ulceration in rats 51,69.  
Calcium supplementation of a FOS diet counteracts FOS induced intestinal permeability. Calcium prevents acidification 
of intestinal contents during fermentation and thus formation of protonated-SCFA. 
Gut lumen
Epithelium
Permeability
Expression 
Mitochondrial genes 
FOS
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intracellular transport of  misfolded proteins from the ER to the proteasome was significantly 
increased 1.4 fold (p<0.001) by FOS. 
Increased proteasomal gene expression might also reflect the formation of  immunoproteasomes 
(I-proteasomes). The I-proteasome plays a role in antigen processing and is composed of  the   
20S proteasome complex coupled to 2 homologous complexes called PA28-α (Psme1) and -β 
Psme281. FOS supplementation significantly increased both Psme subunits. I-proteasome derived 
proteolysed antigen fragments are loaded on class I MHC and presented to receptors on CD8+ T-
cells leading to activation of  an immune response via NF-кb81.The expression of  PA28 is known 
to be induced by cytokines like IFNγ and microbial infection71. Alterations in the I-proteasome in 
injured intestinal epithelium are observed in colon biopsies of  IBD patients and IBD-mouse 
models26,81. The increased intestinal permeability due to the FOS diet can cause increased 
exposure of  the mucosa to bacteria and therefore induce I-proteasome gene expression. 
 
The top 10 most significantly changed genes by FOS showed to be good representatives of  the 
major biological processes selected from pathway analysis. Four of  these ten are members of  
mitochondria related processes (Ndufb6, NADH-ubiquinone oxidoreductase Mlrq, Ndufb5 and 
Atp5f1). Another top 10 member, Psma3l, represented the second biological process induced by 
FOS, namely protein turnover. In addition to these genes, the gene coding for cellular retinol-
binding protein (Rbp7) was the most highly induced gene (4-fold) and another cellular retinol 
binding protein, Rbp2 was induced 2-fold by FOS. RBPs are required for uptake, intracellular 
transport and metabolism of  vitamin A. Vitamin A is a fat-soluble vitamin necessary for growth 
and differentiation of  epithelial tissues. RBP7 and RBP2 belong to the fatty-acid binding protein 
(FABP) family. FOS also significantly increased Fabp1 2.9 fold. At present, we cannot explain the 
FOS induced expression of  these genes and its relation to the functional effects observed in this 
and our earlier FOS studies. 
Proglucagon is one of  the most highly induced gene by FOS (2.6-fold, p<0.001). The 
proglucagon gene is a precursor encoding several glucagon-like peptides. In intestinal 
enteroendocrine cells the gene codes for oxyntomodulin, GLP1 and GLP231. This gene was 
previously found to be induced by non digestible oligosaccharides12. Our study confirms that 
dietary FOS increases proglucagon gene expression and GLP-1 protein expression in the colon 
mucosa of  rats. Besides FOS induced expression of  proglucagon, FOS induced the expression 
of  several other gut-derived peptide hormones, namely cholecystokinin (Cck), peptide YY (Pyy) 
and pancreatic polypeptide (Ppy). Increase of  PYY has previously been reported in rat colon by 
SCFA86. Proglucagon, PYY, PPY and CCK are all expressed by enteroendocrine L cells in colon 
and play a role in gut-nutrient sensing16. In the hypothalamus nutrient sensing is also regulated by 
these hormones and directly related to ATP status38. It is speculated that the same mechanism is 
applicable to enteroendocrine L cells in de gut86. Since in our study, increased gene expression of  
these 4 peptide hormone genes coincides with alterations in mitochondrial processes, it is 
tempting to speculate that these hormones also influence or respond to energy metabolism in 
intestinal epithelial cells. Besides a role in energy homeostasis, GLP2, PYY and CCK have 
growth-promoting properties on the intestinal epithelium in vivo25. GLP1 stimulated cell 
proliferation has been reported for liver and pancreas21. GLP2 is involved in regulation of  
mucosal epithelial integrity22. It stimulates intestinal crypt cell proliferation27 and reduces 
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apoptosis, therefore enhances mucosal regeneration. It has beneficial effects on many causes of  
intestinal injury, such as stress, vascular ischemia, NSAID administration and chemically induced 
injury in rodents, and decreases subsequent intestinal permeability35,55. The upregulation of  these 
genes gene might thus be a response to the impaired intestinal barrier in FOS-fed rats. 
 
FOS consistently increased intestinal permeability, but the present study showed hardly any effect 
on expression of  well known intestinal integrity genes. Most surprisingly no changes were 
observed in genes related to tight junctions that were expected since tight junctions are key 
regulators of  paracellular transport. However, changes in epithelial permeability are a result of  
internalization of  the tight-junction proteins occludin, claudin and junctional adhesion molecule-
A66. These cellular translocations can occur without concomitant changes in mRNA gene 
expression. Detection of  such effects would require a different approach from transcriptomics. 
Imunohistochemistry could show whether translocation of  TJ proteins occurred in the FOS fed 
rats compared with control fed rats and is under current investigation.  
 
Altogether we show that altered barrier integrity induced by FOS-diet coincides with a clear 
increase in mitochondrial gene expression, suggesting that mitochondrial energy metabolism is 
important for maintaining the intestinal barrier. The role of  mitochondria in maintenance of  the 
intestinal barrier is already accepted in NSAID or DNP uncoupling studies. We speculate that 
excess production of  SCFA and acidification of  luminal contents results in SCFA induced ATP 
depletion of  colonic epithelial cells. Insight into the role of  mitochondrial function and ATP 
depletion is of  relevance, not only for the application of  FOS and other prebiotics in food 
products on the current market, but especially for mechanistic understanding of  intestinal 
disorders where gut permeability changes are observed.  
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1 Introduction 
 
One of the current challenges in nutritional science is to improve gut health by dietary 
modulation. To improve gut health, insight into the molecular mechanisms of the gut mucosal 
barrier is required, since disturbance of these molecular barrier mechanisms leads to disease. 
Increased knowledge of gut mucosal barrier mechanisms can, for example, aid in understanding 
intestinal disease processes, which is necessary for the development of functional foods or 
medications that promote gut health. Moreover, in-depth knowledge of mechanisms can provide 
biomarkers that enable monitoring of gut health in humans.  
 
The importance of the gut to health and disease is reflected in the large amount of research on 
the gut. Most of this research has focused on the intestinal barrier in relation to diseases such as 
chronic inflammatory bowel disease and infectious disease26 or in relation to nutritional 
modulation, for example using probiotics and prebiotics18. Despite this large amount of attention, 
key molecular mechanisms that determine a healthy barrier are not completely understood due to 
the complexity of the barrier. The barrier is complex because it is composed of several 
components that constantly interact with each other, such as the epithelial cells, the mucus layer, 
the immune system and the microflora. However, most research on the barrier has concentrated 
on only one or two of these components. Few studies have focused on the intact gut mucosal 
barrier in a living organism. This last approach is required to really understand the gut mucosal 
barrier. We therefore chose to study the complete barrier complex in a living organism. 
Examining the function and key mechanisms of a healthy biological cell, tissue or organ generally 
requires looking for differences between the healthy control condition and a treatment or disease 
condition. Mechanisms in the intestine that are activated by treatment or disease are important 
for barrier system homeostasis. For the intestine this means that the barrier must be stimulated 
with different stress challenges to test its capacity to withstand those challenges; this reveals 
molecular responses that are important for the gut mucosal barrier. Examples of stress challenges 
for the intestinal barrier are infection with pathogens like Salmonella and exposure to nutrients 
like FOS. Previous functional observations have shown that infection results in translocation of 
Salmonella across the intestinal barrier to extra-intestinal organs and that dietary FOS induces 
increased intestinal permeability76,77. 
Salmonella is a frequently used model pathogen in gut barrier research53,68. One reason for this is 
that Salmonella is a main cause of human foodborne infectious disease. Despite the large amount 
of data on host molecular responses to Salmonella infection, a full overview of the in vivo 
molecular mucosal response is lacking, since most data are derived from in vitro cell culture 
studies or ex vivo model systems33.  
Studies on the effects of FOS on the intestine clearly show effects on the intestinal barrier of rats. 
For example, it increases both Salmonella translocation and intestinal permeability76,77. The 
mechanisms responsible for these effects of FOS on the intestine are unknown, but are probably 
related to enhanced colonic fermentation and production of organic acids by the gut microflora. 
Because of their clear effects on the intestinal barrier, both Salmonella and FOS are relevant gut 
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barrier challenges and are therefore useful as tools or models to examine processes important for 
barrier functioning. 
Since little is known about the various intestinal mechanisms that are influenced by Salmonella 
and FOS, we used transcriptome analysis to look at the whole genome instead of focusing on 
obvious mechanisms. This allows identification of all possible biological processes active at the 
time of examination. Besides examination of known and expected molecular mechanisms, this 
technique allows the identification of new biological processes that were previously not related to 
the barrier function.   
 
The aim of our microarray experiments was to identify the gene expression response of the 
intestinal mucosa in rats after exposure to Salmonella and FOS.   
 
2 Main findings 
 
1 The mucosal gene expression response to Salmonella showed that detoxification, glucose, lipid, 
peptide and ion transport and proteolysis were involved in the early mucosal response to 
Salmonella-induced stress. This was previously unreported in the literature. However, genes 
related to expected barrier mechanisms, such as tight junctions, mucin or toll-like receptors, were 
not shown to be induced. Despite clear translocation of Salmonella to extra-intestinal sites at day 
one post infection, the induction of immune response genes such as cytokines and chemokines 
was not observed at this early stage, but only later on (day 3 and day 6). This in vivo transcriptomic 
approach showed that important genes and processes, but not the expected ones, play a role in 
the early response of the intestinal barrier to Salmonella. 
 
2 The early gene expression response to Salmonella in the colon was comparable in magnitude to 
the response observed in the ileum, indicating that Salmonella infection in rats is certainly not 
restricted to the small intestine, as is often presumed. The ileum and the colon show a divergent 
gene expression response to the same stimulus, which reflects different response mechanisms in 
these two intestinal segments.  
 
3 Several genes showed an early and pronounced response to Salmonella or FOS, such as 
pancreatitis-associated protein, lipocalin, calprotectin and phospholipase a2. These genes are new 
candidates for gut health biomarkers.  
 
4 Salmonella infection in vivo was found to differ from findings derived from in vitro systems. We 
observed only minor gene expression changes in the intestine following oral Salmonella infection, 
in contrast with in vitro models where major gene changes are observed. Therefore, extrapolation 
of results obtained in model systems to be relevant for in vivo gut barrier functioning should be 
done cautiously. 
 
5 FOS-induced intestinal permeability was not related to the altered expression of known barrier 
genes such as tight junction genes, but to induced transcription of mitochondrial genes in the 
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colon mucosa. This finding supports a role for mitochondrial energy metabolism in barrier 
functioning.  
 
6 The increased intestinal permeability induced by dietary FOS increased Salmonella translocation 
and coincided with enhanced induction of Salmonella-responsive genes. Increased expression of 
genes involved in defence or immune responses are often interpreted as increased defence and 
are used as surrogate markers for improved gut health. The present study shows that these 
surrogate markers need careful interpretation and correlation with functional effects or clinical 
endpoints.  
 
3 Interpretation of findings: what determines intestinal barrier function? 
 
3.1 Mechanisms that are part of the early gut mucosal response to Salmonella 
Salmonella clearly affected detoxification in the ileum, proteolysis in the colon and transporters 
and antimicrobials in both segments. These processes had not previously been related to barrier 
functioning, but are part of general cellular maintenance. Detoxification is defined as the 
metabolism of xenobiotics and endogenous toxins; it involves many proteins including 
cytochrome P450. It is currently not understood how downregulation of detoxification affects 
the host response to infection. Two recent microarray studies on early barrier responses to 
Salmonella in pigs30 and chickens80 substantiate our finding that detoxification is downregulated 
in the early barrier response to Salmonella. Downregulation of cytochrome P450 genes 
expression has also been reported to occur through inflammatory mediators such as cytokines 
and reactive oxygen species51,62. However, in our study the induced expression of 
proinflammatory cytokines observed at day 3 p.i was mild whereas the decrease in detoxification 
genes at that time point was abundant. One explanation of why cells may shut down cellular 
systems such as detoxification in response to bacterial infection is to save energy. Another 
explanation is that cytochrome P450 generates epoxyeicosatrienoic acids that have anti-
inflammatory effects22. Thus, for cells to assure progression of an inflammatory response against 
Salmonella, downregulation of cytochrome P450 is one mechanism to prevent formation of anti-
inflammatory mediators. 
It is noteworthy that the Ah receptor nuclear translocator (Arntl), the transcription factor 
regulating Cyp1a1, Ugt1a6 and Gsta288, did show decreased expression at day 1; an additional 
possibility could therefore be that Salmonella actively reduces cellular detoxification systems. To 
clarify a role for detoxification in the host response to bacterial infection, functional studies are 
necessary, for example examination of protein levels, enzyme activity and histology.   
In both ileal and colonic mucosa at early time points p.i., transporters and antimicrobial defence 
genes were altered (see Chapters 2 and 3). This differential expression of the wide range of 
transporters such as glucose, lipid, peptide and ion transporters may reflect increased cellular 
energy demand. An increase in energy demand has been reported in wounded cells. These cells 
increase transport of glucose into the cell to meet the metabolic demand of processes such as 
wound healing, cell proliferation and synthesis of extracellular matrix75. Since Salmonella most 
certainly induces cell damage of mucosal cells, this can explain the increased expression of the 
diverse transporters in mucosal cells. Alternatively, Salmonella might use host cellular energy for 
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its own purpose, ultimately leading to increased energy needs for the host cells. Additionally, the 
increase in transporters may be a general host response to bacterial contact, since commensal 
bacteria are also known to alter host transporter functioning31. The exact role of this process in 
the host barrier response requires more in-depth study. 
Antimicrobial peptides are part of the host innate immune defence and are active against a broad 
spectrum of bacteria and other microbes66. Antimicrobial defence genes, such as lipocalin 2 and 
phospholipase A2, were among the highest induced genes after Salmonella exposure in both the 
ileum and colon. Antimicrobial defensin 5 was downregulated by Salmonella in both the ileum 
and colon. Down-regulation of defensins has also been reported previously in mucosal biopsies 
of patients with Shigella infection34 and in mice orally infected with Salmonella65. Since 
Salmonella is known to manipulate host signalling56, repression of mucosal antimicrobial peptide 
expression could be a sophisticated strategy of pathogenic bacteria to overcome host innate 
defences at the mucosal surface.  
Unexpectedly, many known barrier genes, for example genes coding for mucin proteins or toll-
like receptors, were not regulated by Salmonella at day 1 p.i. Immune response genes such as 
cytokines and chemokines were also not induced at day 1 p.i., despite clear translocation of 
Salmonella to extra-intestinal sites at that time point. This could indicate that Salmonella infection 
in rats is a targeted and controlled process. Furthermore, communication and feedback 
mechanisms between different mucosal cell types may help to maintain mucosal homeostasis. At 
later time points, days 3 and 6, immune response genes such as cytokines and chemokines were 
observed. However, even at these relatively late time points, induction of immune and 
inflammation related genes was modest.  
The results of our in vivo transcriptomic approach supports the idea that gut barrier research 
should not be restricted to expected barrier processes alone. In our research, unexpected genes 
and processes were found to be important in the early response. 
 
3.2 Salmonella-induced responses in different intestinal segments 
In chapter 3, we showed that the colon was clearly a target for Salmonella in rats. Most 
Salmonella research in pigs, mice and rats focuses on the ileum and ileal Peyer’s patches (PPs) as 
primary site of Salmonella translocation, however several reports on Salmonella infection in 
humans also mention involvement of the colon49,81. We expected involvement of the colon in 
Salmonella infection, since dietary FOS increases Salmonella translocation in rats77 and FOS is 
known to be fermented in the colon and not in the ileum4.  
Do the ileum and colon differ in their response to Salmonella? We found that the response 
differed in both time and type. This variation in reactions of the ileum and colon was expected 
due differences in anatomy and environment. Where the ileum is composed of crypts and villi to 
increase the surface necessary for nutrient and water absorption16, the surface of the colon only 
contains crypts, which give it a relatively smaller surfaces compared to the ileum. Furthermore, 
the two segments differ in environmental characteristics such as transit time and the presence of 
microflora. These surface and environmental differences are major determinants in the amount 
and the type of contact between the host and pathogens. However, general mechanisms were 
also identified between ileum and colon, such as changes in transporters and antimicrobials. 
Although both tissues showed signs of an inflammatory response at later time points, the 
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responsible genes were not the same. In the ileum, many chemokines were induced that were not 
observed in the colon. Furthermore, the response of the colon was characterized by a clear 
interferon γ response, which was absent in the ileum. These differences in type of immune 
response indicate different regulators in the two intestinal segments. This could be caused by 
differences in host-pathogen contact due to surface differences as mentioned above. 
Alternatively, the presence of microflora in the colon could cause the different colonic host 
response. It has been reported that host-microflora interactions keep inflammatory processes in 
check12,35,40. 
The magnitude of the response of colon and ileum can not be directly compared because they 
were studied with different array platforms. However if we compare the percentage of changed 
genes relative to the number of genes expressed in the specific intestinal tissues, the responses of 
the ileum and colon at day 1 are comparable (Figure 1). At day 3, the colon and ileum showed 
large difference in magnitude of gene expression responses; the colonic response was much 
smaller regarding the number of genes than the ileum. The PPs show an especially large response 
at this time point. This large response of the PPs was expected, since this tissue is part of the gut-
associated lymphoid tissue and is important in activating the immune system. The delay of the 
colon response until day 3 could be caused by protection from the endogenous microflora, as 
mentioned above. This protection is very probable, since disruption of the microflora by 
antibiotics, chemotherapy or radiation results in increased colonization and translocation of 
pathogens47. At day 6, all three tissues responded to the same extent; the responses of all three 
tissues were then mainly characterized by advanced immune and inflammatory responses.  
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Figure 1. Percentage of genes, relative 
to total number of expressed genes 
present on the array used, that are 
differentially affected by Salmonella 
FC>2.0 in ileal mucosa (white bar), 
Peyer’s patches (gray bar) and colonic 
mucosa (black bar). 
 
3.3 Gut health biomarkers 
Our approach identified several potential gut health biomarkers. A biomarker is “a characteristic 
that is objectively measured and evaluated as an indicator of normal biologic processes, 
pathogenic processes, or pharmacologic responses to a therapeutic intervention”55. Biomarkers in 
nutrition enable researchers to characterize and quantify the extent of a condition and the 
efficacy of a nutrient on the condition. Nutritional gut health research would benefit from more 
and better biomarkers to monitor the state of the mucosal barrier. At present, expensive and 
large-scale human probiotic and prebiotic studies have yielded poor results, possibly due to lack 
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of useful quantifiable biomarkers61. A biomarker can be an individual gene, protein or metabolite, 
or a pattern of genes, proteins or metabolites. In this research, we aimed to find individual genes. 
In our research, a potential new biomarker should reflect gut mucosal stress. We therefore 
focused on genes with a large fold change between stressed and control conditions. One 
candidate as a gut mucosal biomarker for Salmonella infection was Pancreatitis-associated protein 
(Pap). This gene was among the highest induced genes in both the ileum and colon. Moreover, 
the gene was also sensitive to dietary modulation of Salmonella infection severity, which was 
demonstrate by the induced expression of Pap in FOS fed rats (Chapter 3) and the lowered 
expression of Pap in calcium-fed rats (Chapter 4). Pap gene expression therefore reflected the 
Salmonella-induced physiological response, since FOS increases Salmonella translocation, 
whereas calcium inhibits Salmonella infection (Chapter 4).  
Other potential biomarkers identified in Chapters 2 and 3 were lipocalin, calprotectin and 
phospholipase A2. Calprotectin is a promising candidate, as it is already used as a biomarker of 
intestinal inflammation, more specifically in monitoring inflammatory episodes and drug efficacy 
in IBD patients84. Lipocalin is also a candidate for further development, as it is highly expressed 
in chronically inflamed mucosa of IBD patients and in animal models of this disease11.  
Phospholipase A2 group IIA was among the highest induced genes by Salmonella and FOS, and 
was further induced in FOS-fed infected rats, indicating that this gene reflects the severity of gut 
barrier stress by different stimuli and therefore is another potential candidate biomarker.  
Induced gene expression alone is not enough for a gene to function as biomarker. In addition to 
gene expression, the candidates should be studied at the protein level. The best candidates for 
nutritional research are genes for which protein products are easy to measure, preferably in 
biological samples obtained by non-invasive means. This enables fast and inexpensive sampling 
in large-scale studies with humans58. Easy-to-measure gene products which are secreted in stool 
and are resistant to enzymatic degradation by intestinal contents would be very interesting. In 
Chapter 4, we examined the potential gut health biomarker Pap at the protein level, its intestinal 
mucosal localization and its presence and stability in faeces. An initial step in screening for 
potential biomarker candidates from a large gene list could be to determine whether a gene 
contains a secretion signal sequence, indicating that the protein is excreted. For the purposes of 
gut research, excretion to the luminal site is more useful than excretion to the serosal site, as stool 
samples are less invasive to collect than blood samples. PAP was shown to fulfil this criterion.  
 
Did we succeed in finding new gut health biomarkers that aid in identifying the effects of 
nutritional interventions? We showed that transcriptomic studies can deliver many candidates. 
However, studying their validity and functionality is a real effort and absolutely required in the 
development and application of new biomarkers. The cellular origin and faecal excretion of PAP 
have now been demonstrated. But additional studies are required, for example to find out 
whether the protein behaves similarly in humans. A final bottleneck for the application of new 
biomarkers is that golden standard biomarkers are not easily replaced. Acceptance of new 
candidates requires many published studies showing good correlation between old and new 
biomarkers. We offered new ideas, but further validation studies are required to bring these 
markers to the point that they will be accepted as a read-out of the physiological state of the 
intestinal mucosa. 
 - 141 -
Chapter 7 
3.4 In vivo gut barrier versus in vitro models   
The early in vivo modulation of gene expression by Salmonella was small in both the ileum and 
colon. This contrasts with the results reported in infection studies of in vitro cell models, where 
pathogens cause much larger gene expression changes19. Apparently, the gut mucosal cells in the 
intact barrier display much more subtle responses. One explanation for this subtle response in 
the intact tissue is that different cell types interact together via various feedback mechanisms that 
keep the reaction against invading pathogens in check. This differs from in vitro cell cultures 
consisting of only one cell type. Furthermore, in the intact animal, the protective mucus layer and 
microflora provide an effective barrier to pathogens. Therefore bacterial-host contact is probably 
less than in cell cultures. The mild gene expression changes in vivo are in accordance with 
physiological observations. No inflammatory changes are observed in vivo on the first day after 
oral infection with Salmonella, whereas in vitro models show massive cell death after 24 hours of 
Salmonella exposure and ileal loop models show epithelial detachment after 8 hours of exposure 
to Salmonella67.  
Besides physiological changes, the small gene expression changes in our study could be partly 
explained by the technical approach used. The collected mucosal scrapings contain a 
heterogeneous population of cells, whereas in vitro cell cultures contain only one cell type, and all 
cells are exposed to the pathogen at the same time point, often at a high dosage. As a result, 
genes expressed in only a subset of cells in the mucosal scrapings might be missed due to dilution 
of the signal. This mixture and possible dilution of cells can be overcome by using laser capture 
techniques. This technique has proven to be successful in isolating specific cell types from 
intestinal tissue72. Although the RNA yield per tissue is much lower using this technique, with the 
rapid progress in microarrays using amplification, arrays can already be performed from 50 
nanograms of total RNA, thus enabling this cell-specific approach.  
When compared to data from in vitro studies, the results of our in vivo approach show that the 
intact gut barrier system must be examined in order to study barrier responses to bacterial or 
nutritional stress. In vitro models are useful for in-depth studies of one particular cell type or 
process. Similarly, intestinal loop models can be useful for screening several components or 
products, because this method allows the use of several loops per animal, thereby decreasing 
animal numbers and variation between samples. In both model systems, however, extrapolation 
to the in vivo relevance for gut barrier functioning should be done cautiously. 
 
3.5 Dietary FOS-induced gut mucosal response 
Despite FOS-induced intestinal permeability, we did not observe changes in tight junction genes 
as expected. However, FOS induced a large number of mitochondrial genes in the colon mucosa. 
Increased expression of mitochondrial genes indicates disturbed energy homeostasis, or more 
specifically ATP homeostasis, caused by increased energy demand or decreased mitochondrial 
energy supply60,86. We showed for the first time that the increased barrier permeability induced by 
FOS supplementation coincides with alterations in genes related to energy metabolism. 
Previously, a relation between increased intestinal permeability and intestinal energy metabolism 
was observed in studies with chronic supplementation of non-steroidal anti-inflammatory drugs 
or administration of mitochondrial uncouplers to animals64. Together with our results, this 
suggests that energy metabolism is important in barrier functioning and is likely involved in the 
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FOS-induced barrier changes. The exact role of energy metabolism in FOS-induced mucosal 
effects requires additional experimental proof. The next important step would be to measure the 
energy status of intestinal cells by measuring energy metabolism parameters such as the ratios of 
cellular ATP to ADP and AMP64. Additional proof, that decreased ATP levels cause the FOS-
induced intestinal permeability, can be derived from studies on direct ATP supplementation, 
similar to that of Bours et al. In that study, local intestinal co-administration of ATP with non-
steroidal anti-inflammatory drugs attenuated the induced intestinal permeability8. It would be 
interesting to examine whether ATP supplementation to the colon of FOS-fed rats would lead to 
decreased permeability. Further experimental proof of the suggested FOS effects on 
mitochondria could also come from electron microscopy studies, since in uncoupling studies in 
fibroblasts, Rohas et al showed that upregulation of genes encoding for mitochondrial proteins 
coincided with increased mitochondrial density64. Mitochondrial swelling, ATP depletion, and 
permeability changes are also observed in other situations of weakened gut barrier, for example in 
mucosal biopsies of Crohn’s disease patients and in intestinal tissue after ischemia-
reperfusion43,63,71. Additional studies using direct administration of uncouplers in the intestine 
could clarify whether altered energy metabolism is also causing the FOS-induced increased mucus 
secretion and decreased resistance to Salmonella.  
FOS is currently being studied in the obesity research field because it induces release of 
gastrointestinal peptides such as glucagon-like protein, which is thought to promote satiety10.The 
use of mitochondrial uncouplers is also being studied as a possible therapeutic approach to treat 
obesity, since mild but chronic treatment with mitochondrial uncouples should cause increased 
energy expenditure64. Our results indicate that the potential negative effects of these two 
approaches on the gut barrier should be given attention in both these research fields.  
 
3.6 FOS effect on Salmonella-induced colonic gene expression 
In FOS-fed rats, three times more genes were significantly altered by Salmonella compared to 
cellulose-fed control rats. This colonic gene expression response reflects the increase in 
physiological parameters that are known to be modulated by FOS during Salmonella infection, 
such as Salmonella translocation, mucin secretion and intestinal permeability in rats77. Although 
the magnitude of the gene expression response was larger in FOS-fed rats infected with 
Salmonella, the genes reflected the same biological processes in both FOS-fed and cellulose-fed 
rats. This could indicate that the intestine uses generic mechanisms to respond to a variety of 
harmful stimuli. Oxidative stress and proteolysis were among the biological processes that were 
induced in the colonic mucosa by both Salmonella (Chapter 3) and FOS (Chapter 6). Indeed, 
increased oxidative stress can cause protein oxidation and subsequent misfolding, leading to 
increased protein degradation37. An alternative explanation for the increased proteolysis is the 
need for increased antigen presentation in the stressed mucosa, which is known to require 
protein breakdown by immunoproteasomes83. Additional transcriptomic studies of the intestine 
under healthy conditions and a variety of stressed conditions are necessary to distinguish generic 
mechanisms from stress stimuli-dependent mechanisms. 
The potential beneficial effects of FOS and other prebiotics are based on effects of these 
nutrients on promotion of surrogate markers, such as increased mucin production, increased 
cytokine production and increased faecal or ileal IgA32,52,69,74,85. Changes in these markers are often 
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presumed to reflect increased barrier protection or resistance to pathogenic bacteria, but actual 
measurement of these functional effects is lacking in most studies. An increased immune 
response activation might however not indicate beneficial increased surveillance, but could 
actually indicate induced tissue damage. In our study, genes involved in antimicrobial defence, 
immune response and inflammation were all induced by Salmonella infection and further 
enhanced by dietary FOS. This coincided with increased translocation of Salmonella by dietary 
FOS. Thus, these surrogate markers should be interpreted with caution and always interpreted in 
conjunction with functional effects or clinical endpoints.  
 
4 Transcriptomics in gut barrier research: technical aspects and data analysis 
Transcriptomics is thought to be most successfully used in a hypothesis-driven approach, but we 
have shown that this technique is also successful in hypothesis generation. Specifically, we used 
information provided by differential gene expression caused by Salmonella and FOS to generate 
new hypotheses about the gut mucosal barrier. The generated hypothesis resulted in leads for 
further gut barrier research associated with energy metabolism, detoxification and transporters. 
However, such hypothesis-generating research does require a clear study design to prevent a 
subjective search for genes which could be selected by chance and are actually noise variables. 
Distinguishing between true differences and noise in microarray datasets is a challenging task, 
especially in gene expression datasets derived from nutritional studies, which are characterized by 
subtle changes and large variability between the individuals studied1,14,57. Indeed, both the dietary 
FOS dataset and the Salmonella dataset were characterized by subtle gene expression changes.  
The transcriptomic studies conducted in this thesis research delivered several technical aspects 
regarding experimental set up and data analysis. These aspects are important to extract reliable 
and valuable information from microarray datasets with subtle gene expression and to convert 
gene expression data into biological insights. 
 
4.1 Reproducibility  
In general, the gene expression data were highly reproducible between experiments and array 
platforms used in the studies. Three array platforms, cDNA, oligo and commercial, were used in 
the research, two of which, oligo and commercial, are described in this thesis. Reported 
differences between platforms have raised doubts about the quality and reproducibility of 
microarrays44,59. However, with solid experimental design and strict quality control, all platforms 
can offer qualitatively good data. This was demonstrated by a large microarray quality control 
project that showed consistent results between different platforms and laboratories70. This large 
study proved the reliability and reproducibility of microarrays technology for assessing gene 
expression changes. In agreement with this study, we observed that different platforms, 
independent hybridizations or independent biological samples showed consistent data. For 
example, the Salmonella-induced increase of the gene Pap was identified on all three platforms. 
Furthermore, the results from all three platforms were consistently confirmed by an independent 
method: quantitative real-time RT-PCR (Q-PCR).  
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4.2 Experimental set up  
Q-PCR confirmation of the pooled array data in Chapters 2 and 3 showed that the inter-
individual variation between the rats was high. The selection method based on fold change, does 
not take this variability in the data into account. In contrast, datasets derived from individual 
hybridization provide insight into this variability and therefore enable inclusion of subtle but 
statistically significant data. Using this insight into the inter-individual variation in gene 
expression in the rats, we choose a different approach for the dietary FOS study (Chapters 5 and 
6). In this study we enlarged the group size from 8 to 12 rats per group to obtain more power for 
detection of significant treatment effects, and we performed the micorarray experiment on 
individual rats instead of using pooled samples. This allowed the use of statistical tests to analyze 
the data instead of fold change alone.  
 
It is recognized that in micorarray datasets true differences are difficult to distinguish from noise; 
this is not only caused by the large variability among individuals studied or the small sample sizes, 
but especially by the large number of genes tested50,90. This is because testing these large numbers 
of genes, up to 40.000, increases the chance of selecting false positive genes due to the multiple 
testing problem. For example, by testing a dataset of 10.000 genes, a probability of 5% results in 
selection of about 500 genes just by chance. Therefore, an important aspect in data analysis is the 
choice of an appropriate statistical test. 
 
4.3 Statistical data analysis 
The growing popularity of transcriptomics coincides with a growing list of statistical tools to 
analyze transcriptomic data33, for example multiple testing procedures (FDR, FWER)6,7, 
significance analysis of microarray data (SAM)79, analysis of variance (ANOVA), empirical bayes 
t-statistic and many others. There are several drawbacks to most of these statistical methods. 
First, most of the methods were developed for classification, which intends to select the smallest 
set of most differential genes. Second, the methods are tested on gene sets consisting of large 
gene expression differences such as cancer studies or pharmaceutical interventions. Third, most 
methods consider genes as independent variables, which means that each gene is tested 
independently. These tests can successfully identify the main effects in a dataset. However, genes 
are not completely independent. Small genetic effects that make an important distinction between 
different study groups only in interaction with each other, will therefore not be detected with 
these methods. These genes should be included in the selection, especially in nutritional studies, 
which are characterized by subtle gene expression effects. These interactions between genes are 
important in biology because gene-gene interactions occur during biological responses due to co-
regulation of genes, for example by one transcription factor29. It is also recognized that genes 
with similar functions often share similar overall expressions due to common activators or 
inhibitors20,46,87. Moreover, genes that encode different subunits of larger complexes are 
coordinately regulated50. Therefore, statistical tests should not only test each gene independently, 
but preferably include interaction between genes. In Chapter 5 we applied the Random Forest 
method, which integrates interaction into the statistical analysis. Random Forests not only takes 
interaction into account, but also ranks genes. We examined whether Random Forests could 
provide an objective threshold to distinguish real effects from noise. Choosing a threshold is 
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difficult but important, since the threshold choice determines the selection of relevant genes and 
therefore the translation into biological information. In microarray datasets obtained from pooled 
samples, fold change is often used as threshold, with the precise cut-off arbitrarily chosen by the 
researcher. The same is true for datasets obtained from individual hybridizations, where  
thresholds for statistical tests are also arbitrarily chosen to some extent. With Random Forests, 
we were able to define an objective threshold for gene selection. Biological interpretation of these 
selected genes is the next step. 
 
4.4 Functional data analysis  
Microarrays have grown in size from several hundred genes on cDNA arrays to about 40.000 
genes on the commercial whole genome arrays. As a result, manual searching for biological 
interpretation of selected gene lists became difficult and time consuming. Pathway analysis is an 
increasingly popular and useful way to interpret large microarray derived gene lists. Pathway 
analysis programs group individual gene lists into functional biological categories, such as 
biological processes, signal transduction pathways or cellular location21. The number of pathway 
programs has expanded rapidly over the last few of years, including open source programs such 
as David15, ErmineJ45 and GSEA73 as well as commercial programs such as Metacore21 and 
Ingenuity. All programs use the same basic principles; they require the input of a list of gene 
identifiers such as accession number or gene symbol, and they link this list to gene annotation 
databases such as Gene Ontology25, Kyoto Encyclopedia of Genes and Genomes (KEGG)38 or 
Fatigo3, returning groups of genes that belong to the same functional class (reviewed in Dopazo 
et al17). The programs calculate if certain functional classes are statistically overrepresented in the 
selected gene list compared to the rest of the genome28. This information provides objective 
insight into biological processes that are responding to the treatment. 
 
One advantage of pathway analysis is that it allows reliable identification of subtle changes in 
gene expression. Especially in studies with overall subtle gene expression changes, analysis on the 
level of biological processes, instead of individual gene lists, reduces the chance of introducing 
false positive genes13. This is because genes are not tested individually, but in the context of a 
functional group. Genes with subtle gene expression differences within one significantly 
regulated biological process can be selected with greater certainty than similarly subtle changed 
genes not belonging to an altered biological process. This is essential in nutritional studies, and as 
shown in Chapters 2 and 3, also for early events of pathogen-host responses. In those two 
chapters we performed pathway analysis with all genes changed more than twofold, but added 
genes with a fold change between 1.5 and twofold when these genes were part of a selected 
biological process, since this decreased the probability that these genes were selected by chance. 
 
Another advantage of analysis at the biological process level is that experiments are more 
comparable at the process level than at the level of individual gene lists. This is shown in Chapter 
3, where two independent Salmonella infection experiments of the colon mucosa showed highly 
similar results at the biological process level, but at the individual gene level these two 
independent studies gave only moderate overlap. The improved comparison also accounts for 
different studies. For example, in Chapter 3 and Chapter 6, proteolysis was found to be induced 
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in the colon by Salmonella and by FOS respectively. In addition, Salmonella-induced decrease of 
detoxification was found in our rat studies and recently in chickens80 and pigs30, although these 
studies used different array platforms and individual genes did not fully overlap. This lack of 
overlap at individual gene level and large overlap at process level is inherent to mRNA studies; 
genes are switched on and off quickly and the half-life of mRNA is short. However, genes within 
a similar process are likely to be similarly regulated and therefore more overlap at the process 
level will occur than at individual gene expression level2. This clearly highlights the importance of 
interpreting experiments at the level of biological processes rather than using gene-to-gene 
comparison.  
 
However, a disadvantage of complete dependency on pathway programs is that these programs 
rely on the ability to assign functions to each regulated gene41. Annotation of genes and uniform 
naming is far from optimal. The availability of genome information for humans, mice, rats and 
other species has accelerated the identification of genes involved in biological processes, but it is 
important to realize that for many genes, no functional information is yet available. About half of 
the probes on the commercial whole genome arrays represent transcripts of unknown function 
and are therefore excluded from further pathway analysis, despite possible significant regulation 
(Chapter 5). Pathway analysis is therefore not fully functional. Another problem is microarray 
probes ID. There is no single database available that can cross reference between various gene 
identifiers such as accession number, unigene number, agilent ID, gene symbol and protein 
name. This is problematic and might cause loss of genes during the analysis, since  input ID does 
not match the ID of the database used by the pathway program41. Functional annotation and 
uniform naming is being given increasing attention and will most likely improve rapidly. 
Additionally, pathway programs are increasingly incorporating refinements to construct 
regulatory networks and processes not only based on biological function, but also on other types 
of annotations such as promoter elements, chromosome position or sequence information about 
secretion signals23,42. This will increase biological insight into microarray data and will show that 
these long gene lists are very suitable to study physiology.  
 
4.5 Connecting array data to physiology  
Array data should preferably be linked to strong physiological data, such as intestinal permeability 
or Salmonella translocation. Otherwise it is difficult to determine whether changes in gene 
expression are positive or negative for the organism. In Chapter 6, the data on FOS increased 
permeability were essential to link the effects on mitochondrial genes to negative effects on the 
mucosal barrier. And in Chapter 3, the known increase in Salmonella translocation in FOS-fed 
rats was required to interpret the enhanced gene expression data in FOS-fed vs. cellulose-fed 
infected rats as a negative effect. In this study we have shown that transcriptomics is extremely 
suitable as a hypothesis generating technique, provided that physiological data are available. 
These two aspects, transcriptomics and physiology, should be combined much more strongly to 
increase insight into the molecular mechanisms that link the treatment, for instance FOS, with 
the physiological output, for instance intestinal permeability. 
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Microarray data as new complementary data for physiology is not always accepted. This is mainly 
due to early failures in generating useful data48. However, with the improved quality and reliability 
of microarrays, the growing insight into data analysis and the availability of comparative datasets, 
acceptance should improve. 
 
5 Recommendations 
 
5.1 Follow-up studies  
The transcriptomic approach we used in our research provided new hypotheses about the 
response of the intestinal barrier to stress. Processes likely to be involved in barrier functioning 
are detoxification, transport, energy metabolism and proteolysis. However, mRNA expression 
does not necessarily reflect protein expression and activity; mRNA stability, post-translational 
modification, protein localization and protein degradation determine whether a gene is translated 
to a protein and whether the protein is active and metabolites are produced. Not all genes are 
ultimately transcribed into proteins, and not all transcribed proteins are active. Secondary 
modulation, such as phosphorylation, acetylation or cleavage, is often necessary for full activity9. 
Hypotheses on biological processes or possible biomarkers observed in microarray studies should 
therefore be followed up with more detailed or functional studies to really define a role for these 
biomarkers and processes in gut barrier function. Confirmatory studies on protein level (as in 
Chapter 4) are the most logical follow-up studies for potential biomarkers. To resolve the role of 
one gene in the in vivo situation knock outs, RNAi mediated gene silencing or genetically modified 
animal models can be used. Recently, a PAP knock-out mouse was developed, and it would be 
very interesting to study the resistance of these mice to Salmonella27. More in-depth studies on 
the role of energy metabolism on gut barrier function are also required, such as functional studies 
to define the role of ATP in barrier functioning or protein studies which can reveal possible 
effects of FOS on regulation of tight junction proteins. Although FOS did not affect tight 
junction genes, immuno-histochemistry could show effects on cellular re-distribution of tight 
junction proteins affecting paracellular permeability. Another field that is gaining more attention 
is the combination of transcriptomic with other broad-scale techniques such as proteomics and 
metabolomics24,78. This combination will provide information about the more downstream effects 
of a treatment. These and additional functional studies will help to provide further insight into 
gut barrier physiology. Another approach to gain insight into the newly found barrier 
mechanisms is comparison with other gene expression datasets derived from in vivo barrier 
studies. As mentioned earlier, detoxification was recently related to barrier function in other 
species than rats. This shows that comparison of the microarray results in our study with the 
results of other related studies lead to confirmation of one observed barrier process, 
detoxification, and might reveal more overlapping mechanisms. The strength of this large 
comparison approach is shown by Jenner et al.36, who compared 160 in vitro transcriptomic 
datasets of the host response to various pathogens. This revealed a general host response to 
pathogens. Similar comparisons of in vivo data might identify new host response processes as 
possible targets for dietary or pharmaceutical modulation. To enable comparisons of different 
studies, datasets should become publicly available. An important contribution in this regard is 
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that most journals now require all microarray datasets to be deposited in public databases such as 
the Gene expression omnibus54 or Arrayexpress5.  
 
5.2 Application of findings for humane gut research   
It is not possible to directly extrapolate the results obtained in rats to the human situation. The 
rat model is a good model for Salmonella infection and dietary studies. Nevertheless, rats are not 
humans. The rat intestine differs from the human intestine; the cecum of rodents is relatively 
much larger than in humans. The relative length of the cecum compared to the total length of the 
large intestine is 26% in rats and only 5% in humans16. Although the cecum is involved in FOS 
fermentation in rats, we decided to focus on FOS effects in the rat colon, as the large intestine is 
more relevant to fermentation of prebiotics in humans.  
Another difficulty with extrapolation is that gene expression patterns in one strain, or genotype, 
may be unique to that genotype39,89. To minimize genotype-dependent results, we chose to use an 
outbred rat strain82. The use of outbred rats requires larger study groups than inbred strains to 
obtain equal power for detection of significant treatment effects. In Chapter 6, subtle differences 
were identified as highly significant using 12 animals per group. Human studies cannot be 
controlled as rigidly as animal studies, and most likely should include many more subjects to 
reach enough power. However, several aspects of our transcriptomic approach are relevant for 
human gut research. For example, statistical methods that test gene-gene interaction could also be 
more powerful in human genomics studies, where individual variation might cover up results 
when each gene is tested individually. Nevertheless animal studies are relevant to the human 
situation, since these studies can deliver knowledge on treatments that are impossible to obtain 
from human studies, for example insight into dietary modulation of a Salmonella infection. 
Furthermore, animal studies allow much easier sampling of biological material such as intestinal 
tissue than human studies. These biological materials are required to identify new biomarkers, 
which can subsequently be used in human studies. 
 
6 Conclusions 
 
We determined that detoxification, transport, energy metabolism and proteolysis are part of the 
early gene expression responses of the rat gut mucosa upon exposure to Salmonella and FOS. 
Expected barrier related genes were not affected by Salmonella or FOS, and immune response 
genes showed a delayed and mild response. Barrier research should therefore not only focus on a 
small panel of “known” barrier genes. Furthermore, our data clearly showed that the barrier in an 
intact organism shows much milder responses following Salmonella challenge than in vitro 
models. Therefore, extrapolating data from model systems to the intact animal should be done 
cautiously. 
Analyzing transcriptomic data with subtle gene expression changes is a powerful approach, 
provided that a solid strategy is followed to prevent discarding valuable data or introducing noise. 
Before newly found processes and biomarkers that are identified in transcriptome analysis can be 
used in practice, functional follow-up studies are required. Nevertheless, our transcriptome 
analyses have significantly increased the understanding of the actual in vivo barrier processes and 
have provided starting points for functional studies in gut barrier research.  
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Inleiding 
 
Met de dagelijkse inname van voedsel komen er naast voedingsstoffen ook schadelijke stoffen 
binnen zoals pathogenen (bacteriën en virussen). Deze schadelijke stoffen komen terecht in de 
darm. De wand van de darm is het grootste grensoppervlak tussen de buitenwereld en het 
lichaam. In een volwassen persoon is het oppervlak bijvoorbeeld 100 keer groter dan het 
huidoppervlak. De darmwand is uitgerust met elementen die voorkomen dat schadelijke stoffen 
in het lichaam door kunnen dringen en zo ziekten veroorzaken. Ten eerste zijn er darmcellen die 
het oppervlak bekleden met een nauw gesloten laag. Deze darmcellen scheiden antibacteriële 
moleculen uit en ze maken een slijmlaag die het darmoppervlak bedekt. De slijmlaag vormt een 
barrière tegen pathogenen en beschermt de darmcellen tegen schadelijke objecten. Een tweede 
barrière bestaat uit een groot aantal darmflorabacteriën. Deze “goede”  bacteriën zorgen er voor 
dat de slechte bacteriën geen voedsel kunnen vinden en dat ze zich niet aan de darmwand kunnen 
binden. Ten derde is er het immuunsysteem dat ongewilde indringers uitschakelt. Deze 
verschillende elementen beïnvloeden elkaar en vormen samen een effectieve barrière tegen 
pathogenen en andere schadelijke stoffen.  
Toch komen darminfecties, veroorzaakt door bacteriën, virussen of andere schadelijke stoffen, 
nog regelmatig voor. Vooral ouderen, zieken en baby’s zijn extra gevoelig vanwege hun zwakkere 
afweersysteem. Versterking van de darmbarrière kan zorgen voor een betere bescherming. Er 
staat tegenwoordig een groeiend aantal producten in de supermarkt die claimen de 
darmgezondheid te bevorderen en zo de weerstand te verhogen. Wat deze stoffen precies doen 
en of ze echt een verbetering van de barrière geven is vaak onduidelijk.  
 
Doel van dit proefschrift is het identificeren van biologische processen die van belang zijn voor 
de barrièrefunctie van darmcellen in een levend dier, zodat we beter begrijpen hoe darminfecties 
en verstoring van darmfuncties (zoals verhoogde darmdoorlaatbaarheid) ontstaan. De uitkomsten 
moeten bijdragen aan de ontwikkeling van voedingstoffen die de darmgezondheid verbeteren. 
Vooral de vroege reacties van de darmwand op pathogenen en schadelijke stoffen zijn 
interessant, omdat in deze fase erger kan worden voorkomen.  
 
 
Aanpak 
 
Om de darmbarrière beter te begrijpen, is het nodig om effecten van pathogenen en 
voedingsmiddelen op de darm in een levend organisme te bestuderen. Tot nu toe is onderzoek 
naar de darmbarrière vooral gedaan door middel van zogenaamde in vitro-  modellen. Dit zijn 
celkweekstudies of bacteriecultures, waarvan de verschillende elementen in een reageerbuis of op 
een petrischaal apart onderzocht worden. De onderlinge samenhang tussen de verschillende 
elementen gaat dan verloren. Dat maakt het lastig de resultaten te vertalen naar mens of dier. 
Deze vertaalslag is echter noodzakelijk om de resultaten van het onderzoek, naar effecten van 
voeding of medicijnen op de darmbarrière, uiteindelijk te kunnen toepassen voor het voorkomen 
van darmontstekingen bij mensen. In dit onderzoek hebben we daarom gebruik gemaakt van 
levende ratten als proefdieren.  
 - 156 - 
  Samenvatting 
 
Om de biologische processen in de darm van de rat te kunnen identificeren maakten we gebruik 
van transcriptomics. Dit is een methode die het mogelijk maakt om van een groot aantal genen 
tegelijk de genexpressie te meten. De genexpressie is een afspiegeling van de biologische processen 
die actief zijn in het onderzochte weefsel, in dit geval de binnenste laag van de darmwand van een 
rattendarm. We vergeleken de genexpressie-profielen (een verzameling datapunten die aangeven 
welk gen er actief is en welke niet) in de darm van behandelde ratten met onbehandelde ratten. 
Zo kregen we inzicht in alle biologische processen, die op een bepaald tijdstip verschilden tussen 
de behandelde groep en de onbehandelde (controle)groep.  
We hebben de darmwand geprikkeld met schadelijke stoffen en het effect van deze prikkeling op 
de genexpressie in de darmwand gemeten. We hebben twee verschillende stoffen gebruikt die 
stress van de darmbarrière veroorzaken: ten eerste het veel voorkomende voedselpathogeen 
Salmonella en ten tweede het voedingsmiddel Fructo-oligosacchariden (FOS).  
Salmonella 
Salmonella enteritidis is wereldwijd een van de meest voorkomende oorzaken van voedselinfecties. 
Het veroorzaakt ontsteking van de darmwand en diarree. Het verloop van een Salmonella-infectie 
bij de mens komt overeen met het verloop van een infectie bij ratten. De ratten werden 
geïnfecteerd met Salmonella en op drie verschillende momenten na de infectie hebben we 
darmweefsel van het ileum (dunne darm) en het colon (dikke darm) verwijderd van geïnfecteerde en 
van controle dieren. Vervolgens hebben we de genexpressie van dit weefsel geanalyseerd. De 
resultaten van deze analyses in het ileum staan beschreven in hoofdstuk 2 en de resultaten van 
het colon in hoofdstuk 3.  
FOS 
Er is veel wetenschappelijke en commerciële belangstelling naar prebiotica. Dit zijn niet-verteerbare 
voedingsvezels, zoals FOS, die in de dunne darm niet afgebroken worden door de 
spijsverteringsenzymen en daardoor onverteerd de dikke darm bereiken. Daar vormen ze een 
voedingsbron voor de darmflora (fermentatie). Er is wetenschappelijk bewijs dat FOS daardoor de 
groei van ‘goede’ darmbacteriën stimuleren. Deze toename in darmflorabacteriën wordt gezien 
als gezond en vormt de wetenschappelijke basis waarop prebiotica aan zuivelproducten, 
zuigelingenvoeding en brood worden toegevoegd. Voorgaande studies naar het effect van FOS 
op de darmen van ratten hebben - in tegenstelling tot de algemene verwachting - aangetoond dat 
een FOS-dieet een negatieve invloed heeft op de darmgezondheid. Ratten op een FOS-dieet 
hebben een hogere darmdoorlaatbaarheid en een verhoogde passage van de Salmonellabacterie 
door de darmwand dan ratten op een controledieet. Verhoogde darmdoorlaatbaarheid is een 
teken van beschadiging van de darmbarrière en verhoogt de kans dat schadelijke stoffen en 
bacteriën de darmbarrière doordringen. Door middel van welk mechanisme FOS de darmbarrière 
verzwakken is nog niet bekend. Om deze mechanismen te bestuderen hebben we de reactie van 
de darm op FOS en Salmonella onderzocht in ratten. We hebben ratten twee weken een dieet 
gegeven met FOS of een controledieet. Een deel van de dieren hebben we geïnfecteerd met 
Salmonella. Aangezien FOS werkzaam zijn in het colon, hebben we ons onderzoek daarop 
gericht. De resultaten van het effect van FOS op de verhoogde passage van de Salmonella 
bacterie door de darmwand staan beschreven in hoofdstuk 3. De resultaten van het effect van 
FOS op de darmdoorlaatbaarheid staan in hoofdstuk 6.  
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Resultaten 
 
Barrière mechanismen 
Met de genexpressie-analyse na infectie met Salmonella en FOS hebben we nieuwe biologische 
processen aangetoond die een rol spelen in de darmbarrière. Deze processen zijn niet eerder 
betrokken in onderzoek naar weerstand tegen een pathogeen of een andere schadelijke stof. Een 
van de processen die we gevonden hebben, is bijvoorbeeld dat FOS veel genen veranderen die 
voor de energie-huishouding in de cel zorgen. Het is bekend dat een verstoorde energie-huishouding 
van darmcellen verhoogde darmdoorlaatbaarheid kan veroorzaken. Nieuw is onze bevinding dat 
FOS door het mechanisme van verstoorde energie-huishouding de darmdoorlaatbaarheid 
verhogen.  
De genexpressie-analyses tonen verder aan dat Salmonella en FOS de genen, waarvan we 
verwachten dat ze verantwoordelijk zijn voor de barrièremechanismen, niet beïnvloeden. Deze 
genen zijn bijvoorbeeld de genen verantwoordelijk voor de nauwe aansluiting van de darmcellen 
en de genen verantwoordelijk voor de slijmlaagproductie. Daarnaast vonden we dat Salmonella in 
de rattendarm minder genen beïnvloedt dan in in vitro-modellen. 
De aanpak van ons darmbarrière-onderzoek in levende dieren benadrukt dat: 
1) extrapolatie van resultaten uit in vitro-modellen naar de situatie in een levend organisme, 
in het geval van darmbarrière-functie, niet altijd relevant is en dus met grote voorzichtigheid moet 
gebeuren; 
2) darmbarrière-onderzoek zich niet alleen moet richten op verwachte barrièreprocessen: 
andere onverwachte genen en processen kunnen belangrijk zijn in de vroege response op een 
pathogeen of schadelijke stof.  
FOS en Salmonella 
In de ratten op het FOS dieet veranderden meer genen door Salmonella dan in ratten op een 
controledieet. In de FOS dieet groep vonden we onder andere een verhoging van het aantal 
immuungenen, wat in prebiotica onderzoek ook wel gebruikt wordt om aan te tonen dat 
prebiotica een verhoogde bescherming biedt. Onze studie heeft aangetoond dat een verhoging 
van het aantal immuungenen in de darm gerelateerd is aan een verhoogde passage van Salmonella 
door de darmwand. En dus dat een verhoging van het aantal immuungenen een reactie is op 
stress van de darmwand en niet een verhoogde weerstand betekent. Dit betekent dat verhoging 
van immuungenen voorzichtig geïnterpreteerd moet worden, bij voorkeur altijd gekoppeld aan 
meetbare eindpunten zoals passage van de bacteriën door de darmwand. 
Plaats in de darm 
We hebben aangetoond dat Salmonella-infectie in ratten zeker niet beperkt is tot het ileum, zoals 
algemeen wordt aangenomen. Een Salmonella-infectie veroorzaakte in een vroeg stadium 
namelijk een vergelijkbare genexpressie-reactie in het colon en het ileum.  
Functionele studies naar de mogelijke biomarker PAP 
Biomarkers zijn biologische indicatoren die gebruikt kunnen worden om ziekten aan te tonen, het 
verloop van ziekten te volgen en om effecten van de omgeving op ziekten te meten. In 
voedingsstudies maken biomarkers het mogelijk om bijvoorbeeld de werking van een nutriënt 
(voedingsmiddel) op darmgezondheid  te meten. In het darmgericht voedingsonderzoek is 
behoefte aan nieuwe biomarkers die de conditie van de darmbarrière kunnen meten en volgen. 
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We hebben een aantal genen gevonden die mogelijk geschikt zijn als biomarker. Van één gen, 
PAP, hebben we in hoofdstuk 4 de bruikbaarheid als biomarker nader bestudeerd door het 
eiwitproduct te onderzoeken. Voordat PAP als nieuwe biomarker voor darmgezondheid 
geaccepteerd kan worden, zijn echter aanvullende studies nodig, bijvoorbeeld om uit te zoeken of 
het eiwit zich in de mens hetzelfde gedraagt.  
Data analyse in transcriptomic studies  
De gegevens uit transcriptomic (genexpressie) studies zijn zeer complex door de enorme 
hoeveelheid informatie (het hoge aantal genen). Daar komt bij dat de effecten op genexpressie in 
voedingsstudies klein zijn en er grote variatie in genexpressie binnen groepen gevonden wordt. 
Dit was ook het geval in onze Salmonella en FOS studies. Deze combinatie van veel genen, 
kleine effecten en grote variatie maakt het ingewikkeld om te bepalen welke genen betrouwbaar 
veranderd zijn en welke genen bij toeval veranderd lijken, ofwel tot de ruis behoren. 
Gebruikelijke statistische tests bleken te strikt voor de kleine effecten veroorzaakt door 
Salmonella en FOS. In hoofdstuk 5 bestudeerden we een nieuwe statistische methode die 
geschikt is om kleine genexpressie-verschillen te analyseren. Met deze methode waren we in staat 
om een objectieve scheidslijn te bepalen tussen genen die significant veranderd waren en genen 
die tot de ruis behoorden. Deze methode kan in de toekomst nuttig zijn in humane genexpressie-
studies, waar individuele variatie nog groter is dan in de studies met ratten.  
 
 
Conclusies, toekomst 
 
De studies in dit proefschrift laten zien dat het gebruik van transcriptomics (genexpressie-studies) 
een succesvolle aanpak is voor het identificeren van nieuwe biomarkers (zoals PAP) en 
biologische processen (zoals energie-huishouding), die belangrijk zijn bij de barrièrefunctie van de 
darm in ratten.  
De studies tonen aan dat onderzoek naar de darmbarrière niet alleen gericht moet zijn op een 
kleine groep “bekende” barrière genen. Daarnaast is voorzichtigheid geboden bij het extrapoleren 
van data uit in vitro-modellen naar levende organismen en bij het positief interpreteren van 
verhoogde weerstand markers zonder koppeling met meetbare eindpunten.  
De volgende stap in darmbarrière-onderzoek is om de in dit onderzoek aangetoonde resultaten 
op het gebied van genexpressie te bevestigen in vervolgonderzoek, zodat ze uiteindelijk gebruikt 
kunnen worden om wetenschappelijk aan te tonen of een voedingstof of medicijn de 
darmgezondheid daadwerkelijk beïnvloedt.  
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BOX 1. Transcriptomic technique 
The sequences of thousands of genes are available for whole genomes; this allows the design of sequence fragments or 
probes representing individual genes. These gene-specific probes are printed on nylon membranes, glass slides or silicon 
chips. Hybridization of single stranded DNA allows determination of mRNA levels of all genes spotted on the array. 
Procedure: 1) Isolation of mRNA from biological samples. 2) Fluorescent label incorporation into cDNA copy of the mRNA. 
3) Hybridization of labeled sample to the array: each cDNA anneals to the complementary cDNA probe for a specific gene 
on the surface. 4) Scanning the array to determine the fluorescent amount of labeled cDNA hybridized to each spot.  
5) Quantification of the fluorescent signal, and data normalization to enable comparison between the different arrays.  
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Hierarchical clustering of genes with a fold 
change greater than 2 (infected/control). 
Genes and experiments were clustered using 
Pearson UPGMA (GeneMathsXT). Color scale 
represents ratio infected/control (B).  
Figure 1. The number of differentially 
expressed genes with a fold change greater 
than 2 in ileal mucosa and ileal Peyer’s 
patches of rats orally infected with Salmonella 
at 1, 3 or 6 days postinfection compared to 
sham treated controls (A).  
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Supplemental table 2.1  Sequences of the primers used for Q-PCR analysis.  
Gene 
symbol 
Sequence ID Forward primer (5'   3') Reverse primer (5'   3') 
Product 
 length 
Actb NM_031144 CTTTCTACAATGAGCTGCGTGTG GTCAGGATCTTCATGAGGTAGTCTGTC 315 
Cyp1a1 NM_012540 CCCACAGCACCATAAGAGATACAAG GCCCAAACCAAAGAGAATGACCTTC 200 
Cyp3a9 U60085 CTGTATTGGCATGAGGTTTGCTCTC AGAAGCAGTGGCTTTTCTGGTTG 150 
Cyp4f14 NM_019623 CTCACCCCTGATGGGATGCG TCCGACAGCTCCTTTCCATCTTC 200 
Rd5 XM_214386 TGTCCTCCTTTCTGCCCTTGTC TCAGCGGCAACAGAGTATGAGG 271 
Ephx1 M26125 CCTTCTGGGCTTTGTCATCTACTGG CCTCTGGTGTAAGTCCTTGATCTCC 172 
Gro D11444 ACCGAAGTCATAGCCACACTCAAG CACCAGACAGACGCCATCGG 150 
Lcn2 NM_130741 TCTCTGGGCCTCAAGGATAACAAC AGGAAAGATGGAGCGGCAGAC 150 
Lys NM_012771 CAATGTGCGAAGAGAGTTGTGAGG AGAGACAGTGTGAGCTGAGTAGAAG 149 
Mmp7 NM_012864 CGACATTGCAGGCATCCAGAAG GGAGTAAGTGTGGCTCAGGAAGG 105 
NFкB L26267 AAGTGATCCAGGCAGCCTTCC TTCAGAGATAGCAGTGGGCCATC 220 
Pap L07127 CTGCCAGAAGAGACCTGAAGGAC CACCTCCATTGGGTTCTCCACC 154 
PapIII U09193 GCTTCCTTTGTGTCCTCCTTGATT TACTCCACTCCCATCCACCTCTG 116 
Plekha3 NM_001013077 GCAGAACCTACTCGGACACAGAC TCTTCCCGAATGGCTGCTGATG 150 
Slc2a2 NM_012879 ACCAACTGGCTCTTGTCACAGG GGTACAGCAGATAGGCCAAGTAGG 109 
Slc2a5 NM_031741 CCCTGACTGTCTCCATGTTCCC CCCTTTTCTGCCCAAGTTATTCACC 86 
Slc5a1 NM_013033 TTTATCCTGACTGGGTTTGCTTTCC GTCGGCCCTGGGTGTGTAAC 138 
Timp1 NM_053819 TGGTTCCCTGGCATAATCTGAGC CACAAGCAATGACTGTCACTCTCC 136 
AY197552 GATTTGTTTCCTGTGTTTTAAGACCATCC TGAAGCAGAAGTAGGCGTCGTATC 104 Tlr5 
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o Supplemental figure 2.1 Salmonella affected 
genes in vitro vs. in vivo. 
Scatter plot for 30 genes that were more than 
twofold altered in vitro in HT-29 cells 3 hours 
after Salmonella infection (Eckmann et al) 
compared to the in vivo fold expression changes 
of the same genes in ileal mucosa 1 day after 
Salmonella infection. No correlation was found 
(r2=0.0004).   
 
 
Supplemental table 2.2 Salmonella affected genes in vitro vs in vivo.  
Accession number In vitro In vivo 
Gene name Human Rat 3 hours p.i. 1 day p.i. 
Macrophage inflammatory protein-2  X53799 NM_053647 78.0 1.0 
Tyrosine kinase related to TRK/ Ddr2 X74764 NM_031764 23.4 1.0 
Interferon regulatory factor-1 X14454 NM_012591 10.8 1.0 
Inhibinβ A-subunit J03634 NM_017128 10.1 1.1 
G-CSF X03438 NM_017104 9.1 1.0 
Glial growth factor L12261 U02316 4.9 1.0 
Cysteine protease Mch2α/ Caspase 6 W45688 NM_031775 4.4 -1.2 
Platelet-derived growth factor, beta chain X02811 AF359356 3.8 -1.0 
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Follistatin-related protein U06863 NM_024369 3.5 -1.1 
Cysteine-rich fibroblast growth factor receptor 1/ Glg1 H66617 NM_017211 3.4 -1.0 
CC chemokine receptor 6 N57964 NM_019310 3.1 1.2 
CXCR4 D10924 NM_022205 2.7 -1.0 
LI-cadherin AA088861 NM_053977 2.7 1.2 
Ubiquitin-conjugating enzyme E2 H20743 NM_013050 2.6 -1.1 
Glucosidase I AA291490 NM_031749 2.6 -1.1 
Nuclear-specific cyclophilin-60 AA682506 NM_017101 2.6 -1.2 
Interleukin 8 AA102526 NM_138522 2.5 1.3 
Ribosomal protein L27a AA599178 X52733 2.5 -1.1 
FMLP receptor homologue-1 M76673 NM_022218 2.5 1.1 
Transfer RNA synthetase-like protein W96450 Rn.8968 2.5 -1.5 
Macrophage migratory inhibitory factor M25639 NM_031051 2.4 -1.3 
BGT-1 N49856 NM_017335 2.4 1.1 
Heterogeneous nuclear ribonucleoprotein AA490991 Rn.23677 2.4 -1.1 
Acidic calponin 3 AA043228 NM_019359 2.3 -1.3 
HLA Class I, C heavy chain AA464246 AF074609 2.3 -1.2 
CCAAT displacement protein AA292536 Rn.10455 2.3 1.1 
BCNT craniofacial development protein 1 AA682613 Rn.128746 2.3 1.0 
HLA Class II AA669055 X56596 2.3 2.1 
Guanosine 5'-monophosphate synthase N59764 Rn.12593 2.3 -1.3 
Insulin receptor M10051 NM_017071 2.2 1.0 
 
Supplemental table 2.3 Salmonella induced gene expression changes in ileal mucosa.  
Genes with a fold-change in expression greater than 2.0 are given for day 1, 3 and 6 postinfection in ileal mucosa between rats 
that were orally infected by Salmonella relative to their sham-treated controls. The file is available at the website of Physiological 
Genomics (http://physiolgenomics.physiology.org/).  
 
Supplemental table 2.4 Salmonella induced gene expression changes in Peyer’s patches. 
Genes with a fold-change in expression greater than 2.0 are given for day 1, 3 and 6 postinfection in Peyer’s patches between 
rats that were orally infected by Salmonella relative to their sham-treated controls. The file is available at the website of 
Physiological Genomics (http://physiolgenomics.physiology.org/).  
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Additional File 3.1. Salmonella affected colonic genes.  
Genes that were upregulated of downregulated at least 1.5-fold in rat colon mucosa by Salmonella at days 1, 3, and 6 after oral 
Salmonella infection compared to colon mucosa of non-infected rats. This file is available at the BMC website 
(http://www.biomedcentral.com). 
 
Supplemental table 3.1 Primer sequences of the primers used for Q-PCR analysis.  
Gene 
symbol 
Sequence ID Forward primer (5'   3') Reverse primer (5'   3') 
product 
length  
Actin   NM_031144 CTTTCTACAATGAGCTGCGTGTG GTCAGGATCTTCATGAGGTAGTCTGTC 315 
Arf1 NM_022518 CTCCGAGATGCCGTTCTCTTG GGTAGCCTGAATGTACCAGTTCC 128 
Clca6 NM_201419 GATGGGGAAAAGATCAGTCTAACATGG GTTTCTGGTTTAAAGGCAAAGGTTTCC 200 
Gbp2 XM_225909 GACCTCAAGCCTAGAGCACAC GACTTCAAGCAAATAAAGCCACAG 106 
Gpx2 NM_183403 GCCTAGTGGTTCTCGGCTTCC AGGGTAGGGCAGCTTGTCTTTC 200 
Ifi47 NM_172019 GTGCGGTTGGTGGTGGTTG CCGAGTCTGTTGCTCACTGC 83 
Il1b NM_031512 AAGGGGTTGAATCTATACCTGTCCTG TGCTCTGCTTGAGAGGTGCTG 200 
Pap NM_053289 CTGCCAGAAGAGACCTGAAGGAC CACCTCCATTGGGTTCTCCACC 154 
Pla2g2a NM_031598 CAAAGTTTCTGACCTACAAGTTCTCCTAC CTTTCAGCAACTGGGCGTCTTC 200 
Rps29 NM_012876 CCGACAGTGCTTCCGTCAG GACAGTTGGTTTCATTGGGTAGAC 102 
Stat1 NM_032612 GTTCGCCACCATCCGCTTC TCTTCCTCTCCTCCTTCAGACAG 200 
Tgm2 NM_019386 CACTTTCTGATTCCCTGTATGACTGTG ACCCTTGACCGACTTCAGCTTG 200 
 
Supplemental table 3.2 Housekeeping and cell type specific genes. 
The fold change in expression of housekeeping genes and cell-type specific genes in the colon mucosa at days 1, 3 and 6 after 
oral Salmonella infection.  
Fold Change infected vs non-infected 
rats on different days p.i. 
Gene Name Gene symbol Sequence ID Time course infection study 
Dietary 
infection 
studya
     Day 1 Day 3 Day 6 Day 2 
Housekeeping genes       
Actin beta Actb NM_031144 1.1 1.2 1.1 1.2 
Glyceraldehyde-3-phosphate dehydrogenase Gapdh NM_017008 1.0 1.0 1.0 1.0 
Aldolase a, fructose-biphosphate Aldoa NM_01495 1.1 1.0 1.0 -1.1 
Phosphoglucerate kinase 1 Pgk NM_053291 1.0 1.2 1.2 1.1 
Adp-ribosylation factor 1 Arf NM_022518 1.0 1.0 1.0 1.1 
H3 histone, family 3B H3f3b NM_053985 1.0 -1.1 1.0 1.0 
Succinate dehydrogenase complex, subunit A Sdha NM_0130428 1.0 -1.1 -1.1 1.0 
Ribosomal protein S26 Rps26 NM_013224 -1.1 -1.1 1.0 1.1 
Pleckstrin homology domain-containing family 
A member 3 
Plekha3 NM_001013077 1.0 -1.1 1.0 1.1 
Cell type specific genes       
Enterocyte       
Intestinal fatty acid binding protein 2 Fabp2 NM_013068 -1.6 -1.5 -2.0 -1.5 
Villin 2 Vil2 NM_019357 1.2 1.1 1.0 1.0 
Intestinal alkaline phosphatase-II gene Alpi2 NM_022680 1.1 1.0 -1.0 -1.3 
Goblet Cell       
Colonic mucin 2 Muc2 TC556623 -1.1 -1.0 -1.1 -1.1 
Mucin 3 Muc3 U76551 1.7 1.3 1.3 1.0 
Trefoil factor 1 Tff1 NM_057129 -1.0 -1.0 -1.2 -1.2 
Trefoil factor 3 Tff3 NM_013042 1.1 -1.4 1.0 1.2 
Chloride channel calcium activated 3  Clca3 XM_217689 1.1 -1.5 -1.2 -1.2 
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Chloride channel calcium activated 6 Clca6 NM_201419 2.3 2.2 3.7 2.3 
Sialyltransferase 8  B Siat8b NM_057156 -1.0 1.0 1.0 ND 
Sialyltransferase 9  Siat9 NM_031337 1.1 1.0 1.0 1.2 
Leukocytes       
Leukocyte cell derived chemotaxin 1 Lect1 NM_030854 1.2 1.2 1.1 1.1 
CD84 leukocyte antigen CD84 XM_577290 1.1 -1.0 1.5 ND 
SP140 nuclear body protein Sp140 XM_237361 1.1 -1.0 1.2 1.1 
Leucocyte specific transcript 1 Lst1 NM_022634 -1.0 1.2 1.1 -1.0 
RT1 class I, CE12 RT1-CE12 XM_227986 1.2 1.0 1.5 1.1 
RT1 class Ib, locus Aw2 RT1-Aw2 Y13890 1.1 -1.0 1.6 1.0 
Granzyme A Gzma NM_153468 1.0 -1.0 1.7 1.0 
Granzyme B Gzmb NM_138517 -1.0 -1.0 1.1 1.1 
Granzyme C Gzmc NM_134332 1.1 1.0 1.3 -1.1 
a Fold Change infected vs non-infected rats fed a cellulose diet at day 2 p.i (obtained from the dietary infection study).  
Genes not detected in this independent study are indicated by ND. 
 
Supplemental table 3.3 Dietary modulated genes. 
Processes regulated in colon by Salmonella at day 2 in cellulose fed and FOS fed rats. 
Fold Change infected 
vs non-infected ratsa
Gene Name 
Gene 
symbol Sequence ID 
Cellulose 
diet 
FOS 
diet 
Overlap (17 genes)     
Transport     
Chloride channel calcium activated 6 Clca6 NM_201419 2.3 3.9 
Oxidative stress     
Glutathione peroxidase 2 Gpx2 NM_183403 2.2 4.2 
Immune response, Antimicrobial defense and Inflammatory response  
Pancreatitis-associated protein Pap NM_053289 17.7 35.6 
Phospholipase A2, group IIA (platelets, synovial fluid) Pla2g2a NM_031598 7.3 18.9 
Interleukin 1 beta Il1b NM_031512 2.6 3.5 
TRAF2 binding protein  Traf2bp NM_001014044 2.4 3.4 
Chemokine (C-C motif) ligand 2 Ccl2 NM_031530 2.8 3.2 
Chemokine (C-X-C motif) ligand 10 Cxcl10 NM_139089 2.3 3.2 
Interferon     
Interferon gamma inducible protein Ifi47 NM_172019 2.6 5.2 
Interferon-inducible GTPase Iigp1 NM_001012353 2.4 3.4 
Proteolysis     
Ubiquitin D Ubd NM_053299 3.4 7.6 
Proteosome (prosome, macropain) subunit, beta type 9 Psmb9 NM_012708 2.0 3.1 
Miscellaneous     
Unknown - BF555121 3.9 10.4 
Unknown - TC555318 2.4 4.2 
Unknown - AI234967 2.7 3.9 
Palmitoyl-protein thioesterase Ppt XM_342904 2.8 3.9 
Neurexin 2 Nrxn2 NM_053846 -3.3 -3.1 
Cellulose only (3 genes)     
Protease, serine, 3 (mesotrypsin)  Prss3 XM_342668 10.7 -1.7 
Unknown - TC526384 2.2 1.5 
Unknown - NM_001014241 -4.4 -1.4 
FOS only (58 genes)     
Transport     
Solute carrier family 10, member 2 Slc10a2 NM_017222 1.2 2.1 
Oxidative stress     
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Dual oxidase 2 Duox2 NM_024141 1.6 2.9 
Xanthine dehydrogenase Xdh NM_017154 1.4 2.7 
Immune response, Antimicrobial defense and Inflammatory response  
Myxovirus (influenza virus) resistance 2 Mx2 NM_134350 1.4 3.0 
Schlafen 3 Slfn3 NM_053687 2.0 3.0 
Interleukin 1 beta Il1b NM_031512 1.9 2.6 
Serum amyloid A 3  Saa3 AY325259 1.4 2.5 
Regenerating islet-derived 3 gamma Reg3g NM_173097 1.9 2.4 
Fatty acid binding protein 5, epidermal Fabp5 NM_145878 1.6 2.3 
Lymphocyte antigen 6 complex, locus E  Ly6e NM_001017467 1.5 2.3 
Chemokine (C-C motif) ligand 7 Ccl7 NM_001007612 2.0 2.2 
Lipopolysaccharide binding protein Lbp NM_017208 1.3 2.0 
Interleukin 1 alpha Il1a NM_017019 1.4 2.0 
Toll-like receptor 2 Tlr2 NM_198769 1.3 2.0 
Interferon     
Interferon-inducible GTPase  Iigp NM_001024884 1.7 3.7 
guanylate nucleotide binding protein 2 Gbp2 NM_133624 1.7 3.4 
signal transducer and activator of transcription 1 Stat1 NM_032612 1.8 3.0 
interferon, alpha-inducible protein  G1p2 XM_216605 1.5 2.6 
indoleamine 2,3-dioxygenase Indo NM_023973 1.5 2.3 
interferon gamma induced GTPase Igtp XM_220451 1.3 2.3 
interferon inducible protein 1 Ifi1 NM_001012007 1.4 2.3 
Interferon regulatory factor 7  Irf7 NM_001033691 1.3 2.2 
EF hand domain containing 2  Efhd2 NM_001031648 1.3 2.1 
Proteolysis     
transglutaminase 2, C polypeptide Tgm2 NM_019386 1.8 4.4 
proteosome (prosome, macropain) subunit, beta type 8 Psmb8 NM_080767 1.7 2.7 
protease, serine, 22  Prss22 XM_220222 1.6 2.4 
serine (or cysteine) peptidase inhibitor, clade G, member 1 Serping1 NM_199093 1.7 2.4 
potential ubiquitin ligase Herc6 XM_342700 1.5 2.4 
carboxypeptidase B gene, exons 6, 7, and 8 Carb7 M23953 1.5 2.2 
stefin A2 Stfa2 NM_001004129 1.2 2.2 
Parkin Park2 NM_020093 1.4 2.1 
Legumain Lgmn NM_022226 1.4 2.1 
stefin 2-like  Stf2 XM_221409 1.2 2.1 
proteasome (prosome, macropain) subunit, beta type 10  Psmb10 NM_001025637 1.5 2.0 
Miscellaneous     
Unknown - XM_225905 1.6 3.6 
adipocyte complement related protein/ Adiponectin Acdc NM_144744 1.3 2.9 
Unknown - XM_221401 1.5 2.6 
tripartite motif protein 15  Trim15 XM_227945 1.6 2.4 
matrix Gla protein Mgp NM_012862 1.7 2.4 
glucosaminyl (N-acetyl) transferase 3, mucin type Gcnt3 NM_173312 1.8 2.4 
membrane-spanning 4-domains, subfamily A, member 12  Ms4a12 XM_219588 1.4 2.4 
receptor-interacting serine-threonine kinase 3 Ripk3 NM_139342 1.4 2.4 
Unknown - XM_221376 1.4 2.3 
Unknown  CO402999 1.4 2.3 
zymogen granule protein 16 Zg16 NM_134409 1.2 2.2 
histidyl tRNA synthetase 2  Hars2 BQ207049 1.2 2.2 
Unknown - AA924770 1.1 2.1 
round spermatids protein STDP2 Stdp2 XM_573991 1.2 2.1 
Unknown - AW920888 1.3 2.1 
B-cell leukemia/lymphoma 2 related protein A1 Bcl2a1 NM_133416 1.7 2.1 
GLI pathogenesis-related 2  Glipr2 XM_342827 1.4 2.1 
  Supplemental data   
2.1 Unknown XM_223906 1.2 - 
2.1 Unknown XM_575189 1.4 - 
2.0 Unknown NM_001014209 1.5 - 
2.0 MAp19 protein Y18568 1.2 - 
2.0 basic transcription element binding protein 1 NM_057211 1.3 Bteb1 
2.0 Unknown BF281337 1.2 - 
-2.2 period homolog 2 (Drosophila) NM_031678 -1.1 Per2 
a Values in bold exceed cut-off value FC>2 or FC<-2.  
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Figure 4. Pancreatitis associated protein/regenerating gene III (PAP/RegIII) protein expression in the ileal mucosa of non-
infected and Salmonella infected rats fed either the control or calcium-supplemented diet. PAP/RegIII protein was present in 
epithelial cells at the crypt-villus junction (A, 12.5x; B, 40x). Immunostaining for lysozyme precisely identified paneth cells at the 
base of the crypts were PAP/RegIII staining was absent (data not shown). The number of PAP/RegIII positive cells increased 
after infection, especially in the direction of villus tips (A). Dietary calcium reduced PAP/RegIII expression in infected animals. No 
staining was observed in sections incubated without primary antibody (data not shown). All sections were counterstained with 
haematoxylin to visualise nuclei.  
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gure 2 a and b. Genes, of 100 random sets (black lines) and real sets with different seed values (colored lines), ranked by the 
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BOX 1. A framework for identification of physiological responses in microarray based gene expression studies. The framework 
is composed of the following steps: Gene ranking, gene selection, gene grouping and biological interpretation. Essential 
features of the data-analysis framework are that 1) all genes (annotated and non-annotated) in the dataset are included in the 
analysis, 2) interaction between genes is taken into account and, 3) an objective threshold is used for selection of a well-defined 
gene set. Random forest has these features. Gene grouping can provide information on new targets and add information above 
pathway analysis. Despite loss of information due to incomplete annotation of the complete dataset, Gene set enrichment 
analysis can provide additional information on related genes with small differences.   
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Supplemental table 6.1 Primer sequences of the primers used for Q-PCR analysis. 
 Gene 
symbol Acc. Nr Sense Anti-sense 
Product 
 length 
ActB NM_031144 CTTTCTACAATGAGCTGCGTGTG GTCAGGATCTTCATGAGGTAGTCTGTC 315 
Akr1b8 NM_173136 TTCACTATTACAGGACCCCAAGATTAAAG CGCTCAACTGGAAGTCAAAGACC 170 
Atp5i XM_001075306 TGACTTACTCAGAGCCTCGATTAGC AGCCAACAACACCACGTTTGC 243 
Cox7b NM_182819 AGAAGACACCTACTTTCCATGACAAATATG TTTAATGAGTACATGATTCTTTGACTTGGC 250 
Gcg NM_012707 AGGGACCTTTACCAGTGATGTGAG TTCACCAGCCAAGCAATGAATTCC 75 
Me1 M30596 CTTTCAGGCGTGACTTACAGTGTAG CCCAGATAACTACCCTGAGGAAACC 76 
Ndufb9 XM_216929 CGAGTGCTACAAGGTTCCAGAATG TGCGGTGCCTGTCTCTATGTG 273 
Nup37 XM_216872 ATCACTCGGTCCAGTTATCCTCAAG AGCTTATGGTCTCCTCCAACTGC 248 
Pla2g2a NM_031598 TTCTGACCTACAAGTTCTCCTACCG TCAGCAACTGGGCGTCTTCC 191 
Plekha6 XM_341118 TCAATAAGGAGCTATCCACTCCAGAC GCACAGGAGATTTCAATCCGCTTC 250 
Psma31 BN000326 AAGCTGCAAAGACAGAAATAGAAAAGC TTGTCGTCATCTGATTCATCTTCTTCC 250 
Rbp7 XM_575960 CTGGGAGAACGACAAACTCACTTG CCAATATAAGGCTCTTTATCAACCCAAAAC 250 
Mrps16 XM_001064095 CACTACCTAACAGTCATGGAGAAAAGC CACTGAAGTCAGCTTGCTTCTGTC 250 
Sdhb XM_216558 AGGCTTATCGCTGGATGATCGAC GAAGGGACTCACGCCAGAGC 250 
Tff3 NM_013042 CACATCAGAGCAGTGTAACAACCG GCTGACTGTAAGGTCTTTATTCTTCTGG 250 
Timm8b NM_022541 TGGTGAAGCGGACGAAGCG ATGGCAAGAGTAGTGTCAATGAATCG 198 
Uqcrb XM_001074024 TGAGAGATGATACAATACCTGAAACTGAAG TCTCCTTTCTTTCCCAAATAACCTCTTTC 216 
 
 
Supplemental table 6.2 The effect of FOS on the expression of potential barrier associated genes.  
Gene name Gene name* Sequence ID 
Fold 
change† p-value 
Tight junctions     
claudin 2  Cldn2 XM_236535 1.0 0.519 
claudin 4 Cldn4 XM_222088 1.0 0.823 
claudin 23 Cldn23 XM_224915 1.2 0.001 
Occludin Ocln NM_031329 1.0 0.960 
cadherin 1 Cdh1 NM_031334 1.0 0.626 
cadherin 5  Cdh5 XM_226213 1.0 0.924 
beta catenin-like 1 Ctnlb1 CB546891 1.0 0.575 
desmocollin 2 Dsc2 XM_226120 -1.2 0.271 
junctional adhesion molecule 3 Jam3 NM_001004269 1.0 0.955 
tight junction protein 1  Tjp1 XM_218747 -1.3 0.014 
Apoptosis     
apoptosis antagonizing transcription factor Aatf NM_053720 1.1 0.001 
apoptosis related protein p18 protein  Apr3 XM_216650 1.3 0.001 
apoptotic peptidase activating factor 1 Apaf1 NM_023979 1.0 0.637 
BAX protein, cytoplasmic isoform delta Bax AF235993 1.3 <0.001 
B-cell CLL/lymphoma 10 Bcl10 NM_031328 1.0 0.969 
B-cell leukemia/lymphoma 2 Bcl2 NM_016993 1.1 0.047 
BCL2/adenovirus E1B 19kDa-interacting protein 1 Bnip1 NM_080897 1.2 0.001 
BCL2-antagonist/killer 1 Bak1 NM_053812 1.5 <0.001 
Bcl2-associated athanogene 1  Bag1 XM_216377 1.2 0.010 
bcl2-associated death promoter Bad NM_022698 1.2 0.012 
Bcl2-interacting killer Biklk NM_053704 1.1 0.299 
Bcl2-like 1 Bcl2l1 AW142029 1.0 0.948 
Bcl-2-related ovarian killer protein Bok NM_017312 1.1 0.315 
BH3 interacting domain death agonist Bid NM_022684 1.0 0.793 
caspase 2 Casp2 NM_022522 -1.1 0.269 
caspase 3, apoptosis related cysteine protease Casp3 NM_012922 1.2 0.032 
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caspase 7 Casp7 NM_022260 1.2 0.001 
catalase Cat NM_012520 1.3 0.014 
CDC42 effector protein (Rho GTPase binding) 5  Cdc42ep5 XM_341784 1.2 0.016 
CDC42 small effector 1 Cdc42se1 AW920756 1.2 0.001 
cell division cycle 42 homolog (S. cerevisiae) Cdc42 NM_171994 1.3 0.006 
cell division cycle and apoptosis regulator 1   Ccar1 XM_342143 1.2 0.001 
deoxyribonuclease I Dnase1 NM_013097 2.3 <0.001 
programmed cell death 6   Pdcd6 XM_217732 1.2 <0.001 
programmed cell death 8 Pdcd8 NM_031356 1.3 0.001 
PYD and CARD domain containing Pycard NM_172322 1.6 <0.001 
STEAP family member 3 Steap3 NM_133314 1.4 <0.001 
TatD DNase domain containing 1  Tatdn1 XM_228158 1.3 <0.001 
transmembrane BAX inhibitor motif containing 4 Tmbim4 NM_199116 1.2 0.001 
v-crk sarcoma virus CT10 oncogene homolog (avian) Crk BG671506 1.1 0.013 
Mucosal defense     
mucin 2 Muc2 U07615 -1.2 0.381 
mucin 3 Muc3 U76551 1.1 0.519 
gastric mucin  Muc XM_344685 1.7 <0.001 
defensin NP-4 precursor Np4 NM_173299 -1.4 0.026 
defensin related cryptdin 4 Rd5 XM_214386 -1.1 0.730 
defensin, alpha 5, Paneth cell-specific Defa NM_173329 -1.1 0.090 
lipocalin 2 Lcn2 NM_130741 1.0 0.635 
phospholipase A2, group IIA (platelets, synovial fluid) Pla2g2a NM_031598 3.7 <0.001 
matrix metallopeptidase 7 Mmp7 NM_012864 -1.1 0.111 
lipopolysaccharide binding protein Lbp NM_017208 1.7 0.018 
cathelicidin antimicrobial peptide CRAMP CA509601 1.1 0.173 
S100 calcium binding protein A8 (calgranulin A) S100a8 NM_053822 1.3 0.091 
S100 calcium binding protein A9 (calgranulin B) S100a9 NM_053587 1.4 0.003 
toll-like receptor 1  Tlr1 XM_223421 1.5 <0.001 
toll-like receptor 2 Tlr2 NM_198769 1.1 0.294 
toll-like receptor 3 Tlr3 NM_198791 1.1 0.489 
toll-like receptor 4 Tlr4 NM_019178 -1.1 0.150 
toll-like receptor 5 Tlr5 XM_223016 1.1 0.588 
toll-like receptor 9 Tlr9 NM_198131 1.0 0.732 
trefoil factor 1 Tff1 NM_057129 1.6 <0.001 
trefoil factor 3 Tff3 NM_013042 1.7 <0.001 
beta-2 microglobulin B2m NM_012512 1.4 <0.001 
MHC class II region expressed gene KE2 Ke2 NM_212506 1.4 <0.001 
matrix metallopeptidase 7 Mmp7 NM_012864 -1.1 0.111 
lipopolysaccharide binding protein Lbp NM_017208 1.7 0.018 
immunoglobulin joining chain Igj XM_341195 1.2 0.422 
CD79A antigen (immunoglobulin-associated alpha) Iga XM_001077003     1.0 0.987 
lectin, mannose-binding 2  Lman2 XM_214428 1.3 0.001 
* Genes significantly regulated by FOS are shown in bold gene symbols.  
† Ratio FOS diet/ Control diet. 
 
 
Supplemental table 6.3 Functional classification of FOS affected genes by Metacore. 
 Number of genes  
  Process* Selection Total   p-value§
Generation of precursor metabolites and energy 1 53 323 2.3E-17 
Translation: Translation in mitochondria 2 31 187 6.7E-13 
Mitochondrial electron transport, NADH to ubiquinone 1 11 30 2.6E-08 
Protein targeting to mitochondrion 1 10 25 4.3E-08 
Mitochondrial transport 1 12 41 1.1E-07 
Electron transport 1 19 108 1.9E-07 
Supplemental data 
1Oxidative phosphorylation 13 52 2.5E-07 
1ATP synthesis coupled electron transport 11 37 3.1E-07 
2Proteolysis: Ubiquitin-proteasomal proteolysis 21 167 6.1E-07 
2Response to hypoxia and oxidative stress 13 93 2.9E-05 
Coenzyme metabolic process 1 14 91 3.8E-05 
Regulation of carbohydrate metabolic process 1 6 17 5.7E-05 
1Protein thiol-disulfide exchange 3 3 8.4E-05 
2Immune: antigen presentation 19 196 9.1E-05 
Carbohydrate metabolic process 1 30 328 1.1E-04 
Muscle filament sliding 1 4 8 2.2E-04 
1Energy derivation by oxidation of organic compounds 16 133 2.3E-04 
1Cytoskeleton-dependent intracellular transport 11 73 3.1E-04 
Cofactor metabolic process 1 15 125 3.6E-04 
1Response to copper ion 4 9 3.9E-04 
1Response to inorganic substance 7 34 5.7E-04 
Main pathways of carbohydrate metabolic process 1 10 68 7.1E-04 
1Nucleosome assembly 7 36 8.3E-04 
1 * Biological processes based on Metacore GO-analysis or 2Metacore GeneGo-analysis. 
† The number of genes affected by FOS (selection) and the total number of genes present in the process are given (total). 
§ Metacore derived p-value. 
Processes containing >500 genes were excluded from the analysis, as these processes represent uninformative broad classes 
such as “biological function”.  
 
Supplemental table 6.4 Genesets enriched in FOS versus control dataset according to GSEA analysis. 
Process * N ES NES q-value† 
1Oxidative phosphorylation 25 0.65 1.96 0.07 
Propanoate metabolism1 24 0.62 1.92 0.10 
1Proteasome 16 0.82 1.83 0.16 
2Free Radical Induced Apoptosis 8 0.72 1.80 0.19 
Butanoate metabolism1 20 0.66 1.79 0.19 
Programmed cell death3 10 0.68 1.77 0.20 
1Valine, leucine and isoleucine degradation 27 0.62 1.75 0.23 
1Krebs TCA cycle 22 0.63 1.74 0.25 
Proteasome pathway2 17 0.77 1.73 0.25 
1 2 3* Biological processes based on GenMapp, Biocart and SigmaAldrich.  
† q-value>0.25 was used as cut-off as advised by GSEA. 
N, Number of genes in the geneset.  
ES, enrichment score for the gene set. 
NES, normalized enrichment score.  
q-values, FDR derived q-values.  
 
Supplemental table 6.5 Complete dataset of FOS affected colonic genes is available at www.foodbioactives.nl. 
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Alle mensen die een bijdrage hebben geleverd aan het totstandkomen van mijn proefschrift: Heel 
erg bedankt. Een aantal mensen wil ik speciaal bedanken. 
 
Jaap, Ingeborg, Roelof  en Martijn, bedankt voor de goede samenwerking binnen dit project.  
Vier “leermeesters” met ieder een eigen kijk op de zaak leerde mij dat een onderzoek van veel 
kanten benaderd kan worden, maar vooral leerde het me een eigen kijk op de zaak te vormen. 
Jaap, ondanks je drukke agenda stond je deur altijd open en wist je m’n stukken in rap tempo te 
corrigeren. Geweldig hoe jij uit de wirwar van genexpressie data altijd weer een duidelijk 
schemaatje weet te toveren. Naast je gedrevenheid voor het onderzoek bewonder ik je aandacht 
voor de onderzoeker. Door jouw inzicht in persoonlijke zaken, en het besef  dat ook dat 
belangrijk is voor succesvol onderzoek, heb ik de afgelopen vier jaar veel over mijzelf  geleerd.  
Ingeborg, we hadden steeds vaker overleg op afstand. Gelukkig is de afstand Ede-Wageningen 
klein, en zo voelde het ook. Door je scherpe focus zag jij de gaten in m’n redeneringen en gaf  me 
altijd goede suggesties waar ik weer mee vooruit kon. Jouw grondige beoordeling van 
manuscripten leverde mooie track change-manuscripten op, ik zal je “mooie zinnen” erg gaan 
missen!  
Roelof, officieel sta je niet in het lijstje begeleiders, maar de praktijk was anders. Jouw kritische 
vragen leverde interessante en leerzame discussies op. Jouw grenzeloze kennis over de darm 
waren belangrijk voor de vertaalslag van genenlijsten naar relevante processen in de darm. 
Martijn, van een afstand bewaakte je de voortgang van het project. Je scherpzinnige opmerkingen 
en vragen zetten mij altijd goed aan het denken. Je stuurde het project, en mij, de goede kant op, 
bedankt! 
 
Evelien, jouw bijdrage aan dit project was onmisbaar! Je zou “stand in” kunnen zijn tijdens m’n 
promotie. We klikken erg goed op aanpak van proeven maar ook op persoonlijk vlak kan ik met 
jou altijd even bijkletsen. Zullen we maar gewoon de rest van onze carrière een duobaan nemen? 
Carolien, jouw nuchterheid tijdens het stressvolle spotten van de arrays, drukke dierproeven of  
moeizame schrijfmomenten was heel welkom, de expressie van m’n stress-genen schoot omlaag! 
Annelies, je zat officieel niet in m’n project, maar door je grote betrokkenheid leek dat wel zo. Je 
hebt waarschijnlijk ook als één van de weinigen m’n proefschrift zo grondig gelezen! Bedankt 
voor alle hulp en humor op het lab! Susan, door jou werd hoofdstuk 3 een feit. Naast je 
wetenschappelijke bijdrage was het vooral ook erg gezellig om met jou samen te werken!  
 
Ik heb met veel plezier op het RIKILT gewerkt. Vooral de tijd op kamer 1.53 was super; die 
kamer blijft toch het centrum van gezelligheid! Ik zou met de belevenissen en verhalen van de 
afgelopen vier jaar met gemak een boek kunnen vullen (sorry één boek dit jaar is toch even 
genoeg)! Naast de vele tijdelijke gasten was er altijd een harde “blij dat je blijft” kern. Evelien en 
Annelies, ik had de zakdoekjes bijna echt nodig toen ik met m’n kar naar boven vertrok. 
Marjolein, Susan en Melissa bedankt voor de ontelbaar vele gezellige koffie-momenten, en voor 
een luisterend oor na succesvolle resultaten, maar vooral ook bij dipjes.  
Vincent, Evert, Nicole, Ping, Jeroen, Hakan en Marjoke voor iedere data analyse vraag wist ik 
jullie te vinden. Hakan, ook al kende ik alle schroefjes van de scanner steeds beter, scannen 
zonder jou in de buurt durfde ik bijna niet meer aan, dank je voor je vele reddingen!  
Alle Food Bioactives collega’s en andere Moleculaire Biologie collega’s van het RIKILT, bedankt 
voor alle discussies, hulp en adviezen, maar vooral ook de goede sfeer, gezellige koffie pauzes en 
niet te vergeten de succesvolle deelnames aan de WE-day zeskamp. Jan en Ruud bedankt voor 
alle computer ondersteuning. 
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De collega’s van de Health & Safety groep van het NIZO wil ik bedanken voor alle actieve 
literatuur en werkbesprekingen. Deze besprekingen waren heel belangrijk voor m’n “gut- feeling” 
over voeding en de darm. Sandra en Mischa jullie gaven het stokje met veel hulp aan mij door, 
bedankt! Nizo-Aio’s Gabriele, Marleen en Marloes, wanneer gaan we een volgend restaurant in 
Utrecht uittesten? Denise, Hans, Corinne, Carolien, Arjan, Johan en Fanny bedankt voor hulp, 
gezellige koffie pauzes en discussies.  
 
Wilma, Judith, Pam en andere CKP-ers bedankt voor de verzorging van de vele ratten wat tijdens 
een Salmonella-FOS proef  niet altijd een pretje was. Door jullie liepen de proeven en de secties 
altijd gesmeerd. 
 
Collega’s van TI Food and Nutrition programma 1, bedankt voor de kennismaking met het 
onderzoek in de humane voeding tijdens de donderdag ochtend bijeenkomsten. Het was leerzaam 
en leuk om in zo’n multidisciplinaire omgeving m’n onderzoek te presenteren en te 
bediscussiëren. Rianne, Hannie en andere TIFN-medewerkers bedankt voor alle hulp.  
De AiO’s van Humane voeding leerde ik in Australië goed kennen, deze geweldige ervaring was 
een goede basis om niet als vreemde op de vakgroep rond te lopen. Jan, ook al kwam de 
onderwijs begeleiding me tijd-technisch nooit goed uit, de practicum middagen vond ik een leuke 
onderbreking van m’n onderzoek. Geert, bedankt voor de goede samenwerking op de vele 
werkplekken die we hadden! Of  het nu RIKILT, RIVM, Universiteit Maastricht of  de WUR was, 
we vonden altijd wel een computer om aan te werken! Heleen, onze gezamenlijke eindsprint en 
de promotie-hotline gaven me een rustig gevoel; we zouden toch zeker niet beide iets heel 
belangrijks vergeten?  
 
Naast alle collega’s wil ik ook vrienden en familie bedanken. Zonder de broodnodige sportieve en 
sociale uitspattingen zat ik hier niet zo ontspannen dit dankwoord te typen. Bedankt voor al jullie 
interesse en aanmoediging, het evenwicht was even kwijt de afgelopen maanden, maar dat ga ik 
zo snel mogelijk weer herstellen.  
Ineke, na een heerlijk weekendje Herkenbosch kon ik er altijd weer even tegenaan!  
Pap bedankt voor je enthousiasme en interesse in m’n werk, en mam toch een beetje in je 
voetsporen getreden! Vanaf  nu geen zorgen meer over promotie-stress, ook voor jullie een 
opluchting! 
Joost, deze ereplaats is voor jou, de eindsprint was niet mogelijk geweest zonder zo’n geweldige 
thuisbasis, bedankt voor je onvoorwaardelijke steun de afgelopen jaren.  
 
Bedankt! 
Wendy 
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